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Abstract 
Background: Investigating the manner in which genetic and environmental factors 
interact to increase susceptibility to iron deficiency, has the potential to impact on 
strategies to overcome iron deficiency as well as the development of biomarkers to 
monitor iron status in populations. Single nucleotide polymorphisms or genetic variants 
that may affect the composition and hence the functionality of proteins involved in iron 
metabolism have been the subject of recent genetic association studies. However, these 
investigations have not yet been carried out in African populations that differ genetically 
from populations of European ancestry and which bear the highest burden of iron 
deficiency. The overall aim of this thesis was to investigate the genetics of iron status in 
African populations using a candidate gene approach. 
Methods: In order to evaluate the association between identified TMPRSS6 gene 
variants and iron status we conducted a systematic review with meta-analyses. We 
primarily searched the literature using the HuGE Navigator, Pubmed and Scopus 
databases for primarily genome wide association studies. Fixed effects meta-analysis 
was used to obtain summary estimates. Associations between reported variants and iron 
status as well as gene-gene and variant interactions that influence iron status were 
investigated in a female black South African cohort (n=686; range 32–86 years) which 
were part of the Prospective Urban and Rural Epidemiology (PURE) study. 
Concentrations of haemoglobin, serum ferritin, serum transferrin receptor and body iron 
stores were determined. Thirty SNPs were genotyped and passed all quality criteria. To 
investigate whether previously identified associations in populations of European 
ancestry are replicated in populations of African ancestry, we conducted candidate gene 
association studies. Twenty iron status-associated variants in 628 Kenyans, 609 
Tanzanians, 608 South Africans and 228 African Americans were genotyped and 
associations investigated using haemoglobin and serum ferritin as outcome measures. 
Finally, we assessed the effect of TNF-α allele variants (TNF‒1031, TNF‒308) on malaria 
rates, the severity of malaria as indicated by haemoglobin concentrations at the time of 
presentation with febrile episodes and the association between Plasmodium infection 
and haemoglobin concentration in symptomless parasite carriers. We used data from a 
placebo-controlled trial which consisted of  612 Tanzanian children aged 6–60 months. 
Cox regression models were used in the primary analysis to account for multiple 
episodes per child. 
  
 
Results: In our systematic review we included eleven studies on Caucasian populations, 
four on Asian populations and one study on an African-American population. Differences 
in minor allele frequencies (MAF) of 8 TMPRSS6 SNPs (rs855791, rs4820268, 
rs2111833, rs1421312, rs228921, rs228918, rs228919 and rs575620) across ethnic groups 
were observed; with the MAF of rs855791 being significantly higher in Asian populations 
than in Caucasians (0.55 vs 0.42). In the meta-analysis, the A allele of rs855791 was 
associated with lower haemoglobin and ferritin concentrations in all populations. This 
allele was also associated with increased serum transferrin receptor and transferrin 
concentrations. We observed similar associations for the G allele in rs4820268. In 
general, minor allele frequencies (MAF) from females in the PURE population were 
lower compared to those of males and females of European ancestry populations in the 
1000 Genomes Project. In the TF gene, the SNP rs1799852 was associated with 
decreased serum ferritin (p=0.01) and body iron concentrations (p=0.03) and increased 
serum transferrin receptor (sTfR) concentrations (P=0.004), while rs3811647 was 
associated with transferrin receptor and body iron (both P=0.03) in a U-shaped manner. 
The chromosome 6 SNP allele combination (AAA) consisting of rs1799964 and rs1800629 
both in TNF α and rs2071592 in NFKBIL1 was associated with higher odds for low 
serum ferritin concentrations (serum ferritin<15µg/L; OR:1.86 (95%-CI, 1.23-2.79)). The 
chromosome 22 SNP allele combination (GG) consisting of rs228918 and rs228921 in the 
TMPRSS6 gene was associated with lower odds for increased sTfR concentrations 
(sTfR>8.3mg/L; OR:0.79 (95%-CI,0.63-0.98). We successfully replicated reported 
significant associations with lowered haemoglobin concentrations for two loci in 
TMPRSS6 namely rs2413450 and rs4820268 and with increased haemoglobin 
concentrations for one locus in TF (rs3811658) when analysing the four populations of 
African ancestry. When ferritin was considered as an outcome measure, we replicated 
associations with increased ferritin concentrations in two loci namely, rs228918 in 
TMPRSS6 and rs1525892 in TF. No other significant associations were determined. 
Malaria rates were higher in Tanzanian children with the TNF‒1031CC genotype 
(rs1799964) compared to the AA genotype (crude hazard ratio (HR), 95%CI: 1.41 
[1.01‒1.97], adjusted HR 1.31 [0.97‒1.76]y) but were lower in those with the TNF‒308AA 
genotype (rs1800629) (adjusted HR 0.13 [0.02‒0.63]) compared to those harbouring the 
wild type homozygous genotype.  
Conclusions: This thesis demonstrates previously observed associations between 
TMPRSS6 gene variants and haemoglobin concentrations in European ancestry 
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populations are replicated in African populations. Replication of results in other loci 
previously associated with iron status in European ancestry populations was not 
achieved. Additionally, minor allele frequencies of single nucleotide polymorphisms 
associated with iron status are generally higher in European ancestry cohorts compared 
to those of African ancestry populations. The lack of association of reported variants may 
indicate that novel loci are responsible for the heritability of iron status in African 
populations. We have additionally observed that TNF α variants increase malaria 
severity. Malaria is a major cause of iron deficiency in malaria endemic areas. Our 
finding emphasizes that to alleviate iron deficiency in malaria endemic areas prevention 
and treatment of malaria is necessary. This thesis highlights the need to conduct genetic 
association studies in African populations where iron deficiency is of utmost public 
health significance. In addition, investigations into the genetics of iron status are bound 
to contribute towards the development of biomarkers that are useful in the 
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Background 
Anaemia has been associated with increased mortality and morbidity as well as with 
decreased physical functioning and quality of life [1, 2]. The causes of anaemia are 
multifactorial, intertwined, and context-specific. Important known risk factors for 
anaemia include micronutrient deficiencies (e.g. iron, vitamin A, folate, vitamin B-12), 
infections (e.g. intestinal parasites, schistosomiasis, malaria, human immunodeficiency 
virus [HIV]), and inherited red blood cell disorders (e.g. sickle cell, α-thalassemia) [3]. On 
average, globally, 50% of anaemia is assumed to be attributable to iron deficiency [4-6]. 
It is known that low iron intake and low bioavailability of dietary iron are crucial in the 
development of iron deficiency [7]. In developing countries, haem iron which is highly 
bioavailable, is often consumed in small amounts as most of the iron is from plant 
sources (non-haem iron). Non-haem iron is poorly absorbed as the diets rich in this form 
of iron are often also high in constituents that impair iron absorption [8]. After digestion, 
the efficiency of iron absorption is determined by several factors to ensure sufficient iron 
is available for physiological functions while avoiding the accumulation of excessive iron. 
These factors include the presence of dietary components with various iron-binding 
strengths and iron-reducing properties, the iron status of the individual and heritable 
factors [9]. In terms of heritable factors, single nucleotide polymorphisms/mutations in 
the genes encoding proteins involved in iron uptake, absorption and transport may 
influence eventual iron status. This is because these mutations affect the functions and 
the quantities of proteins they encode [10]. 
It is well established that genetics plays a significant role in iron overload but much less 
is reported about the genetic basis of iron deficiency. Of even greater interest is the 
manner in which genetic factors interact with factors such as diet to increase 
susceptibility to iron deficiency. Understanding the genetics of iron status is key to 
optimizing strategies to address iron deficiency as well as discovering appropriate 
biomarkers to monitor iron status in populations. Rare genetic mutations and knock-out 
animal models have been invaluable tools for elucidating the molecular events 
controlling iron metabolism [11, 12]. Particularly, the recent progress in genome-wide 
association (GWA) studies has led to the identification of many loci that are associated 
with iron deficiency/lowered iron status, anaemia, or both [13-19]. These findings 
highlight the pivotal role of the genes in influencing iron metabolism and thus affecting 
iron status. However, genetic association studies have mainly concentrated on 
populations of European ancestry. Little has been reported about the presence and 
General Introduction 
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actions of these gene variants in the genetically diverse African populations that carry 
the highest burden of iron deficiency.  
 
Prevalence of iron deficiency in African populations in context: Is genetics a 
potential player? 
 
Various studies have observed a geographical disparity in iron status leading to the 
hypothesis that dissimilarities in genetic alterations across ethnicities may indeed 
contribute to differences in iron status. Globally, in preschool-age children, anaemia 
prevalence is 47.4%, affecting 293 million children. The highest prevalence is in Africa 
(67.6%) and South-East Asia (65.5%) as indicated in Figure 1. In addition, 468.4 million 
non-pregnant women are anaemic (30.2% prevalence globally) with the highest 
prevalence in Africa at 47.5% [4, 5]. The genetic determinants of iron metabolism have 
not been well studied in black Africans, except for haemoglobinopathies such as 
thalassemia and sickle-cell anaemia. Further studies are thus required in these 
populations to ascertain associations of previously reported single nucleotide 
polymorphisms to various iron status measures. 
Understanding the genetics of iron deficiency is crucial due to its consequences. 
Specifically, it affects more people than any other condition, constituting a major public 
health problem. Iron deficiency anaemia (IDA) has substantial health and economic costs 
[7] and adversely affects immune status [20, 21], pregnancy outcomes [20] and children’s 
cognitive development [21, 22]. In order to appreciate the potential role of genetic 
mutations/variants in the iron regulatory system, it is necessary to first present a 
general description of iron metabolism. Regulation of iron uptake, absorption and 
transport is the primary determinant of iron balance as there is no physiological 
mechanism for iron excretion [10, 23]. Homeostatic mechanisms regulating the 
absorption, transport, storage and mobilization of cellular iron are therefore of critical 
importance. 
Iron absorption  
Iron absorption occurs predominantly on the apical surface of the duodenum and upper 
jejunum. Dietary iron changes are sensed by the liver [24] which sends signals to the 
villus enterocytes, where there is a rapid up regulation of iron transporters. The two 
forms of dietary iron, haem and non-haem iron, are absorbed by enterocytes non-
Chapter 1 
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competitively. Haem iron is not chelated by common dietary inhibitors of non-haem iron 
absorption, and therefore is much more readily absorbed compared to non-haem iron. 
Haem iron transporter (HCP1) is responsible for haem transport across the apical 
membrane and it is up regulated by hypoxia and iron deficiency [25]. Once haem iron 
enters the cells, it is released from the protoporphyrin ring by haem oxygenase to release 
the iron II (ferrous) ions (Fe2+) where after it becomes part of the common iron pool. 
Non-haem iron which exists in the iron III (ferric) ionic (Fe3+) state is reduced to ferrous 
iron before it is transported across the intestinal epithelium. This is accomplished by 
dietary components such as ascorbic acid, and the enzyme termed duodenal cytochrome 
b reductase (Dcytb) which is highly expressed in the brush border of enterocytes [26]. 
Once the insoluble Fe3+ is converted to Fe2+, it enters the mucosal phase. The reduced 
Fe3+ is transported across the apical membrane into the cells through a divalent metal 
transporter (DMT1). DMT1 is expressed at the duodenal brush border where it controls 
uptake of dietary iron. The Fe2+ inside the cells can either be stored as ferritin or 
transported across the basolateral surface into the bloodstream. The iron inside the cell 
is exported out of the cell by a transport protein called ferroportin (FPN). Hephaestin, a 
multicopper ferroxidase, works in concert with FPN in the export of iron from the 
enterocytes [27, 28]. It oxidizes Fe2+ to Fe3+ which enables it to be taken up by 
transferrin (TF). 
  
Transport, uptake and storage of iron 
 
Transferrin (TF) receives and binds iron for delivery to the transferrin receptors of the 
recipient cells, after which apotransferrin is returned to the plasma to again function as 
an iron transporter [29]. Transferrin receptor 1 (TfR1) mediates the uptake of TF-bound 
iron and remains a major regulatory site for iron homeostasis [30, 31]. When iron-loaded 
TF attaches to TfR1, this interaction triggers the formation of intracellular TF-TfR1 
containing endosomes. The proton pumps present in the endosomal membrane pump 
hydrogen (H+) ions into the endosome from the cytoplasm, which induces a 
conformational change of the TF and its receptor resulting in the release of iron. The 
released Fe3+ is converted to Fe2+ by six-transmembrane epithelial antigen of the 
prostate (STEAP) family member 3 (STEAP3), which is a metalloreductase present in 
the endosomes. The Fe2+ is then transported out of the endosomes by DMT1. Human TfR 
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shedding is caused by an integral membrane metalloprotease, releasing soluble TfR 
(sTfR) into the plasma [32, 33]. This process is controlled by TF, and the level of sTfR is 
an indicator of available functional iron, independent of the iron stores [34]. Thus, the 
higher the sTfR concentration, the lower the levels of functional iron. Protein bound 
forms of iron such as isoferritin and haemoglobin can also be taken up by the cells [35]. 
Haemoglobin released by intravascular haemolysis is bound by haptoglobin and then 





Iron is conserved and recycled within the body (20–25 mg/day), mainly for the purpose of 
red blood cell formation. However, there is an obligatory loss of approximately 1-2 mg of 
iron originating from the daily loss of blood (menstrual and other sources of bleeding), 
sweat, intestinal cells, skin and hair. The lost iron needs to be replenished with dietary 
iron. Hepcidin is involved in the systemic regulation of iron absorption. Once hepcidin is 
produced, it directly binds to ferroportin causing it to be internalized and degraded, 
thereby blocking cellular iron export [37]. When iron stores are adequate or high, the 
liver produces hepcidin which reduces iron efflux from duodenal cells and macrophages. 
In understanding the molecular events leading up to the production of hepcidin, variants 
within transmembrane protease, serine 6 (TMPRSS6 ) which encodes matriptase-2, are 
currently of great interest. The exact mechanism through which TMPRSS6 action is 
exerted is still under investigation. It has generally been hypothesised that TMPRSS6 
polymorphisms affect hepcidin transcription, thereby altering hepcidin concentrations in 
response to systemic iron concentrations [1, 38-40]. However, two recent studies [41, 42] 
did not confirm an intermediate role for hepcidin in the SNP-iron status parameters 
associations. These studies instead indicate pleiotropic SNP effects on hepcidin and iron 
status parameters.  
Chapter 1 




Figure 1: Prevalence of iron deficiency is based on the percentage of children 6–59 months of age with haemoglobin below 110g/L  
Note: Public health significance is classified as none (<5.0%), mild (≥5.0%–<20.0%), moderate (≥20.0%–<40.0%), or severe (≥40.0%). 
Source: Worldwide Prevalence of Anaemia 1993–2005: WHO Global Database of Anaemia World Health Organization, World Health 
Organization, 2008.http://www.who.int/vmnis/anaemia/en/) 
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Iron homeostasis and genetic variations 
 
Over the past decade, heritable, overtly pathological iron deficiencies and iron overload 
syndromes have been accredited to mutations in several key genes that regulate iron 
homeostasis [43, 44]. Insight into the rare monogenic causes of iron deficiency and iron 
overload in humans is useful in identifying candidate genes that may harbour genetic 
variation that could influence iron status. From a public health perspective, the 
existence of common mutations or single nucleotide polymorphisms that lower iron 
status in African populations is of interest, given the high prevalence of iron deficiency. 
This is because these polymorphisms might heighten susceptibility to poor iron status 
especially in environments of low bioavailable iron diets.  
Evidence for genetic influences on iron status in humans can be obtained from the 
classical twin design in which the resemblance of genetically identical monozygotic (MZ) 
twins is compared to the resemblance of dizygotic (DZ) twins for a specific trait of 
interest e.g. iron status. Comparing the resemblance of MZ twins for a trait or disease 
with the resemblance of DZ twins offers the first estimate of the extent to which genetic 
variation determines phenotypic variation of the trait [45]. 
Two twin studies have been conducted to investigate the genetics of iron status. One 
twin study demonstrated that the heritability of serum ferritin (SF) and soluble 
transferrin receptor was 44% and 54%, respectively [10]. Another study observed that 
after correction for age and body-mass index, 23% and 31% of the variance in serum iron, 
66% and 49% of the variance in transferrin, 33% and 47% of the variance in transferrin 
saturation, and 47% and 47% of the variance in ferritin could be explained by additive 
genetic factors for men and women respectively [46]. Heritability estimates for iron 
status of 20%–30% have also been calculated from other population studies [46-49] and 
this further suggests a substantial genetic contribution to iron regulation. 
Recently, GWA studies have observed associations between the presence of single 
nucleotide polymorphisms and iron status biomarkers. Specifically, GWA studies have 
consistently highlighted the significance of matriptase-2 in the control of iron 
homeostasis by identifying common TMPRSS6 variants associated with abnormal 
haematological parameters, including haemoglobin, transferrin saturation, erythrocyte 
mean cell volume (MCV) and serum iron concentrations [13, 14, 16]. Genetic variants or 
SNPs present in the transferrin (TF), hemochromatosis (HFE) and transferrin receptor 2 
(TFR2) genes have also been associated with iron status measures in population-based 
Chapter 1 
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studies [15, 17, 50-53]. These associations have however not yet been demonstrated in 
African populations. Additionally, with a few exceptions, GWA studies have been centred 
on populations of European descent which contain only a subset of human genetic 
variation. Since populations may vary in terms of allele frequencies and biological 
adaptations, it is necessary to investigate the genetics of iron deficiency in non-European 
populations and to establish the generality of findings obtained initially in Europeans 
and European-Americans. Furthermore, the high levels of genetic diversity in African 
populations [54] and their demographic history make these populations particularly 
informative for the investigation of the genetics of iron deficiency.  
Identifying common genetic variants influencing iron status in African populations may 
further offer insights into variants that may also modify the severity of malaria. 
Anaemia due to malaria is a major public health problem [55] (especially in African 
children) that remains a challenge to treat. The key to understanding the 
pathophysiology of iron metabolism in malaria is the activity of the iron regulatory 
hormone hepcidin. Hepcidin gene expression is up regulated by (among other factors) 
inflammatory cytokines such as TNF α [56]. Single nucleotide polymorphisms in the 
TNF α locus have been identified as potential risk factors in the aetiology of malaria [57]. 
Investigating the regulation of hepcidin by inflammatory cytokines may offer 
opportunities to formulate better approaches to address anaemia in malaria endemic 
areas. 
Studies on the genetics of iron status in African populations may raise several questions. 
In particular, will the same results observed in Europeans be detected in African 
populations? Will causal variants have similar allele frequencies and iron deficiency risk 
in African populations? How will these causal variants influence iron status and the 
resulting disease severity?  
Expansion of studies on the genetics of iron status in African populations is thus 
important for the ultimate goal of characterizing risk variants beyond what can be 
determined from populations of European descent alone. This information will further be 
useful in informing strategies to address iron deficiency. 
 
General Introduction 
19 | P a g e  
 
Rationale, research questions  
Despite the success of recent GWA studies, there remains a lack of research on the 
prevalence of genetic factors and their effects on iron metabolism in African populations. 
As the overview makes clear, the single nucleotide polymorphisms associated with iron 
status in African populations are not fully understood. The unearthing of these genetic 
factors is especially important in understanding the heterogeneity of response to 
interventions designed to address iron deficiency. In general this project was aimed at 
harnessing the potential of genetics to address iron deficiency in African populations. 
However, prior to utilizing this potential, specific fundamental questions with regard to 
the genetics of iron status in African populations need to be answered.  
The primary research question was therefore:  
Do the single nucleotide polymorphisms previously identified as being associated with 
iron status in non-African populations present with similar associations in African 
populations?  
The secondary research questions were:  
1. Are the minor allele frequencies of single nucleotide polymorphisms associated 
with iron status in African populations similar to those of non-African populations? 
2. How do the single nucleotide polymorphisms associated with iron status influence 
disease severity in the African population? 
 
Outline of this thesis 
 
Based on the above rationale, the studies undertaken in this thesis are focussed on the 
genetics of iron status in African populations. In Chapter 2, a detailed systematic review 
with meta analyses on the inter-ethnic differences in single nucleotide polymorphisms 
within TMPRSS6  that are associated with iron status indicators is presented. In 
particular we focused on the magnitude of effect sizes, direction of associations and 
minor allele frequency differences across study populations. In the study designed in 
Chapter 3, we aimed to explore common variants and gene-gene interactions associated 
with iron status in a female black South African population using the candidate gene 
approach. In Chapter 4, the influence of single nucleotide polymorphisms involved in the 
inflammatory response on iron status and effects on eventual malaria severity were 
Chapter 1 
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explored using a population-based genetic approach. In Chapter 5, we explored the 
question of transferability and generalizability of association results previously obtained 
in European ancestry populations in several African ancestry populations. The candidate 
gene approach was used for this study. Finally in Chapter 6, we have discussed the 
findings of this thesis, methodological aspects that may have impacted on these findings 
as well as their public health relevance. Furthermore, recommendations for further 
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Background: Transmembrane protease, serine 6 (TMPRSS6 ) is likely to be involved in 
iron metabolism through its pleiotropic effect on hepcidin concentrations. Recently, 
genome-wide association studies have identified common variants in the TMPRSS6  
gene to be linked to anaemia and low iron status. To get a more precise evaluation of 
identified TMPRSS6  single nucleotide polymorphism associations with iron status in 
cohorts of differing continental ancestry, we conducted a systematic review with meta 
analyses. 
Methods: We searched the literature using HuGE Navigator, Pubmed and Scopus 
databases for primarily genome wide association studies using TMPRSS6  as a free term. 
Fixed effects meta-analysis was used to obtain summary estimates of associations. 
Results: Eleven studies comprised Caucasian populations, four included an Asian 
population and one study included an African-American population. Differences in minor 
allele frequencies (MAF) of 8 TMPRSS6 SNPs (rs855791, rs4820268, rs2111833, 
rs1421312, rs228921, rs228918, rs228919 and rs575620) across ethnic groups were 
observed; with the MAF of rs855791 significantly higher in Asian populations than in 
Caucasians (0.55 vs 0.42, P<0.0001). In the meta-analysis, the A allele of rs855791 was 
associated with lower Hb and ferritin concentrations in all populations. This allele was 
also associated with increased serum transferrin receptor and transferrin 
concentrations. We observed similar associations for the G allele in rs4820268. 
Conclusions: Clear disparities in associations were found for the African-American 
population, although not statistically significant. Associations between TMPRSS6  SNPs 
and anaemia are consistent across Caucasian and Asian populations. This study 
highlights the need to conduct studies in African populations where iron deficiency is of 
utmost public health significance.  
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 Introduction  
 
Iron deficiency has previously been hypothesized to originate entirely from dietary 
and/or other environmental factors. However, several discoveries regarding disorders of 
iron metabolism have indicated that there is a genetic contribution to the development of 
iron deficiency [1-3]. In particular, polymorphisms in the Trans Membrane Protease 
Serine 6 (TMPRSS6 ) gene have been implicated as influencing iron metabolism in both 
animal and human studies. In the mask mutant mouse, loss of the catalytic domain of 
matriptase-2 (protein produced due to TMPRSS6  expression) results in an increase in 
hepcidin expression in the liver, lowered dietary iron absorption, and severe microcytic 
anaemia [4]. Similar findings have been observed in TMPRSS6 knockout mice 
(TMPRSS6 2/2) [5] and in zebra-fish over-expressing mutant matriptase-2 [6]. 
Contrariwise, over-expression of wild-type matripatse-2 in human hepatoblastoma 
(HepG2) cells has been observed to result in suppression of hepcidin gene promoter 
activation [4]. Mutations in the TMPRSS6 gene have also been implicated in iron 
deficiency anaemia refractory to oral iron therapy within Caucasian populations [7-9]. 
Further evidence of the association of TMPRSS6  polymorphisms with iron status in 
persons not affected by overt genetic disorders of iron metabolism have been observed in 
several GWAS though not all findings are consistent across studies [10-13]. 
At the population level, various studies have observed a geographic disparity in iron 
status leading to the hypothesis that dissimilarities in genetic alterations across 
ethnicities may indeed contribute to differences in iron status [14-17]. Specifically, 
studies have shown that Asia and Africa have the highest proportion of individuals 
affected by anaemia according to the WHO regional prevalence estimates [18]. 
Furthermore, in studies conducted in the US, African-Americans appear to have lower 
haemoglobin concentrations and serum transferrin saturation (TS) as compared to 
Caucasians [19-23]. Disparities in iron status have also been observed between Mexican 
American and non-Hispanic white women of childbearing age [24]. It is not known, 
however, if these differences contain a genetic component. 
In order to shed light on the contradictory findings from GWAS and to evaluate the role 
of ethnicity as an explanatory factor, we performed a systematic review with meta-
analysis on TMPRSS6  loci identified in cohorts of differing continental ancestry.  
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Methods 
Search Strategy  
An electronic literature search was conducted using HuGE Navigator which is a 
database of published population-based epidemiological studies of human genes 
extracted and curated from PubMed since 2001. The search term ‘TMPRSS6  × [Text 
MesH]’ was used. The latest search was conducted on 31st August 2013. In addition, the 
PubMed and Scopus databases were searched to include any articles that may have been 
published on the topic prior to 2001. Searches in both databases were conducted with 




The first step in the study selection was exclusion of duplicates followed by examination 
of titles and abstracts obtained. Articles were included when they were: original research 
articles; conducted in humans; and when testing for TMPRSS6  SNP associations with 
iron status measures i.e. haemoglobin (Hb), serum or plasma ferritin (SF/PF) and/or 
serum transferrin receptor (sTfR), was undertaken. In addition, we included studies on 
associations of dichotomous outcomes (anaemia, iron deficiency, or iron deficiency 
anaemia) with TMPRSS6  SNPs. Animal, single patient studies and studies on disorders 
of iron metabolism (iron-refractory iron deficiency anaemia (IRIDA), hemojuvelin, 
hereditary hemochromatosis) were excluded. The full text of each remaining study was 
reviewed to establish eligibility, and all relevant information and data were extracted.  
 
Data Extraction 
Data extraction was conducted by one author (WGW) and repeated by two other authors 
(AMB and EJF) for 30% of the papers that met the inclusion criteria. The latter was 
done for quality control purposes. For each article, information on authors, publication 
year, sample size, ethnicity, health status of the population (e.g. type 2 diabetes type 
patients), study design, mean age, gender distribution, minor allele frequencies, 
genotyping platform, call rate, beta values, standard errors, confidence intervals, 
reported measure of variance, agreement with Hardy-Weinberg equilibrium and model 
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adjustments were extracted. In the case of GWA studies, information on the main and 
replication study was reported separately. Additionally, where several cohorts were 
included in a study, information on each cohort was reported separately. In the case that 
information provided was missing, insufficient or unclear, authors were contacted for 
further information. Any recalculation of values required prior to meta-analyses was 




Meta analyses were performed on genetic variants with information from more than two 
studies or cohorts and results ordered by ethnicity. Results were presented at the sub-
group and overall levels. The sub-groups were designated as Caucasian, Asian and 
Mixed, with Mixed implying that the study results presented were from more than one 
ethnicity.  
All data for specific iron status measures i.e. Hb, SF/PF and sTfR were transformed into 
identical units before meta-analyses. In the case where all extracted values had different 
transformations, values were back transformed to comparable units to enable 
comparison. New standard error values were obtained by calculating the ratio between 
the untransformed beta values and their standard errors and applying this ratio to the 
recalculated beta value. 
Our goal in conducting the meta analyses was to compute the common effect size for the 
identified populations, and not to generalize the findings to other populations. 
Additionally, the studies with complete information were few. For these reasons, we 
used the fixed effects model to assign study weights as well as combine summary 
statistics. We also conducted a random effect analyses to check for heterogeneity 
between studies. 
An estimate of potential publication bias was carried out by generating funnel plots. The 
symmetry of the funnel plot was assessed both visually and formally by using Egger’s 
test [25]. The chi square test was conducted to test for heterogeneity and I square values 
reported. We conducted an independent samples T test on summary estimates per SNP 
for each outcome measure to determine whether differences observed between ethnicities 
were statistically significant. 
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We found 20 articles through HuGE navigator, 84 articles through PubMed and 86 
articles through Scopus and four articles through manual search of the references. In 
total we obtained 14 articles that contained information from various cohorts (Figure 1 
and Table 1). Articles identified as eligible for meta analyses (n=14) contained complete 
information on two TMPRSS6  variants. In addition, 11 articles on MAF comparisons 
and 3 articles on 4 TMPRSS6  variants were included in the systematic review (Figure 
1). Only one study corrected for iron intake in association analyses. Additional data on 
covariates considered in association analyses in the various studies can be found in 
Table 1. The majority of the articles were based on studies conducted entirely in subjects 
of Caucasian ethnicity (n = 11; 73%). Three studies had multiple ethnicities as part of 
the cohorts investigated [11, 27, 28]. We did not find any studies conducted among 
individuals from the African population (Table 1 and 2).No publication bias was present 
in the meta analyses performed except for the association between rs855791 and 
transferrin in the Caucasian population. 
In rs855791, MAF was higher in the Asian than in Caucasian populations (0.55 vs 0.42, 
P<0.0001). The MAF of the rs2111833 SNP ranged from 0.20 in the Hispanic population 
to 0.47 in the Caucasian population, while the MAF of  rs1421312 was 0.31 in the Asian 
population and 0.47 in the Caucasian population. MAF for rs228921, rs228918, rs228919 
and rs575620 were comparable in Caucasian and Indian Asians (Table 1). 
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Health professional follow up 
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Table 1 Continued         
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Table 1 Continued         
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Table 1 Continued         
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Ethnicities with similar vowels next to them were analysed and compared in the same study 
*adjustments considered in association testing with serum ferritin 
information not available 
ln-natural log transformation 
Covariate definitions: carcinoembryonic antigen (CEA), c-reactive protein (CRP), gamma-glutamyltransferase (GGT), HFE gene 
C282Y/H63D genotype, CagA strain infection status (infected vs. non-infected) 
haemoglobin (Hb), serum iron (SI), serum ferritin (SF), plasma ferritin (PF), transferrin (TRFN), serum transferrin (sTfRN), serum transferrin 
receptor (sTfR), free erythrocyte porphyrins (FEP), total iron binding capacity (TIBC), unsaturated iron-binding capacity (UIBC), hematocrit (Hct), 
mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), mean corpuscular volume (MCV), red blood cell (RBC) 
 















































































Figure 1:Study selection 
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Table 2: Minor allele frequencies of TMPRSS6  SNPs in various populations 
SNP Cohort Ethnicity  MAF Reference 
rs855791 (A) - Han (East) 0.53 [29] 
 
- Han (North) 0.55 [29] 
 
- Zhuang 0.63 [29] 
 
- Han 0.53 [32] 
 
CHARGE+HAEMGEN Caucasian 0.39 [12] 
 
InCHIANTI + BLSA + 
WHAS I+WHAS II Caucasian 0.41 [13] 
 
Australian  
Twin families Caucasian 0.42 [10] 
 LOLLIPOP Caucasian 0.34 [11] 
 LOLLIPOP Indian Asians 0.53 [11] 
 SAPPHIR Caucasian 0.43 [35] 
 NBS Caucasian 0.46 [35] 
 - Mixed 0.37 [28] 
 ValBorbera study Caucasian 0.45 [36] 
 NBS Caucasian 0.46 [37] 
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rs4820268 (G) - Han (East) 0.51 [29] 
  
Han (North) 0.53 [29] 
  
Zhuang 0.61 [29] 
 




WHAS II Caucasian 0.46 [13] 
  
Caucasian 0.47 [10] 
 
LOLLIPOP Caucasian 0.43 [11] 
LOLLIPOP Indian Asians 0.55 [11] 
 SAPPHIR Caucasian 0.45 [35] 
 NBS Caucasian 0.47 [35] 
rs2111833 (T) HEIRS Caucasian 0.34 [27] 
 HEIRS African-American 0.39 [27] 
 HEIRS Hispanic 0.20 [27] 
 HEIRS Asian 0.31 [27] 
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Table 2 Continued  
rs1421312 (G) HEIRS Caucasian 0.40 [27] 
 HEIRS African-American 0.61 [27] 
 HEIRS Hispanic 0.34 [27] 
 HEIRS Asian 0.31 [27] 
 
InCHIANTI+  
BLSA+ WHAS I+ 
WHAS II Caucasian 0.39 [13] 
 LOLLIPOP Caucasian 0.46 [11] 
 LOLLIPOP Indian Asians 0.54 [11] 
rs228921 (G) LOLLIPOP Caucasian 0.41 [11] 
 LOLLIPOP Indian Asians 0.48 [11] 
rs228918 (C) LOLLIPOP Caucasian 0.47 [11] 
 LOLLIPOP Indian Asians 0.48 [11] 
rs228919 (T) LOLLIPOP Caucasian 0.40 [11] 
 LOLLIPOP Indian Asians 0.48 [11] 
rs5756520 (A) LOLLIPOP Caucasian 0.41 [11] 
  LOLLIPOP Indian Asians 0.48  [11] 
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Associations of rs855791 with Hb and iron status  
 
The rs855791 (c. 2207 T>C) SNP causes the matriptase-2 valine to alanine amino acid 
substitution (p.Val736Ala) [38]. In our association analyses we considered the A allele 
which is the minor allele on the reverse strand (similar to the T allele on the forward 
strand). The meta analysis of the association of rs855791 with Hb indicates that each A 
allele (encoding for Valine [Val]) was associated with 0.11 g/dl (95% CI -0.11,-0.10) lower 
Hb concentrations overall, with values of -0.08 (95% CI -0.11, -0.04), -0.15 (95% CI -0.18,-
0.12) and -0.11 (95% CI -0.11,-0.10) g/dl in the Caucasian, Asian and mixed populations, 
respectively (Figure 2). The difference in the effect estimates between Caucasian and 
Asian populations, based on 11 and 5 separate study populations, respectively, was not 
significant (P=0.85). Heterogeneity was high among the studies within the Caucasian 
population (I2=96.2%, P=<0.0001, n=11) and in the mixed populations ( I2=96.3%, 
P<0.0001, n=2), but was absent for the Asian cohorts (I2=0.00%, P=0.47, n=5). 
Data from 13 study populations were available to study the associations of the A allele 
and serum ferritin concentration. Overall, a reduction of 3.71 ug/L (95% CI -4.12,-3.31) 
was observed, without significant differences between ethnicities (P>0.05) (Figure 3). As 
for Hb, heterogeneity was high in the Caucasian population (I2=65.2%, P=0.02) but not 
in the Asian populations (I2=0.00%). 
Associations of rs855791 with serum transferrin receptor concentration were only 
conducted within the Caucasian population. Based on three study populations, the 
estimate shows that the A allele was associated with an increase of 0.02 mg/dl (95% CI 
0.01,0.02) in serum transferrin receptor concentration (Figure 4). Heterogeneity between 
the studies was low (I2=0.00%, P=0.93). 
In determining the association with transferrin, overall meta-analysis of five study 
populations indicated that the A allele had no effect 0.00 mg/dl (95% CI -0.05,0.06) 
(Figure 5). Heterogeneity between the studies was high(I2=99.7%, P=0.01). Publication 
bias was detected in the meta analyses performed (P=0.01)  
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Figure 2: Fixed-effects meta-analysis of observational studies evaluating association of 
rs855791 with haemoglobin concentration (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 
the standard errors for the summary estimates. Subtitle Mixed refers to a cohort 
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Figure 3: Fixed-effects meta-analysis of observational studies evaluating association of 
rs855791 with ferritin (µg/L) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 
the standard errors for the summary estimates. Subtitle Mixed refers to a cohort 
consisting of more than one ethnicity. Effect allele = A  
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Figure 4: Fixed-effects meta-analysis of observational studies evaluating association of 
rs855791 with serum transferrin receptor (mg/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 








Figure 5: Fixed-effects meta-analysis of observational studies evaluating association of 
rs855791 with with transferrin (mg/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 
the standard errors for the summary estimates. Effect allele = A  
 
Associations of rs4820268 with Hb and iron status 
 
The minor allele at the rs4820268 (c.1563C>T) leads to a synonymous change at 
nucleotide position 521 (p.Asp521Asp). In our association analyses we considered the G 
allele which is the minor allele on the forward strand (similar to the C allele on the 
reverse strand). The meta analysis of the association of rs4820268 with Hb and ferritin 
within the Caucasian and Asian ethnicities indicated that the G allele results in lower 
concentrations of Hb by 0.08 g/dl (95% CI -0.16,-0.01) and 0.16 g/dl (95% CI -0.22,-0.10) 
respectively (Figure 6). The difference in the effect estimates between four Caucasian 
and Asian populations was not significant (P>0.05). We observed a non-significant 
amount of heterogeneity within studies in both the Caucasian (I2=6.20%, P=0.34) and 
Asian population (I2=0.61%, P=0.23).  
We obtained data from 13 study populations on the associations of the G allele and 
serum ferritin concentration. The G allele resulted in an increased ferritin concentration 
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of 0.12 µg/l (95% CI -6.16,6.39) in the Caucasian population and a decrease of 3.69 µg/l 
(95% CI -9.09,1.72) in the Asian population (Figure 7). There was no significant 
difference in the effect estimates between Caucasian and Asian populations (P>0.05). We 
observed a significant amount of heterogeneity in the studies within the Caucasian 
population (I2=65.15%, P=0.02), but not in the Asian studies (I2=0.00%, P=0.43).  
Associations of rs4820268 with sTfR concentration were only conducted in three studies 
within the Caucasian population. The G allele was associated with a reduction by 
0.08mg/dL (95% CI -0.10,-0.06) in the Caucasian population (Figure 8). There was a 
significant amount of heterogeneity detected (I2=65.15%, P=0.02).  
 
Figure 6: Fixed-effects meta-analysis of observational studies evaluating association of 
rs4820268 with haemoglobin concentration (g/dL), Black squares are point estimates for 
each study, horizontal lines are 95% CIs, black diamonds are summary estimates with 
the lateral tips of the open diamond indicating the standard errors for the summary 
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Figure 7: Fixed-effects meta-analysis of observational studies evaluating association of 
rs4820268 with ferritin (µg/L)  
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 
the standard errors for the summary estimates. Effect allele = G  
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Figure 8: Fixed-effects meta-analysis of observational studies evaluating association of 
rs4820268 with serum transferrin receptor (mg/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black 
diamonds are summary estimates with the lateral tips of the open diamond indicating 
the standard errors for the summary estimates. Effect allele = G  
 
TMPRRS6 variants not eligible for meta-analysis 
 
Since the associations of rs2111833 (c.1083G>A) and rs1421312 (c.659-1988T>C) with 
iron status among Caucasians, Asians, Hispanics and African-Americans was described 
in only one study by McLaren and McLachlan [27], these variants were not eligible for 
the meta-analysis. In this study, MAF across the populations for rs211833 indicated that 
the T allele has the lowest frequency among the Hispanic population (20%) while the 
Caucasian, Asian and African-American populations had a MAF of approximately 30% 
(Table 2). When investigating the association of rs2111833 with serum ferritin, the T 
allele was associated with an increase in serum ferritin concentrations across all 
ethnicities. For rs2111833 and sTfR the estimates in each ethnicity indicated an 
association of the T allele with a decrease in concentrations [27]. However, none of the 
observations were significant (P>0.05).  
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The SNP rs1421312 was also studied in four ethnicities. The MAF of this SNP in the 
African-American population was 0.61, higher than the Caucasian population 0.40, 
Asian population 0.41, and Hispanic population, 0.34. Overall, the G allele of rs1421312 
was associated with a non-significant decrease in serum ferritin concentration. However, 
each additional G allele resulted in a non-significant decrease of 30.75 µg/L (95% CI -
159.62,98.12) in SF concentrations within the African-American population, but in 
increases in the other ethnic populations. For sTfR this SNP was associated with non-
significant negative associations in Caucasians (-0.23, (95% CI -0.45, -0.01) and Asians (-
0.25, (95% CI -0.78, 0.28) and a positive association in African-Americans (0.88, (95% CI 
-0.04, 1.80) and Hispanics (0.19, (95% CI -0.48, 0.86) [27]. 
We also identified studies in the Chinese population that have observed rs855791 and 
rs4820268 polymorphisms as genetic risk factors for developing anaemia, iron deficiency 
and iron deficiency anaemia [29, 32]. We additionally identified another study conducted 
among Danish blood donors that has observed that the T and G alleles of rs855791 and 




To our knowledge, this is the first review to focus on the association of TMPRSS6  
genetic variants with iron related parameters in different ethnic groups. Sample sizes 
included in the meta analyses were sufficient to investigate the research question. We 
observed that the A allele of rs855791 is associated with lower concentrations of Hb and 
ferritin across all populations. Additionally, this allele is associated with increased sTfR 
and transferrin concentrations. Based on our meta analyses, the overall effect estimate 
of the Asian studies indicates that for each A and G allele of rs855791 and rs4820268 
respectively, an additional decrease in Hb values of 0.07and 0.12 g/dL is observed, as 
compared to the Caucasian population. Similarly, ferritin concentration is lowered by an 
additional 2.24 µg/l and 3.85 µg/l, respectively, in the Asian populations. The directions 
and magnitudes of associations were identical in both fixed effects and random effects 
model.  
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Although the observed differences in iron status may not be impressive from a clinical 
point of view, it may be of significance on the population level especially in populations 
that already have marginal iron status due to low dietary iron intake.  
The exact mechanism through which TMPRSS6 action is exerted is still under 
investigation. It had generally been thought that TMPRSS6 polymorphisms affect 
hepcidin transcription, thereby altering hepcidin concentrations in response to systemic 
iron concentrations [4, 7, 40]. However, two recent studies [36, 37] did not confirm an 
intermediate role for hepcidin in the SNP-iron status parameters associations. These 
studies instead indicate pleiotropic SNP effects on hepcidin and iron status parameters. 
Currently, it is proposed that matriptase-2 could regulate hepcidin expression by 
cleaving HJV to decrease BMP-SMAD signalling [41]. Further studies are required to 
elucidate the role of hepcidin in TMPRSS6 -iron status parameter associations. 
We have observed similar directions of the effect estimates between rs855791 and 
rs4820268 in associations with iron status parameters. This is probably because these 
two SNPs are in linkage disequilibrium [38]. However, we also observed differences in 
the direction of association of the risk allele in rs1421312 with body iron, serum ferritin 
and serum iron in African-Americans. Similar alleles in different ethnic groups could 
result in variations in the expression of genes [42]. This further strengthens the need to 
conduct ethnicity specific studies when considering the role of genetics in disease 
outcome. 
We observed that the risk allele frequencies of rs855791 and rs4820268 were as high as 
63% in the Asian populations while in the Caucasian populations it was generally less 
than 45%. This difference in MAF across ethnicities has also been observed in the SNPs 
rs211833 and rs1421312. Indeed, allele frequencies for SNPs can vary greatly across 
ethnic groups [43], and this may impact the prevalence and incidence of disease across 
ethnic groups in case of associations [44, 45]. The high frequency of the risk alleles of the 
rs855791 and rs4820268 SNPs in Asian populations and the stronger negative 
associations with Hb and ferritin predisposes this population to iron deficiency. 
Environmental factors such as a diets low in bioavailable iron and high inflammation 
burden further aggravates this predisposition. In this regard, it would have been 
interesting to include in this review studies conducted within the African population as 
well. However, at the time the search was completed, there were no studies conducted 
within the African population other than the one performed in the African-American 
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population. However, this is an admixed population [46] and therefore observations are 
not readily transferrable to the African population. Besides this, it may be that the 
phenotypic expression for the same alleles investigated are different within the 
genetically diverse African population [47-55].  
Several limitations of our study need mentioning. We focussed on SNP–iron status 
measure associations that were investigated in at least two studies and in more than one 
ethnicity. Consequently, significant SNP–iron status measure associations that have 
only been researched in one ethnicity were not described. Additionally, since we only 
included SNPs described in greater than two cohorts and more than one ethnicity, we 
were only able to include two genetic variants from the selected SNPs in the meta-
analyses. For this reason, there may be ethnic differences in other genetic variations 
that have not been included in this review.  
Secondly, high heterogeneity was observed among the Caucasian studies. We attribute 
this to the variation in population characteristics and study designs. Most studies that 
were conducted within the Caucasian populations and have previously been designed to 
study other outcomes, whereas the studies within the Asian population were specifically 
designed to study genetic influences of iron metabolism and are fewer in number.  
Thirdly, in conducting association analyses, only one study [32] included dietary iron as 
a predictor of iron status within the model. This investigation on the interactions 
between SNPs and the environment is crucial in order to quantify the contribution of 
genetic alterations to the development of iron deficiency. Further to this, only two 
studies considered inflammation as a potential confounder in association analyses. These 
studies either excluded subjects with CRP levels above a pre-defined cut off [29, 32, 36] 
or corrected for inflammation [27]. Correction for inflammation or exclusion of values of 
inflamed subjects would ensure that what is observed is a true association. Ferritin and 
Hb are influenced by inflammation and sTfR concentrations might also be influenced 
negatively by inflammatory cytokines [56]. 
In conclusion, we observe that the risk alleles A and G in rs855791 and rs4820268 are 
associated with a reduction in Hb and serum ferritin concentrations and an increase in 
transferrin and serum transferrin receptor concentrations in most populations 
investigated. Our study highlights key information gaps in several areas regarding the 
associations of SNPs in TMPRSS6  and iron status. First of all, more information on the 
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(factors involved in) regulation of TMPRSS6  is required as well as how exactly 
TMPRSS6  exerts its effects on body iron. Moreover, our study also highlights the need 
to conduct further studies in ethnicities or populations where iron deficiency is of public 
health significance. The question is whether populations with high prevalence of risk 
alleles may require higher recommendations for iron intake in order to maintain normal 
erythropoiesis. This is especially relevant in combination with unfavourable 
environmental conditions such as diets with low bioavailable iron and high inflammation 
burden. Knowledge of genetic factors influencing iron status could improve care and 
advice given to populations at risk for iron deficiency.  
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Abstract 
Background: It is unknown whether single nucleotide polymorphisms (SNP) associated 
with iron status in European and Asian populations have the same relationship within 
the African population.  
Objective: This study was designed to investigate associations of reported SNPs with 
iron status in a female black South African cohort. We additionally aimed to investigate 
gene-gene interactions that influence iron status.  
Methods: Blood samples were obtained from women (n=686; range 32–86 years) which 
were part of the Prospective Urban and Rural Epidemiology (PURE) study. 
Concentrations of hemoglobin, serum ferritin, serum transferrin receptor and body iron 
stores were determined. Thirty two single nucleotide polymorphisms in 10 genes were 
selected based on existing GWAS data; 30 SNPs passed quality criteria.  
Results: In the TF gene, the heterozygote genotype (AG) of rs1799852 was associated 
with decreased serum ferritin (p=0.01) and body iron (p=0.03) and increased serum 
transferrin receptor (sTfR) concentrations (P=0.004) compared to the homozygote minor 
allele genotype (AA), while the heterozygote genotype (AG) of rs3811647 was 
significantly associated with the lowest transferrin receptor and body iron 
concentrations (both P=0.03) compared to the homozygote wild type (AA) and minor 
allele groups (GG). The chromosome 6 allele combination (AAA) consisting of rs1799964 
and rs1800629 both in TNF α and rs2071592 in NFKBIL1 was associated with higher 
odds for low serum ferritin concentrations (serum ferritin<15µg/L; OR:1.86 (95%-CI, 
1.23-2.79)).  
The chromosome 22 allele combination (GG) consisting of rs228918 and rs228921 in the 
TMPRSS6 gene was associated with lower odds for increased sTfR concentrations 
(sTfR>8.3mg/L; OR:0.79 (95%-CI,0.63-0.98).  
Conclusion: We conclude that various SNPs and allele combinations in the TF, TNF α 
and TMPRSS6 genes are associated with iron status in this African population; however, 
these association patterns are different compared to European ancestry populations. 








Anaemia, accounts for 3.7% of maternal deaths during pregnancy and childbirth in 
Africa [1]. Maternal iron deﬁciency anaemia escalates the risk of poor pregnancy 
outcomes, predicts iron deﬁciency in infants after four months of age and affects child 
development [2, 3]. In adults, consequences of iron deficiency (ID) include reduced 
physical activity [4] and work performance as well as lethargy [5, 6] which impacts 
greatly on the burgeoning economies of developing countries [7]. 
 
Several discoveries regarding genetic disorders of iron metabolism indicate that there is 
a substantial genetic contribution to the development of iron deficiency [8-10]. In 
addition, iron status biomarkers (serum iron, transferrin, transferrin saturation and 
ferritin) present with significant heritability [11-14] and previous population studies 
have identified relevant single nucleotide polymorphisms (SNPs) and gene loci (TF, 
HFE, TFR2, TMPRSS6 ) to be associated with these biomarkers [15, 16]. HFE and 
TMPRSS6  have also been determined to affect red blood cell count, haemoglobin (Hb), 
and erythrocyte indices [17] most likely by affecting iron availability [17-19] 
 
Nearly all studies on the genetics of iron status, however, have been performed in 
populations of European ancestry. The limited data available from Asian populations 
have pointed to potential ethnic differences in the heritability of specific measures of iron 
status [20-22]. However, the genetic determinants of iron metabolism have hardly been 
studied in the black African population which bears the greatest iron deficiency burden. 
For example, in preschool-age children, anaemia prevalence is 47.4%, affecting 293 
million children globally. The highest prevalence of iron deficiency is in Africa (67.6%) 
and South-East Asia (65.5%). In addition, 468.4 million non-pregnant women are 
anaemic (global prevalence: 30.2%) with the highest prevalence also being in Africa 
(47.5%) [23]. Furthermore, it has been determined that the highest level of genetic 
diversity (both nuclear and mitochondrial) in the global human population is within the 
African population [24-27]. As such, it can be expected that the genetic risk for disease in 
African populations would be more complex due to the greater level of possible 
interactions between the larger amount of genetic diversity present and the numerous 
differential environmental factors that have an impact on iron absorption. As a first step 
to unravelling this in the African population, the main aim of this study was to replicate 
previously reported associations between single nucleotide polymorphisms (SNPs) and 
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low iron status or anaemia in a female black South African cohort. We additionally 
aimed to investigate gene-gene interactions that influence iron status. To assess this, we 
genotyped 32 SNPs previously reported to be involved in the systemic and cellular 
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Figure 1. Iron metabolism in enterocytes, macrophages and hepatocytes 
Dietary iron is present in the gut lumen in two forms - heme and non heme iron. 
Absorption takes place in the enterocytes. Non heme iron (Fe3+) is reduced to Fe2+. Fe2+ is 
then transported into the enterocytes through the divalent metal transporter 1 (DMT1). 
Based on the individual’s iron status, iron in the enterocytes can be stored in ferritin or 
exported into plasma through ferroportin (FPN). Ferroportin is also involved in iron 
export from the macrophages and enterocytes. The exported iron is re-oxidized to Fe3+ by 
hephaestin (HEPH) before transport by transferrin (TF). In cases where transferrin 
within plasma is saturated, excess iron is stored within the liver. The liver plays a 
central role in iron metabolism due to its production and secretion of hepcidin. This 
hormone regulates iron absorption, recycling, and mobilization by binding to ferroportin 
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Figure 2. Regulation of hepatocyte hepcidin expression 
The HAMP gene, which encodes the peptide hormone hepcidin, is activated by elevated 
circulating iron levels, increased body iron status as well as inflammatory cytokines such 
as IL-6.  
Liver iron stores influence the hepatic expression of the extracellular signaling molecule 
bone morphogenetic protein (BMP) 6 (BMP-6). Interaction of BMP-6 with hepatocyte 
BMP receptors initiates intracellular signal transduction through SMAD proteins, 
increasing hepcidin transcription. BMP-6 signaling to hepcidin is heightened by cell-
surface expression of the BMP co receptor hemojuvelin. The circulatory iron signal 
regulating hepcidin is via transferrin, which, on binding iron, serves as a ligand for two 
hepatocellular receptors: transferrin receptor 1 TfR1 and transferrin receptor 2 (TfR2). 
Ferri-transferrin–mediated signaling appears to be modulated by the physical 
interaction of these two receptors with the hemochromatosis protein HFE.  
Under low iron conditions membrane bound HJV is cleaved by the protein matriptase-2 
encoded by TMPRSS6  to form soluble hemojuvelin (sHJV). Soluble hemojuvelin binds to 
BMP6 thus blocking the activation of BMP receptors. Inflammatory cytokines such as 
TNF and NFKBIL1 induce HAMP gene expression. NF-κB appears to be essential for 
the transcriptional activation of tumor necrosis factor (TNF) within monocytes. During 
hypoferremia or inflammation, inflammatory stimuli acting through TNFα suppreses 








The study population included in this analysis was a subset of the participants enrolled 
as part of the South African arm of the Prospective Urban and Rural Epidemiological 
(PURE) study and consisted of only women who are mainly of Tswana ancestry [28] as 
determined by self-report. Participants were only eligible for our sub study if they were 
apparently healthy, not pregnant, non-lactating and were not diagnosed with any 
chronic disease or taking drugs for any chronic disease at the time of blood collection. 
Additionally, we included only participants with all outcome measures determined and 
who were human immune deficiency virus (HIV) negative. The final sample size, after 
all inclusion and exclusion criteria were met, comprised of 686 individuals. Permission to 
conduct the larger PURE study had previously been obtained from the North West 
Department of Health, tribal chiefs, community leaders, employers and mayors as well 
as the Ethics Committee of the North–West University, Potchefstroom, South Africa 
(Approval number NWU-0073-10-A1). Approval for this sub study was also obtained 
from the Ethics Committee of the North–West University, Potchefstroom, South Africa. 
All participants gave written informed consent before being enrolled in the project and 
received pre-counselling regarding the HIV testing in groups of ten. Participants had to 
give special permission for the determination of HIV status as well as whether they 
wanted to receive the results of the test. Post-test counselling was undertaken 
individually with all participants that indicated that they wanted to receive their HIV 
status results. 
Biochemical analyses 
Fasting whole blood samples were collected into EDTA tubes. Fasting serum samples 
were similarly collected into serum tubes, after which the sample was allowed to clot for 
30 minutes. Both types of tubes were in turn centrifuged at 2,000xg for 15 minutes at 
10°C. Four iron status related outcomes were studied namely (Hb), serum ferritin (SF), 
serum transferrin receptor (sTfR) and body iron (BI) stores.  
Haemoglobin was determined spectrophotometrically from whole blood using the 
Hemocue® HB201 haemoglobin meter (Hemocue AB, Angelholm Sweden). Whole blood 
was also used for the determination of HIV status making use of the First Response 
(PMC Medical, India) rapid HIV card test. If tested positive, the test was repeated with 
the Pareeshak (BHAT Bio-tech India) card test. SF and sTfR concentration were 
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determined quantitatively using an enzyme immunoassay procedure (Ramco 
Laboratories, Inc, Stafford Texas). The coefficient of variance (CV) for all assays was 
<10% [29].  
Body iron (BI, mg/kg), was assessed as follows: body iron (mg/kg)=‒[log (serum 
transferrin receptor concentration/ferritin concentration)‒ 2.8229]/0.1207 as defined by 
Cook et al. [30]. C-reactive protein (CRP) was measured from serum via a particle-
enhanced immunoturbidometric assay using Sequential Multiple Analyser Computer 




Weight (kilograms) and height (meters) were determined by qualified level 2 accredited 
anthropometrists (International Society for the Advancement of Kinanthropometry 
(ISAK)). Standardized and calibrated equipment was used for measurements on 
volunteers wearing minimal clothing. Body mass index (BMI) was calculated by dividing 
weight in kilogram by height in meter squared. 
Dietary intake was assessed by means of previously developed [31] and validated [32] 
culturally sensitive quantified food frequency questionnaires. These questionnaires were 
completed by the participants in collaboration with a trained field worker in the 
participant’s preferred language. Nutrient intake was estimated by using the 
Foodfinder3® program (Medical Research Council, Tygerberg, South Africa) which is 
based on the South African Food composition tables [33]. 
 
Genotyping and quality control procedures  
DNA isolation was performed by using Qiagen® Flexigene™ DNA extraction kits 
according to the manufacturer’s instructions. In order to set up a list of reference SNPs, 
we searched for SNPs that were previously reported to be involved in the systemic and 
cellular iron regulation, transport and storage. To this purpose we performed a literature 
search of HUGE navigator database. 
All abstracts were scanned for appropriateness of use i.e. association or linkage of 
a SNP to the hematological parameters or key biomarkers of iron status (Hb, SF, sTfR 
and BI). The search strategy as well as final publications from which information was 
obtained are detailed in Gichohi-Wainaina et al [34]. If appropriate, the reference SNP 
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(rs) number of the polymorphism was recorded and included in the list to be sent to 
Illumina for verification of use in the array. Based on this, we selected 32 SNPs for 
genotyping. All 32 rs numbers were submitted to Illumina Technical Support for 
evaluation using the Assay Design Tool. Each SNP was scored (varying from 0 to 1) by 
the Assay Design Tool from Illumina based on its compatibility for use in a GoldenGate 
genotyping assay. SNPs with a score above 0.4 were chosen for genotyping. No SNP fell 
out based on these criteria. All 32 SNPs were determined using Illumina’s VeraCode™ 
GoldenGate Genotyping Assay on a BeadXpress™ platform. Lack of a detectable signal 
after analysis was designated as a failed genotype call. SNP clustering was also assessed 
visually to determine success of genotyping. SNPs with a GenCall Score of >0.5 and 
samples with a call rate of ≥0.95 were included in the final analysis. 
Information on MAFs from males and females of European (EUR) as well as 
African (AFR) ancestry was obtained from the 1000 Genomes website [35]. The minor 
allele frequencies of the SNPs from the females of the PURE population were then 
determined using the formula: MAF=minor allele count/total allele count 
To investigate gene-gene interactions as well as interactions between SNPs, grouping of 
SNPs into the chromosomes within which they were located was undertaken. There were 
three chromosomes (chromosome 3, 6 and 22) with more than one genotyped SNP that 
were eligible for these analyses. Frequencies of allele combinations were determined by 
means of the software package Haploview version 4.2. Markers with a Hardy-Weinberg 




All outcome variables were determined to be parametric continuous quantitative traits. 
Natural logarithm transformations were applied to the serum ferritin and transferrin 
receptor concentration outcomes to improve their fit to the normal distribution. Potential 
disturbances in the distributions of the genotypes were tested for deviation from the 
assumptions of Hardy Weinberg Equilibrium (HWE) by using the chi-square test. 
Genotypes were coded as 0, 1 or 2 indicating the number of minor alleles. Differences in 
iron status across the genotype classes were assessed by using ANCOVA. In these 
analyses, ferritin and body iron concentrations were adjusted for inflammation by 
including C-reactive protein concentrations as a covariate in the model. Additionally, we 
adjusted for age, area of residence (rural or urban) and the proportion of dietary haem 
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iron intake to total iron intake in all association analyses. We did not adjust mean iron 
status values (per genotype) for BMI and menopausal status as there were negligible 
differences between the crude and adjusted models.  
To investigate gene-gene interactions as well as interactions between SNPs and 
associations with iron status, cases of low iron stores were defined as serum ferritin 
concentration < 15 µg/L after correction for inflammation and controls as corrected 
serum ferritin concentration ≥15 µg/L. In terms of sTfR concentration, cases with iron 
deficiency were defined as those with sTfR> 8.3 mg/L (test kit reference value) and 
controls as ≤ 8.3mg/L. When body iron stores were considered as a marker of iron 
deficiency, cases were defined as body iron < 18 mg/kg and controls as body iron ≥ 18 
mg/kg and excluding subjects with CRP> 5mg/L. Anaemia cases were defined at a Hb 
concentration <12 g/dl and controls at a Hb concentration of ≥12 g/dl [35].  
Statistical analyses were performed using version 20 of the Statistical Package for Social 
Sciences (SPSS Inc Chicago III). All reported P-values were two-tailed and adjustment 
for multiple testing was performed using the false discovery rate method. Statistical 




Following quality control analysis of the genotyping data, two SNPs i.e. rs198846 and 
rs5756504 failed due to low signal strength. Therefore, data was available for 30 SNPs in 
12 genes for 686 individuals. Table 1 presents the main characteristics of the study 
population. Included in the table are the numbers and proportion of participants that 
were rural. Fourteen percent (14%) of the population had a low serum ferritin 
concentration (<15 µg/L), whereas 61% had a sTfR concentration above the reference 
range (>8.3 mg/L). Anaemia was present in 8% of the study population. More than half 
(57%) of the study population was either overweight or obese and almost half (43%) of 
the study population had inflammation as indicated by a C-reactive protein 
concentration >5 mg/L. 
The minor allele frequencies (MAF) determined in our study population were in most 
cases comparable with those of the males and females of the African ancestry 
populations investigated in the 1000 Genomes project (Table 2). We however observed 
differences in MAF at the rs482692 locus (4-fold) and rs2413450 locus (2- fold) in our 
Chapter 3 
 
73 | P a g e  
 
population compared to the males and females of the African ancestry in 1000 Genomes 
project. These differences were not as large as the differences in MAF observed between 
our study population and the European ancestry population in the 1000 Genomes 
Project. Differences in MAF between our study population and males and females of 
European ancestry in the 1000 Genomes project, were observed at the rs2071592 (MAF 
0.63 vs. 0.30,) locus in the NFKBIL1 gene, and the rs2413450 (MAF 0.09 vs. 0.43,), 
rs5756506 (MAF 0.81 vs. 0.40,) and rs855791 (MAF 0.09 vs. 0.40,) loci in the TMPRSS6  
gene (Table 2). Three SNPs i.e. rs2071592, rs1421312, and rs5756506, had MAFs > 0.5, 
indicating that the minor alleles at these loci were actually the major alleles in our study 
population. 
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Table 1: General characteristics and iron status indicators of the South African PURE 
Study female population 1 
 Rural n (%) Total n Value for Total N 
Age, y 400 (59) 678 50 (49,50)  
Dietary Intake    
Energy, kJ 384 (58) 658 7097 (6977,7229) 
Iron, mg 384 (58) 658 12 (11,12) 
Heme iron (% of total iron) 384 (58) 658 13 (13,14) 
BMI, kg/m2 400 (62) 645 27 (27,28)  
Menopausal status, n (% menopausal) 392 (59) 664 369 (56) 
BMI categories    
 < 18 kg/m2 (underweight), n (%) 399 (62) 644 66 (10) 
 18-25 kg/m2 (normal weight), n (%) 399 (62) 644 213 (33) 
 25-30 kg/m2 (overweight), n (%) 399 (62) 644 156 (24) 
>30 kg/m2 (obese), n (%) 399 (62) 644 209 (32) 
Presence of inflammation    
Serum C-reactive protein (CRP), mg/L $ 388 (59) 663 8.4 (8.0,8.8) 
           > 5 mg/L, n (%) 388 (59) 663 288 (43) 
Iron status markers    
Serum transferrin receptor, mg/L $ 400 (59) 678 9.2 (9.1,9.3) 
           > 8.3 mg/L, n (%) 400 (59) 678 414 (61) 
Serum ferritin, µg/L $  686 84.5 ± 3.7 
           <15 µg/L, n, (%) 393 (59) 668 72 (11) 
           <15 µg//L), corrected for inflammation, n (%). 388 (64) 603 60 (10) 
           <15 µg/L, excluding CRP > 5 mg/L, n (%) 222 (60) 369 53 (14) 
Body iron store, mg/kg body weight 400 (59) 678 31.4 (31.2,31.6)  
           <18 mg/kg, n (%) 400 (59) 678 15 (2) 
Hemoglobin, g/dl 301 (60) 474 13.8 (13.1,14.5) 
           < 12 g/dl (anaemia), n (%) 301 (60) 474 40 (8) 
1Values are n (%) or the geometric mean (-1 SD, +1 SD) for the total sample.  
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Table 2: Minor allele frequency of SNPs of the South African PURE Study female population in comparison to African and 
European populations in the 1000 Genomes project 












      rs482692† 1 29154255 A/G 0.18 0.04 0.13 
SRPRB       




      rs1358024† 3 133484188 A/G 0.01 0.01 0.19 
   rs1525892 3 133484712 A/G 0.29 0.25 0.35 
   rs1799852 3 133475722 A/G 0.03 0.05 0.14 
   rs1799899 3 133475812 A/G 0.00 0.01 0.08 
   rs1867504 3 133410661 A/G 0.28 0.23 0.49 
   rs3811647 3 133484029 A/G 0.28 0.20 0.35 
   rs3811658 3 133476852 A/G 0.15 0.13 0.35 
   rs4525863 3 133436136 A/C 0.17 0.27 0.33 
   rs7638018 3 133495461 G/A 0.15 0.15 0.35 




      rs1799964 6 31542308 G/A 0.19 0.17 0.22 




      rs1800562 6 26093141 A/G 0.00 0.00 0.05 
NFKBIL1       
   rs2071592 6 31515340 A/T 0.63 0.51 0.30 
TFR2       
   rs7385804 7 100235970 C/A 0.28 0.33 0.39 
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CUBN       
   rs10904850 10 16997707 A/G 0.29 0.11 0.33 
HAMP       
   rs10421768 19 35772899 G/A 0.15 0.19 0.23 
KIAA1468       
   rs9948708 18 59865121 A/G 0.45 0.44 0.44 
KCTD17       




      rs1421312 22 37487810 G/A 0.68 0.58 0.41 
   rs2111833 22 37480797 A/G 0.27 0.37 0.38 
   rs228918 22 37506680 G/A 0.43 0.43 0.42 
   rs228921 22 37506876 G/A 0.43 0.43 0.43 
   rs2413450 22 37470224 A/G 0.09 0.18 0.43 
   rs4820268 22 37469591 G/A 0.18 0.31 0.44 
   rs5756506 22 37467392 C/G 0.81 0.80 0.40 
   rs5756520† 22 37508507 A/G 0.37 0.46 0.42 
   rs855791 22 37462936 A/G 0.09 0.13 0.40 
†= SNP not in Hardy Weinberg Equilibrium. 1000AFR, 1000 Genomes African population; 1000EUR, 1000 genomes European population, CUBN, cubilin (intrinsic factor-cobalamin 
receptor; HAMP, hepcidin antimicrobial peptide; HFE, hemochromatosis; KCTD17, potassium channel tetramerization domain containing 17; NFKBIL1, MAF= minor allele frequency; 
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; OPRD1, opioid receptor, delta 1; PURE, PURE Study population; SRPRB, signal recognition particle 




77 | P a g e  
 
Table 3 displays the significant associations observed between SNPs investigated and 
iron status parameters. These significant associations were only determined between 
SNPs in the TF gene and  SF, sTfR and BI. None of the SNPs in TF were significantly 
associated with Hb. None of the SNPs in other genes were significantly associated with 
Hb and iron status markers (Supplemental Tables 1-3). The heterozygous genotype class 
of rs1799852 in the TF gene, with a MAF of 0.03 in our study population, presented with 
lower serum ferritin concentration (AG vs. GG; 54.0 µg/L vs 87.9 µg/L, P=0.02) and body 
iron stores (29.4 mg/kg vs. 31.6 mg/kg, P=0.005), and higher serum transferrin 
concentrations (10.2 mg/L vs 9.1 mg/L, P=0.03) as compared to the homozygous wild type 
genotype class. Only the association with body iron stores remained significant after 
adjustment using the false discovery rate method (FDR). For rs3811647 in the same 
gene, the MAF was 0.28 and mean serum concentration of transferrin receptor in both 
homozygous groups as compared to the heterozygote group were higher (9.4 in each case 
vs. 8.8 mg/L P=0.01) and mean body iron store was lower (31.0/31.1 vs. 32.1 mg/kg, 
P=0.03). In a multiple linear regression model, rs1799852 and rs3811647 explained 13% 
of the variation in sTfR concentrations after adjustment for age, area of residence, and 
proportion of haem iron intake. 
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Table 3: Genotype distribution of SNPs in the TF gene and significant associations with iron status measures in the South 
African PURE Study female population 1,2,3 
Outcome Measure SNP P
4
 Genotype  N Mean (95% CI)  
Serum ferritin, µg/L  rs1799852 0.01 GG 603 87.9 (79.8, 96.8) 
   AG 46 54.0 (38.0, 76.7) 
   AA 0 - 
Serum transferrin receptor,  mg/L rs1799852 0.03 GG 619 9.1 (8.8, 9.3) 
  AG 46 10.2 (9.2, 11.3) 
   AA 0 - 
 rs3811647 0.03 GG 355 9.4 (9.1, 9.8) 
   AG 249 8.8 (8.4, 9.1) 
   AA 61 9.4 (8.6, 10.2) 
Body iron stores, mg/kg rs1799852 0.004* GG 619 31.6 (31.2, 32.0) 
  AG 46 29.4 (27.9, 30.8) 
   AA 0 - 
 rs3811647 0.03 GG 355 31.1 (30.5, 31.5) 
   AG 249 32.1 (31.5, 32.7) 
   AA 61 31.1 (29.8, 32.4) 
1For each SNP, top to bottom rows represent values for the homozygote wild type, heterozygotes and homozoygote minor allele genotypes respectively. 2All associations are adjusted for age, 
area of residence (rural or urban), ratio of heme iron intake. 3Associations involving serum ferritin and body iron are additionally adjusted for serum CRP. 4P refers to the p value of the SNP 
association with the corresponding outcome measure. *Polymorphism is significantly associated with outcome measure after adjustment using the false discovery rate (FDR method) (q-
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Gene-gene interaction analyses revealed SNP combinations in chromosome 6 consisting of rs1799964 and rs1800629 in the tumour 
necrosis factor (TNF) gene, and rs2071592 in the NFKBIL1 gene, of which the AAA variant was associated with higher odds for low 
serum ferritin concentrations (serum ferritin<15µg/L; OR:1.86 (95%-CI, 1.23-2.79)) as indicated in Table 4). The chromosome 22 SNP 
allele combination (GG) consisting of rs228918 and rs228921 in the TMPRSS6 gene was associated with lower odds for increased sTfR 
concentrations (sTfR >8.3mg/L; OR:0.79 (95%-CI,0.63-0.98). 
 
 
Table 4: Allele combinations associated with iron deficiency within PURE Study female population 1,2,3 
Chr SNPs Allele 
combinations 
Low SF  
SF<15 µg/L 
 High sTfR 
sTfR>8.3 mg/L 









AGA 0.46 1 (ref) 0.46 1 (ref) 0.46 1 (ref) 0.46 1 (ref) 
  GGT 0.19 0.80 (0.54,1.16) 0.19 0.92 (0.70,1.21) 0.19 0.69 (0.28,1.69) 0.19 0.67 (0.37,1.22) 
  AGT 0.17 0.83 (0.56,1.24) 0.17 0.94 (0.71,1.25) 0.17 0.69 (0.28,1.69) 0.17 1.30 (0.71, 2.38) 
  AAA 0.17 1.86 (1.23, 2.79)* 0.17 1.22 (0.91,1.63) 0.17 2.37 (0.96, 5.88) 0.17 1.19 (0.62, 2.26) 
22 rs2111833; 
rs228918 
GG 0.73 1 (ref) - - - - - - 
  AA 0.27 1.08 (0.74, 1.56) - - - - - - 
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GG 0.91 1 (ref) - - - - - - 
  AA 0.09 0.82 (0.46,1.47) - - - - - - 
 rs228918; 
rs228921 
AA - - 0.57 1 (ref) 0.56 1 (ref) 0.58 1 (ref) 
  GG - - 0.43 0.79 (0.63, 0.98)$ 0.44 1.12 (0.55, 2.27) 0.42 1.11 (0.70, 1.77) 
3 rs3811647; 
rs3811658 
GG 0.72 1 (ref) 0.72 1 (ref) 0.72 1 (ref) 0.72 1 (ref) 
  AA 0.15 0.86 (0.56,1.33) 0.15 0.94 (0.69,1.27) 0.15 0.61 (0.21,1.76) 0.15 0.81 (0.43, 1.53) 
  AG 0.13 0.77 (0.49,1.19) 0.13 0.82 (0.60,1.13) 0.13 0.75 (0.26, 2.15) 0.13 0.92 (0.49, 1.74) 
 rs7638018; 
rs81772248 
AG 0.86 1 (ref) 0.86 1 (ref) 0.86 1 (ref) - - 
  GG 0.09 1.13 (0.68,1.87) 0.09 0.86 (0.56,1.33) 0.09 0.96 (0.33, 2.76) - - 
  GA 0.05 0.70 (0.36,1.39) 0.05 0.77 (0.49,1.19) 0.05 1.05 (0.25, 4.48) - - 
 rs1525892; 
rs1830084 
GT - - - - - - 0.68 1 (ref) 
  AT - - - - - - 0.16 0.81 (0.43, 1.53) 
  AA - - - - - - 0.15 0.92 (0.49, 1.74) 
Cases and controls are defined as: 1corrected serum ferritin concentration <15 µg/L (cases) and ≥15 µg/L and serum CRP <5 mg/L (controls); 2serum transferrin receptor >8.3 mg/L (cases) 
and ≤ 8.3mg/L (controls); or 3body iron store <18 mg/kg (cases) and ≥18 mg/kg (controls). *Allele combination is associated with higher odds for low serum ferritin concentrations. $ Allele 
combination is associated with lower odds for increased sTfR concentrations. BI, body iron stores; Chr, chromosome; SF, serum ferritin; SNPs, single nucleotide polymorphisms; sTfR, serum 
transferrin receptor.  
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We report here the first study focusing on the genetic aetiology of iron status in a 
population of adult black South African women. The most striking finding from our 
study is the general lack of associations between the investigated SNPs and iron status 
indicators in our study population, whereas others have reported such associations in 
European ancestry and Asian populations. For example, rs855791 in the TMPRSS6  
gene has repeatedly been reported to be associated with lower serum ferritin 
concentrations and anaemia [15, 17, 18, 21, 22, 37, 38]. We did not find such an 
association, and the SNP was also hardly present in the females in our study population 
with a MAF of 0.09 compared to a MAF of ~0.40 in males and females of European 
ancestry. Our cohort of women had lower iron status compared to the European ancestry 
populations previously investigated. It would thus imply that all factors being equal, we 
should be able to detect associations in our cohort with lower numbers than previous 
GWA studies. However the low MAFs of the risk alleles in our cohort would require large 
numbers to detect associations. 
We observed several other significant differences in MAF of investigated SNPs between 
our female study population and the male and female Europeans included in the 1000 
Genomes project. The observed differences may be due to certain environmental 
conditions acting through selective pressure to alter the frequency of the genetic variants 
in the European population [39]. This has resulted in specific allele frequencies in the 
European ancestry population that are different from those in the African population. 
These differences in MAF between populations could theoretically result in 
dissimilarities in the prevalence of a disease outcome [28], in this case iron deficiency, 
and could in case of strong gene-disease associations call for population specific 
strategies to address this. MAFs of the females in our study population on the other 
hand were similar to those of the males and females in the African population in the 
1000 Genomes Project. The similarity is probably because MAFs reflected in the 1000 
genomes project represent a wide variation of African populations and would therefore 
capture the great diversity within the population [34]. 
We did, however, observe some significant associations between SNPs and iron status, 
particularly in the TF gene. The TF gene encodes for transferrin, a glycoprotein that 
binds free iron in blood plasma. On the cell surface, ferric transferrin binds to TfR1 to 
allow iron entry into the cell. Additionally, TfR2 helps sense and regulate circulating 
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iron levels in the body by controlling the levels of hepcidin. This feedback mechanism 
between transferrin and transferrin receptor 1 may explain why SNPs in the TF gene 
could be associated with sTfR. Genetic variants within TF have previously been studied 
for their association with iron status [16, 40-44]. The A allele of rs1799852, a non-
synonymous coding SNP in exon 17, has been associated with a reduction in serum 
transferrin concentrations (and thus indirectly higher sTfR concentrations) [16, 45]. In 
our study we observed an association between this SNP and increased sTfR and lower 
body iron stores, which is in line with the expectations. However, the SNP was rare in 
our study population (MAF, 0.03) and therefore the importance of this finding from a 
public health perspective is limited.  
Heterozygous individuals at the rs3811647 locus (AG), which is located in intron 11 of 
the TF gene had the lowest mean sTfR concentrations compared to those harbouring the 
homozygous wildtype (GG) or mutant genotypes (AA). Higher serum transferrin 
concentrations in the AA genotype group have previously been observed in a group of 
menstruating women [45]. In another study, women that harboured the A allele had 
lower transferrin saturation, which may indicate a reduction in iron transport to tissues. 
In order to explain this discrepancy, larger studies are required to confirm this finding. 
Additionally, it would be necessary to conduct further mechanistic and clinical studies. 
In a study by Benyamin et al [16], three SNPs that included rs1800562 (in the HFE 
gene), and both rs1799852 and rs3811647 in the TF gene together explained 40% of the 
genetic variation in sTfR based on analyses performed on an Australian population of 
European decent. In our African population, 13% of the variation in sTfR could be 
explained by the two SNPs in the TF gene. The lower explanation of variance in our 
study may be caused by the low MAF of rs1799852 in our study population. Additionally 
this could indicate that these may not be the most important SNPs explaining variation 
in sTfR in this African population. 
Gene-gene interaction analyses further identified a SNP allele combination i.e. AAA 
(frequency 0.17) consisting of rs1799964, rs1800629, and rs2071592, which was 
associated with higher odds for low serum ferritin concentrations (SF<15µg/L)  as well as 
for low body iron stores (BI <18 mg/kg). This allele combination has previously been 
associated with an increased risk of iron deficiency in a cohort of West African children 
[46]. The SNPs in the identified combination are present in the tumour necrosis factor 
(rs1799964 and rs1800629) and NFKBIL1 (rs2071592) genes, which are both involved in 
inflammatory processes. The rs1800629 SNP increases TNF α gene transcription [47], 
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which would block recycling of macrophage iron [48], inhibit erythropoiesis [49] and has 
been suggested to reduce absorption of dietary iron [50]. The NFKBIL1 gene in turn is 
hypothesized to exert an influence on the expression of the TNF α gene, leading to higher 
circulating concentrations of tumour necrosis factor [51]. The SNP rs1800629 has 
previously been associated with iron deficiency as part of a haplotype together with other 
TNF α SNPs [46], as well as with an increased risk of severe anaemia in low-birth-
weight children in Kenya [52] and increased risk of severe malarial anaemia in Gambian 
children [53]. It has been suggested that this haplotype would only influence iron status 
under pressure of infectious diseases [46]. However, our study was not conducted in a 
malaria endemic area and comprised of apparently healthy adult population. 
Nevertheless, although we excluded subjects with diagnosed HIV infection, there may 
still have been undetected infected individuals in the study population. In addition, over 
half of the subjects were either overweight or obese, which induces low grade 
inflammation. Indeed, 43% of the subjects had raised C-reactive protein concentrations, 
and therefore disease induced inflammatory processes may underlie our findings. 
We observed a combination of single nucleotide polymorphisms consisting of rs228918 
and rs228921 in the TMPRSS6 gene that was associated with lower odds for increased 
sTfR concentrations (sTfR>8.3mg/L), reflecting low iron status. Both SNPs have 
previously been associated with increased haemoglobin concentrations [18]. Genome 
wide association studies have convincingly proven that single nucleotide polymorphisms 
(SNPs) in TMPRSS6  are associated with iron parameters [37, 53], especially iron and 
transferrin saturation but the combinations in the present study have not been described 
before. The exact mechanism by which TMPRSS6  and its encoded protein matriptase-2 
action is exerted is still under investigation. One study proposed that matriptase-2 
regulates hepcidin expression by cleaving HJV to decrease BMP-SMAD signalling [54, 
55]. However, two other studies suggest that the influence of these SNPs is not mediated 
by hepcidin [56, 57]. Further studies are required to ascertain the role of hepcidin in 
TMPRSS6 -iron status parameter associations. 
The strength of our study is the inclusion of potential effect-modifiers as co-variates in 
the association analyses, such as haem iron intake, age, inflammation and area of 
residence. This is not commonly done in association studies, but strengthens the 
confidence in our findings. Moreover, haemoglobinopathies, which are commonly 
prevalent in East and Central Africa, are uncommon in the black South African 
population [58, 59] and therefore do not distort the findings. 
Common variants in the TF, TNF α and TMPRSS6 genes are associated with iron status in a female black 
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 We observed a considerable discrepancy in the prevalence of low iron status when 
estimated using SF (14%) or sTfR (61%). This may be due to the high prevalence of 
inflammation, which increases SF concentrations as an acute phase protein. Despite 
correction for high CRP concentrations, undetected late convalescence of inflammation 
may still have impacted SF concentrations in our study population. Overweight-related 
low-grade inflammation may also have played a role [60]. In the presence of 
inflammation, transferrin receptor concentration is usually regarded as a better 
indicator of iron deficiency [61], but can also be raised due to certain pathologic 
conditions [62]. An alternative to assess iron deficiency in this case would be a bone 
marrow examination (BME) that establishes the absence of stainable iron in the bone 
marrow. BME is, however, invasive, expensive, and requires technical expertise, so that 
it cannot be performed routinely in a field setting. This dilemma stresses once more the 
need to develop an appropriate biomarker to estimate iron deficiency in the presence of 
inflammation. 
In conclusion, we determined several genetic variants and single nucleotide 
polymorphism combinations in the TF, TNF α and TMPRSS6  genes to be associated 
with low iron status in a study population of black South African women. However, 
many of the associations between SNPs and iron status previously described for other 
populations were not replicated in this cohort. This may be explained both by 
heterogeneity in genetic makeup as well as environmental differences between 
populations, especially the extent of inflammation. This calls for population specific 
genome studies rather than inferring genetic data across populations. Discovery and 
validation of additional genetic variants associated with iron status are likely to uncover 
new mechanisms and pathways that affect iron status, offering better insights into iron 
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Locus SNP Genotype n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P 
TMPRSS6 rs1421312 AA 59 13.8 (13.4, 14.3) 0.88 80 78.3 (60.1, 103) 0.68 81 8.8 (8.1, 9.4) 0.42 81 31.3 (30.2, 32.4) 0.76 
 
 AG 191 13.9 (13.7, 14.1) 
 
266 88.9 (76.2, 103) 
 
274 9.2 (8.8, 9.6) 
 
274 31.6 (31.0, 32.2) 
 
 
 GG 220 13.8 (13.6, 14.0) 
 
302 83.3 (72.6, 95.6) 
 
309 9.3 (8.9, 9.6) 
 
309 31.3 (30.7, 31.9) 
 
               
TMPRSS6 rs2111833 GG 256 13.8 (13.6, 14.0) 0.72 344 86.3 (75.9, 98.2) 0.50 352 9.1 (8.8, 9.5) 0.96 352 31.5 (30.9, 32.0) 0.56 
  AG 182 13.9 (13.6, 14.1)  259 80.6 (69.5, 93.5)  265 9.2 (8.8, 9.6)  265 31.2 (30.6, 31.8)  
  AA 33 14.0 (13.5, 14.6)  46 100 (70.5, 143)  48 9.1 (8.2, 10.0)  48 32.1 (30.6, 33.5)  
               
KCDT17 rs2235320 CC 468 13.8 (13.7, 14.0) 0.96 644 85.3 (77.7, 93.7) 0.11 660 9.2 (8.9, 9.4) 0.38 660 31.4 (31.0, 31.8) 0.08 
 
 AC 2 13.8 (11.5, 16.0) 
 
3 27.4 (6.9, 109) 
 
3 10.9 (7.4, 16.3) 
 
3 26.6 (20.9, 32.3) 
 
 








               
TMPRSS6 rs228918 AA 169 13.8 (13.6, 14.1) 0.82 214 83.9 (71.3, 98.9) 0.73 222 9.3 (8.9, 9.7) 0.69 222 31.3 (30.6, 32.0) 0.68 
 
 AG 210 13.8 (13.6, 14.0) 
 
302 88.3 (77.0, 101) 
 
308 9.1 (8.7, 9.4) 
 
308 31.6 (31.0, 32.2) 
 
 
 GG 92 13.9 (13.6, 14.3) 
 
132 80.2 (65.0, 98.8) 
 
134 9.2 (8.6, 9.7) 
 
134 31.2 (30.3, 32.1) 
 
               
TMPRSS6 rs228921 AA 169 13.8 (13.6, 14.1) 0.82 214 84.0 (71.3, 99.0) 0.77 222 9.3 (8.9, 9.7) 0.70 222 31.3 (30.6, 32.0) 0.72 
 
 AG 210 13.8 (13.6, 14.0) 
 
303 87.7 (76.5, 101) 
 
309 9.1 (8.7, 9.4) 
 
309 31.6 (31.0, 32.1) 
 
 
 GG 92 13.9 (13.6, 14.3) 
 
132 80.6 (65.0, 98.8) 
 
134 9.2 (8.6, 9.7) 
 
134 31.2 (30.3, 32.1) 
           
TMPRSS6 rs2413450 GG 384 13.9 (13.7, 14.1) 0.40 532 85.4 (77.0, 94.7) 0.28 545 9.1 (8.9, 9.4) 0.56 545 31.5 (31.0, 31.9) 0.28 
  AG 82 13.6 (13.3, 14.0)  111 79.4 (63.3, 99.6)  113 9.4 (8.8, 10.0)  113 31.1 (30.2, 32.0)  
  AA 5 13.5 (12.1, 14.9)  6 178 (67.2, 472)  7 8.3 (6.4, 10.8)  7 34.1 (30.4, 37.9)  
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TMPRSS6 rs4820268 AA 312 13.9 (13.7, 14.1) 0.25 435 86.8 (77.4, 97.3) 0.58 446 9.1 (8.9, 9.4) 0.95 7 31.5 (31.0, 32.0) 0.71 
 
 AG 142 13.7 (13.4, 14.0) 
 
193 79.4 (66.9, 94.3) 
 
197 9.2 (8.7, 9.6) 
 
197 31.2 (30.5, 31.9) 
 
 
 GG 16 14.3 (13.5, 15.1) 
 
20 101 (58.8, 172) 
 
21 9.4 (8.1, 10.9) 
 
21 32.0 (29.8, 34.1) 
 
               
TMPRSS6 rs5756506 GG 25 13.6 (13.0, 14.2) 0.45 29 96.6 (62.0, 151) 0.66 31 8.0 (7.0, 9.0) 0.07 31 32.1 (30.3, 33.8) 0.68 
  CG 127 13.7 (13.5, 14.0)  180 80.0 (66.9, 95.6)  186 9.2 (8.8, 9.7)  186 31.2 (30.5, 32.0)  
  CC 319 13.9 (13.7, 14.1)  440 86.2 (77.0, 96.7)  448 9.2 (8.9, 9.5)  448 31.5 (31.0, 31.9)  
               
TMPRSS6 rs5756520 GG 136 13.7 (13.4, 14.0) 0.32 172 85.1 (71.1, 102) 0.70 179 9.4 (9.0, 9.9) 0.42 179 31.3 (30.6, 32.0) 0.63 
  AG 219 13.9 (13.7, 14.2)  309 90.4 (79.0, 104)  315 9.0 (8.7, 9.4)  315 31.7 (31.1, 32.2)  
  AA 26 13.6 (12.9, 14.2)  36 76.9 (51.6, 115)  36 9.1 (8.1, 10.2)  36 31.1 (29.5, 32.8)  
               
TMPRSS6 rs855791 GG 412 13.9 (13.7, 14.0) 0.53 566 86.2 (78.0, 95.3) 0.68 578 9.1 (9.0, 9.4) 0.95 578 31.5 (31.1, 31.9) 0.83 
  AG 35 13.7 (13.1, 14.2)  47 74.1 (52.3, 105)  51 9.3 (8.7, 10.2)  51 31.1 (29.7, 32.4)  
  AA 24 13.6 (12.9, 14.2)  36 77.0 (53.5, 119)  36 9.2 (8.1, 10.3)  36 31.2 (29.6, 32.9)  
1
For each SNP, top to bottom rows represent values for the Homozygote wild type, Heterozygotes and Homozoygote minor allele genotypes respectively. 
2
Geometric means 
and confidence intervals presented are adjusted for age, area of residence (rural or urban) and proportion of dietary heme iron intake. 
3
comparisons involving serum ferritin and 
body iron were additionally adjusted for inflammation by including serum C-reactive protein concentrations as a covariate in the model. 
4
P refers to the p value of the SNP 
association with the corresponding outcome measure. *Polymorphism is significantly associated with outcome measure before adjustment for multiple testing (P-values < 0.05). 
BI, body iron (mg/kg); Hb, Hemoglobin (g/dL); SF, serum ferritin (µg/L); sTfR, soluble transferrin receptor (mg/L); TMPRSS6, transmembrane protease serine 6. 
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    Hb   SF   sTfR   BI  
Locus SNP Genotype n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P 
TF rs1358024 GG 465 13.8 (13.7, 14.0) 0.2 636 85.1 (77.4, 93.6) 0.88 652 9.2 (8.9, 9.4) 0.94 652 31.4 (31.0, 31.8) 0.89 
  AG 5 14.7 (13.3, 16.1)  11 71.3 (34.7, 147)  11 9.4 (7.7, 11.6)  11 30.7 (27.7, 33.7)  
  AA 1 16.0 (12.8, 19.2)  2 95.4 (17.6, 517)  2 8.7 (5.4, 14.2)  2 31.9 (24.9, 38.9)  
               
TF rs1525892 GG 220 13.8 (13.6, 14.0) 0.86 307 78.6 (68.6, 90.1) 0.27 316 9.3 (9.0, 9.7) 0.41 316 31.1 (30.6, 31.7) 0.27 
  AG 187 13.9 (13.7, 14.1)  262 92.8 (80.1, 108)  266 9.0 (8.6, 9.4)  266 31.8 (31.2, 32.4)  
  AA 42 13.8 (13.3, 14.3)  51 82.1 (58.7, 115)  54 9.3 (8.5, 10.2)  54 31.3 (30.0, 32.7)  
 






TF rs1799852 GG 437 13.8 (13.7, 14.0) 0.16 603 87.9 (79.8, 96.8) 0.01* 619 9.1 (8.8, 9.3) 0.03* 619 31.6 (31.2, 32.0) 0.004* 
  AG 34 14.2 (13.7, 14.8)  46 54.0 (38.0, 76.7)  46 10.2 (9.2, 11.3)  46 29.4 (27.9, 30.8)  
 
 AA 0 - 
  









     
TF rs1799899 GG 467 13.8 (13.7, 14.0) - 643 84.4 (76.7, 92.7) - 659 9.2 (8.9, 9.4) - 659 31.4 (31.0, 31.8) - 
  AG 0 -  0 -  0 -  0 -  
  AA 0 -  0 -  0 -  0 -  
               
SRPRB rs1830084 AA 325 13.8 (13.6, 14.0) 0.24 457 84.2 (75.3, 94.2) 0.52 469 9.1 (8.8, 9.4) 0.62 469 31.4 (30.9, 31.9) 0.66 
  AT 124 14.1 (13.8, 14.4)  163 88.2 (73.1, 107)  167 9.4 (8.9, 9.9)  167 31.5 (30.8, 32.3)  
  TT 12 13.8 (12.9, 14.7)  15 60.6 (32.6, 113)  15 8.7 (7.3, 10.4)  15 30.3 (27.7, 32.9)  
               
TF rs1867504 GG 242 13.9 (13.7, 14.1) 0.84 332 83.8 (73.4, 95.5) 0.96 341 9.2 (8.9, 9.6) 0.5 341 31.3 (30.7, 31.8) 0.79 
  AG 193 13.8 (13.6, 14.0)  268 86.1 (74.6, 99.6)  278 9.1 (8.8, 9.5)  278 31.5 (30.9, 32.1)  
  AA 36 13.7 (13.2, 14.3)  51 86.0 (60.0, 123)  46 8.7 (7.9, 9.6)  46 31.8 (30.3, 33.2)  
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TF rs3811647 GG 251 13.8 (13.6, 14.0) 0.88 346 77.7 (68.4, 88.3) 0.07 355 9.4 (9.1, 9.8) 0.03* 355 31.0 (30.5, 31.5) 0.03* 
  AG 173 13.9 (13.7, 14.1)  245 97.9 (84.1, 114)  249 8.8 (8.4, 9.1)  249 32.1 (31.5, 32.7)  
 
 AA 47 13.8 (13.3, 14.3) 
 
58 79.0 (57.7, 108) 
 
61 9.4 (8.6, 10.2) 
 
61 31.1 (29.8, 32.4) 
 
               
TF rs3811658 GG 344 13.8 (13.6, 14.0) 0.6 477 86.0 (77.1, 96.0) 0.87 490 9.2 (8.9, 9.5) 0.93 490 31.4 (31.0, 31.9) 0.96 
  AG 111 14.0 (13.7, 14.3)  151 81.1 (66.8, 98.6)  154 9.2 (8.7, 9.7)  154 31.3 (30.5, 32.1)  
  AA 16 13.9 (13.1, 14.7)  21 87.7 (52.1, 148)  21 8.9 (7.7, 10.3)  21 31.5 (29.4, 33.7)  







TF rs4525863 CC 333 13.9 (13.8, 14.1) 0.24 446 84.7 (75.6, 94.8) 0.94 456 9.3 (9.0, 9.6) 0.14 456 31.3 (30.9, 31.8) 0.70 
  AC 125 13.6 (13.4, 13.9)  184 84.6 (70.9, 101)  190 8.9 (8.5, 9.4)  190 31.5 (30.8, 32.3)  
 
 AA 13 13.8 (12.9, 14.7) 
 
19 93.9 (54.1, 163) 
 
19 8.2 (7.0, 9.6) 
 
19 32.2 (29.9, 34.5) 
 
               
TF rs7638018 AA 337 13.8 (13.6, 14.0) 0.76 470 85.0 (76.2, 94.9) 0.99 483 9.1 (8.9, 9.4) 0.88 483 31.4 (31.0, 31.9) 0.99 
  AG 118 13.9 (13.6, 14.2)  158 84.2 (69.5, 102)  161 9.2 (8.8, 9.8)  161 31.4 (30.6, 32.2)  
  GG 16 13.9 (13.1, 14.7)  21 87.7 (52.0, 148)  21 8.9 (7.7, 10.3)  21 31.5 (29.4, 33.7)  
               
TF rs8177248 GG 427 13.8 (13.7, 14.0) 0.39 581 86.1 (78.1, 95.1) 0.34 596 9.2 (8.9, 9.5) 0.65 590 31.4 (31.0, 31.8) 0.64 
  AG 41 13.9 (13.1, 14.1)  63 71.2 (52.7, 96.3)  64 9.0 (8.3, 9.8)  64 30.9 (29.6, 32.1)  
  AA 3 13.9 (13.0, 16.6)  5 137 (47.2, 401)  5 8.0 (5.9, 10.9)  4 32.3 (27.3, 37.2)  
1
For each SNP, top to bottom rows represent values for the Homozygote wild type, Heterozygotes and Homozoygote minor allele genotypes respectively. 
2
Geometric means 
and confidence intervals presented are adjusted for age, area of residence (rural or urban) and proportion of dietary heme iron intake. 
3
comparisons involving serum ferritin and 
body iron were additionally adjusted for inflammation by including serum C-reactive protein concentrations as a covariate in the model. 
4
P refers to the p value of the SNP 
association with the corresponding outcome measure. *Polymorphism is significantly associated with outcome measure before adjustment for multiple testing (P-values < 0.05). 
BI, body iron (mg/kg); Hb, Hemoglobin (g/dL); SF, serum ferritin (µg/L); sTfR, soluble transferrin receptor (mg/L); SRPRB, signal recognition particle receptor, B subunit TF, 
transferrin. 
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     Hb   SF   sTfR   BI  
Chr # Locus SNP Genotype n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P n Mean (95% CI) P 
1 OPRD1 rs482692 GG 332 
 
13.8 (13.6, 14.0) 0.83 449 81.4 (72.7, 91.1) 0.34 463 9.2 (8.9, 9.5) 0.67 463 31.2 (30.8, 31.7) 0.28 
   
AG 106 13.8 (13.5, 14.1)  152 96.1 (79.1, 117)  154 9.0 (8.5, 9.5)  154 31.9 (31.1, 32.7)  
   
AA 31 14.0 (13.4, 14.6)  43 80.3 (55.8, 116)  43 9.5 (8.5, 10.5)  43 31.1 (29.6, 32.6)  
      





6 TNF α rs1799964 AA 314 13.9 (13.7, 14.1) 0.43 439 89.6 (79.8, 101) 0.26 439 9.2 (8.9, 9.5) 0.83 439 31.6 (31.1, 32.1) 0.49 
   AG 138 13.8 (13.6, 14.1)  190 77.9 (65.5, 92.6)  196 9.1 (8.7, 9.6)  196 31.1 (30.4, 31.8)  
   GG 19 13.4 (12.6, 14.1)  30 68.7 (44.4, 106)  30 8.9 (7.8, 10.0) 
 
 
30 30.8 (29.0, 32.6)  
   
   
    
      
6 TNF α rs1800629 GG 332 13.8 (13.7, 14.0) 0.76 440 84.4 (75.4, 94.6) 0.19 452 9.2 (8.9, 9.5) 1.00 452 31.4 (30.9, 31.9) 0.24 
   AG 128 13.9 (13.6, 14.1)  193 82.2 (69.2, 97.5)  197 9.2 (8.7, 9.6)  197 31.3 (30.6, 32.0)  
   AA 11 13.5 (12.5, 14.5)  16 147 (80.6, 266)  16 9.1 (7.7, 10.8)  16 33.4 (30.9, 35.9)  
  
    





6 HFE rs1800562 GG 471 13.8 (13.7, 14.0) - 649 84.9 (77.3, 93.2) - 665 9.2 (8.9, 9.4) - 665 31.4 (31.0, 31.8) - 
   AG 0 -  0 -  0 -  0 -  
   AA 0 -  0 -  0 -  0 -  
  
    
  
        
6 NFKBIL1 rs2071592 TT 54 13.7 (13.3, 14.2) 0.79 82 74.0 (56.9, 96.3) 0.18 83 9.0 (8.4, 9.7) 0.68 83 31.0 (29.9, 32.0) 0.26 
   AT 225 13.9 (13.7, 14.1)  310 80.8 (70.6, 92.6)  320 9.3 (8.9, 9.6)  320 31.2 (30.6, 31.8)  
   AA 192 13.8 (13.6, 14.1)  257 94.2 (81.1, 109)  262 9.1 (8.7, 9.5) 
 
 
262 31.8 (31.2, 32.4)  
                
7 TFR2 rs7385804 AA 243 13.8 (13.6, 14.0) 0.77 331 77.6 (68.0, 88.5) 0.14 339 9.2 (8.9, 9.5) 0.97 339 31.1 (30.5, 31.6) 0.17 
   AC 188 13.9 (13.7, 14.1)  262 93.3 (80.5, 108)  269 9.1 (8.8, 9.5)  269 31.8 (31.1, 32.4)  
   CC 37 13.8 (13.3, 14.4)  53 97.0 (70.0, 135)  54 9.2 (8.4, 10.1)  54 31.9 (30.5, 33.2)  
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10 CUBN rs10904850 GG 236 13.8 (13.6, 14.0) 0.62 330 82.6 (72.4, 94.2) 0.84 338 9.2 (8.9, 9.6) 0.62 338 31.3 (30.7, 31.8) 0.81 
 
  AG 195 13.9 (13.7, 14.2)  268 87.4 (75.5, 101)  273 9.0 (8.7, 9.4)  273 31.6 (31.0, 32.2)  
 
  AA 40 13.8 (13.3, 14.3)  51 87.3 (62.4, 122)  54 9.5 (8.6, 10.4) 
 
 54 31.4 (30.0, 32.8)  
                
19 HAMP rs10421768 AA 348 13.8 (13.7, 14.0) 0.43 470 82.4 (73.8, 91.1) 0.84 481 9.3 (9.0, 9.6) 0.84 481 31.2 (30.8, 31.7) 0.73 
   AG 115 13.9 (13.6, 14.2)  166 94.5 (78.5, 117)  171 8.8 (8.4, 9.3)  171 31.9 (31.2, 32.7)  
   GG 8 13.7 (12.6, 14.9)  13 65.3 (33.6, 116)  13 8.7 (7.2, 10.5) 
 
 
13 30.6 (27.9, 33.4)  
 




        
18 near TMPRSS6 rs9948708 GG 150 13.7 (13.5, 14.0) 0.97 198 82.6 (68.7, 96.5) 0.33 206 9.2 (8.8, 9.7) 0.19 206 31.2 (30.5, 31.9) 0.32 
   AG 228 13.9 (13.7, 14.1)  316 87.4 (76.0, 99.5)  321 9.1 (8.7, 9.4)  321 31.5 (32.0, 32.1)  
   AA 93 14.0 (13.7, 14.3)  135 87.3 (69.5, 105)  138 9.2 (8.7, 9.8) 
 
 
138 31.4 (30.5, 32.2)  
1
For each SNP, top to bottom rows represent values for the Homozygote wild type, Heterozygotes and Homozoygote minor allele genotypes respectively. 
2
Geometric means 
and confidence intervals presented are adjusted for age, area of residence (rural or urban) and proportion of dietary heme iron intake. 
3
comparisons involving serum ferritin and 
body iron were additionally adjusted for inflammation by including serum C-reactive protein concentrations as a covariate in the model. 
4
P refers to the p value of the SNP 
association with the corresponding outcome measure. *Polymorphism is significantly associated with outcome measure before adjustment for multiple testing (P-values < 0.05). 
BI, body iron (mg/kg); CUBN, cubilin (intrinsic factor-cobalamin receptor); HAMP, hepcidin antimicrobial peptide; Hb, Hemoglobin (g/dL); HFE, hemochromatosis; NFKBIL1, 
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; OPRD1, opioid receptor, delta 1; SF, serum ferritin (µg/L); sTfR, soluble transferrin receptor 
(mg/L); TF, transferrin; TFR2, transferrin receptor 2; TMPRSS6, transmembrane protease, serine 6; TNF α, tumor necrosis factor. 
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Abstract 
Background: Large genome-wide association (GWA) studies of European ancestry 
individuals have identified multiple genetic variants influencing iron status. Studies on 
the generalizability of these associations to African ancestry populations have not been 
conducted. These studies are important given interethnic differences in iron status and 
the disproportionate burden of iron deficiency among African ancestry populations. 
Methods: We tested the associations of 20 previously identified iron status-associated 
single nucleotide polymorphisms (SNPs) in 628 Kenyans, 609 Tanzanians, 608 South 
Africans and 228 African Americans. In each study, we examined the associations 
present between 20 SNPs with ferritin and haemoglobin, adjusting for age, sex and CRP 
levels. 
Results: We replicated previously reported associations with lowered haemoglobin 
concentrations for two SNPs (rs2413450, rs4820268) in TMPRSS6 and increased 
haemoglobin concentrations with a locus in TF (rs3811658).  Associations with increased 
ferritin concentrations were also confirmed for two loci, in TMPRSS6   (rs228918) and in 
TF (rs1525892).  
Conclusions: Only 4 of the 20 single nucleotide polymorphisms reported in large GWA 
studies of European ancestry individuals were associated with iron status in the African 
ancestry cohorts included in our study. While there is now evidence for the associations 
of a number of genetic variants with iron status in both European and African ancestry 
populations, the considerable lack of concordance highlights the importance of continued 
ancestry-specific studies to elucidate the genetic underpinnings of iron status in 
ethnically diverse populations. 
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Introduction 
Body iron status is influenced by a combination of genes as well as environmental factors 
like diet, blood loss, pregnancy, alcohol intake and infections [1, 2]. In order to maintain 
iron levels within normal ranges and thus prevent iron excess or iron deficiency, iron 
homeostasis has evolved as a complex trait and a tightly coordinated process of 
interaction between genes and environmental factors. Whether genetic influences on 
iron metabolism may affect iron status at the public health level, is a subject of recent 
interest. This is because segments of populations that are genetically prone to iron 
deficiency can be targeted for interventions. 
Understanding the genetic underpinnings of low iron status is particularly relevant for 
African ancestry populations, who experience a disproportionately high burden of low 
iron status. In particular, it has been observed that in the US, African-Americans have 
lower haemoglobin concentrations and serum transferrin saturation (TS), and higher 
serum ferritin (SF) concentrations compared to Caucasians [3]. Furthermore, according 
to WHO regional prevalence estimates, Africa has the highest proportion of individuals 
affected by anaemia worldwide [3].  
Previous studies on iron status report heritability estimates ranging from of 20% to 30%, 
supporting a genetic component to iron status [4, 5]. Genome-wide association (GWA) 
studies have identified common variants, some in genes associated with Mendelian 
forms of iron deficiency, to be in association with variability in iron status in largely 
European ancestry populations [6-9]. Given the greater levels of linkage disequilibrium 
among European-ancestry individuals [10], it is expected that index single nucleotide 
polymorphisms (SNPs) tag larger regions of the genome than they would among African 
ancestry individuals. Since African populations are exposed to different environmental 
factors that further influence iron status, this may hamper the potential to generalize 
the results from European ancestry populations to African ancestry populations. 
Recently, genetic studies on iron status have also been conducted in the African 
American population [11-15]. This population has varying degrees of admixture that 
may also complicate transferability of these results to African populations [16]. 
Conclusive inferences about the potential generalization of previous findings to African 
ancestry populations have been precluded by the lack of data from African cohorts. In 
the present replication study, we investigated 20 SNPs previously reported to be 
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associated with iron status in GWA studies [6, 7, 9, 13, 17] with haematological 




Study area and population  
 
Four cohorts of African ancestry were selected; from Kenya (n=628), Tanzania (n=609); 
South Africa (n=686) and the United States of America (n=228). The four cohorts differed 
largely in age, gender and burden of inflammation as described in more detail below. 
  
Kenyan cohort 
Samples were obtained from both a cross sectional survey  and from the baseline data of 
an efficacy trial designed to assess the efficacy of bio-fortified cassava to improve vitamin 
A deficiency [18]. Haematological parameters were measured prior to the start of the 
trial. Ancestry was determined by self-report in both studies and consisted of children of 
Kamba (Bantu) ancestry. Cross sectional samples were collected from children aged 6-12 
years (n=375) who were located in the Kibwezi and Makindu districts in Eastern Kenya. 
Trial samples were collected from children aged 5-13 years (n=437) in three primary 
schools in the Kibwezi district, Eastern Kenya. Kibwezi and Makindu that are low 
malarial transmission areas [19]. For the trial, children with low retinol binding protein 
concentrations (0.70 μmol/L) were selected. For both studies. subjects were apparently 
healthy and without fever (ear drum temperature < 37.5°C) upon examination by the 
research physician and children with inflammation (C-reactive protein concentration > 
8mg/L), low haemoglobin concentrations (<70 g/L), or malaria were excluded. The cross 
sectional survey as well as the trial were approved by ethical committees in Kenya and 
the Netherlands. Informed consent was obtained from parents and assent from children. 
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Children in this cohort were part of a randomized placebo controlled trial [20]. 
Haematological parameters as well as all other mesures were measured prior to the 
start of the trial and ancestry was self-reported. People in this area originally belonged 
to the Wazigua and Wabondei Bantu tribes, but settlement of migrant plantation 
workers in the past has resulted in the admixture of many tribes with different origins. 
Samples were obtained from children aged 6-60 months (n=612) with height-for-age z-
score ≤ –1.5 SD in a rural area of the Handeni district in North-Eastern Tanzania, which 
has intense year-round Plasmodium falciparum transmission. Children with severe 
wasting (weight-for-age z-score < –3 SD), haemoglobin concentration < 70 g/L, malaria, 
or signs of chronic illness, were excluded. The study was approved by the Ethical Review 
Committee of Wageningen University, The Netherlands (Approval number: NL: 04/07) 
and the National Health Research Ethics Review sub-Committee, Dar es Salaam, 
Tanzania. Written individual informed consent was obtained from parents or primary 
caretakers.  
 
South African cohort 
This study population was a subset of Tswana speaking pre- and post-menopausal 
women (n=686) enrolled as part of the South African arm of the Prospective Urban and 
Rural Epidemiological (PURE) study. Haematological measures utilized in this study 
were collected in a follow up study conducted in 2010. The participants were from the 
North-West Province in South Africa, aged 35 years or older and were mainly of Tswana 
(Bantu) ancestry as determined by self-report. Women were only eligible for this sub-
study if they were apparently healthy, not pregnant, non-lactating and were at the time 
of blood collection not diagnosed with any chronic disease or taking drugs for any chronic 
disease. Additionally, we included only participants with all outcome measures 
determined and who were HIV negative. HIV testing was undertaken with the 
appropriate pre- and post-test counselling as required by South African law. This study 
was approved by the Ethics Committee of the North-West University and signed 
informed consent forms were received from all participants.  
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African American cohort  
This cohort consisted of participants from the Baltimore Longitudinal Study on Aging 
(BLSA). The BLSA is a population-based study aimed at evaluating contributors of 
healthy aging in the older population residing predominantly in the Baltimore-
Washington DC area [21]. Started in 1958, participants aged 17-94 years were examined 
every one to four years depending on their age. Currently, there are approximately 1,100 
active participants enrolled in the study. For the present study, 228 subjects of African 
ancestry with complete data on both genetic and haematological traits were available 
and were used for the analysis. The BLSA has continuing approval from the 
Institutional Review Board (IRB) of Medstar Research Institute as well as from study 
participants. 
 
Iron related measurements  
 
Kenyan and Tanzanian cohorts 
For the cross sectional study study (Kenyan cohort), serum concentrations of CRP were 
determined by immunoturbidometric assays on a Cobas Integra 800 system (Roche 
Diagnostics, Mannheim, Germany). Serum ferritin concentrations were determined by 
enzymatic immunoassay (Ramco Laboratories, Inc, Stafford Texas). For the Kenyan 
efficacy trial as well as Tanzanian cohort, concentrations of ferritin and concentrations of 
CRP were measured on a Beckman Coulter UniCel DxC 880i analyzer as per 
manufacturer’s instructions. Haemoglobin concentration (Hb) was assessed using a 
hematology analyzer (Celltac-α, MEK-6410K, Nihon Kohden Corporation, Tokyo, Japan).  
 
South African cohort 
Serum concentrations of CRP were measured from serum via a particle-enhanced 
immunoturbidometric assay using Sequential Multiple Analyser Computer (SMAC) 
using the Konelab20iTM auto analyser (Thermo Fisher Scientific Oy, Vantaa, Finland). 
Whole blood was used for the determination of HIV status making use of the First 
Response (PMC Medical, India) rapid HIV Card Test. If tested positive, the test was 
repeated with the Pareeshak (BHAT Bio-tech India) card test. Serum ferritin was 
determined using an enzyme immunoassay procedure (Ramco Laboratories, Inc, Stafford 
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Texas). Hb concentrations were determined spectrophotometrically from whole blood 
using the Hemocue® HB201 haemoglobin meter (Hemocue AB, Angelholm Sweden).  
 
African American cohort  
Serum concentrations of CRP were measured using the BNII nephelometer from Dade 
Behring utilizing a particle enhanced immunonepholometric assay.  
 Serum ferritin was measured using an immunoassay type two-stage sandwich method 
using two antiferritin antibodies (Advia Centaur, Bayer). Haemoglobin was assessed 
using SYSMEX XE-series (Sysmex Corporation).  
 
SNP selection, genotyping and quality control procedures 
 
SNP selection 
To set up the assay it was necessary to develop a list of reference SNPs (rs) numbers 
from Genbank of the SNPs that are to be included in the analysis. This list was setup by 
performing a literature search of Pubmed, Sciencedirect, Ebscohost, HUGE navigator 
and Google Scholar using the following keywords: 
a. Iron, ferritin, transferrin 
b. Anaemia 
c. Haemochromatosis 
d. Human  
e. SNP, Polymorphism, Mutation 
f. Genetic 
All abstracts were scanned for appropriateness of use, that is,  association or linkage of a 
SNP to the haematological parameters or key biomarkers of iron status (Hb, SF, serum 
transferrin receptor (sTfR) and body iron (BI)). If appropriate, the reference SNP (rs) 
number of the polymorphism was recorded and included in the list to be sent to Illumina 
for verification of use in the array. Based on this, we selected 32 SNPs for genotyping. 
Once SNPs were selected, genotyping was performed for the Kenyan, Tanzanian and 
South African cohorts. These data were complemented with the data we obtained from 
the African American cohort in the BLSA. 
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Genotyping and quality control procedures 
For the Kenyan, Tanzanian and South African cohorts, all 32 rs numbers were 
submitted to Illumina Technical Support for evaluation using the Assay Design Tool. 
Each SNP was scored (varying from 0 to 1) by the same, based on its compatibility for 
use in a GoldenGate genotyping assay. SNPs with a score above 0.4 were chosen for 
genotyping. No SNP fell out based on these criteria. Genotyping for Kenyan (efficacy 
trial only), South African and Tanzanian cohorts was conducted using the BeadXpressTM 
platform. Once genotyping was performed, several quality control procedures were 
applied. Lack of a detectable signal after analysis was designated as a failed SNP. SNP 
clustering was also assessed visually to determine success of genotyping. SNPs with a 
GenCall Score of >0.5 and samples with a call rate of ≥0.95 were included in the final 
analysis. Genotyping was performed for only three SNPs in TMPRSS6  (rs2413450, 
rs4820268, rs228918), for the Kenyan pilot study samples using Applied Biosystems 
TaqMan Assays. Data obtained with this method were merged with the data from the 
Kenyan efficacy trial. Eventually, we considered 20 SNPs that had passed all quality 
control procedures in all four cohorts for association analyses (Supplementary table 1).  
For the African American cohort,  genome-wide genotyping was conducted using the 
Illumina Infinium HumanHap 550K. Genotyping was completed for 284 subjects, and 
imputation of ~2.5 million HapMap SNPs was conducted using 501,764 SNPs that 
passed quality control (minor allele frequency > 1%, genotyping completeness > 99%, and 
Hardy Weinberg-equilibrium > 0.0001). Imputation was conducted with MACH using 
the HapMap YRI sample (HapMap data release rel#23a NCBI B36) as a reference. The 
candidate iron-homeostasis SNPs that were either directly genotyped or imputed (with 




Outcome variables (haemoglobin and serum ferritin concentrations) were determined to 
be continuous quantitative traits. Anaemia was defined using different cut offs for each 
cohort as cut offs are age dependent [22]. Cut offs were as follows: Hb concentration 
<11.5 g/dL (Kenyan cohort), <11 g/dL (Tanzanian cohort), <12 g/dL for the South African 
and African American cohorts, while iron deficiency was defined as serum ferritin cut-off 
<15µg/l for Kenyan, South African and African American samples, and plasma ferritin 
<12µg/l for Tanzanian samples. Log10 transformations were applied to the ferritin 
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outcomes to improve their fit to the normal distribution. Results from associations 
involving ferritin were then presented as back transformed data. Potential disturbances 
in the distributions of the genotypes were tested for deviation from the assumptions of 
Hardy Weinberg equilibrium (HWE) by using the Chi-square test. To compare minor 
allele frequencies (MAFs) across cohorts, a spider web graph was generated using 
Microsoft Excel (Version 2010), including European ancestry populations from the 1000 
Genomes Project [30]. Linear regression was used to assess associations between SNPs 
and outcome measures. For association testing, genotypes were coded as 0, 1, and 2 
reflecting the number of copies of the minor allele (additive genetic model), while 
imputed genotypes were coded using fractional counts between 0 and 2 according to the 
estimated number of copies of each minor allele. All associations were adjusted for age 
and gender. Additionally, associations involving ferritin concentrations were adjusted for 
inflammation by including CRP concentrations as a covariate in the model. Statistical 
analyses were performed using version 20 of the Statistical Package for Social Sciences 
(SPSS Inc Chicago III) or SAS version 9.2 (Cary, NC). All reported P-values were two-
tailed, and adjustment for multiple testing was performed using the false discovery rate 
(FDR) method. The R program for statistical computing version 2.15.2 [23] was used to 
perform all meta-analyses and chi square tests conducted to test for between studies. 
Comparisons of effect sizes and directions were made within and across populations, and 
meta-analyses were performed to generate summary effect estimates with and without 
including the African American cohort. Statistical significance for all analyses was 
defined as α < 0.05, while the q values cut-off was set at 0.05. 
 
Results  
There were differences in age between the cohorts, as the studies from Kenya and 
Tanzania were pre- and school going children, while the studies from South Africa and 
the United States were of older adults. With the exception of the South African cohort 
which was all women, the sex distribution was approximately 50% (Table 1). Prevalence 
of inflammation  was below 5% in the Kenyan and African American cohort and 33% and 
43% in the Tanzanian and South African cohort, respectively. Iron deficiency was 
highest in the Kenyan cohort (37%) and lowest in the African American cohort (3%-Table 
1). Anaemia  was highest in the Tanzanian cohort at 32%, and lowest in the Kenyan 
cohort at 7%. 
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$ Values are geometric means (confidence intervals) or otherwise means (±SD), Inflammation cut-off CRP>5mg/L, ID-SF cut-off <15µg/l for Kenyan and 
South African samples and PF <12µg/l for Tanzanian samples, Anaemia cut-off Hb concentration <11.5 g/dL for Kenyan cohort, <11 g/dL for Tanzanian 
cohort, <12 g/dL for the South African and African American cohorts Hb = Haemoglobin, CRP = C-reactive protein 
In comparing minor allele frequencies across cohorts, SNPs genotyped were generally more common in European ancestry cohorts based 
on data from the 1000 Genomes Project (Figure 2). We examined the differences in MAFs of TMPRSS6  SNPs between Europeans and 
Africans using data from the 1000 Genomes Project. In particular, for the commonly investigated rs4820268 SNP, the frequency of the 
allele associated with lower iron status was 27%, 22%, 18%, and 30% in the Kenyan, Tanzanian, South African and African American 


















Age, y 628 9.0 (2.1) 609 2.7 (1.3) 686 50.0 (10.0) 228 67.4 (11.0) 
Gender (% female) 621 52 609 51 686 100 228 59 
Haemoglobin (g/dL) 626 13.9 (1.6) 607 10.3 (12.8) 481 13.8 (1.6) 228 13.0 (1.4) 
Ferritin (µg/L)$ 623 17.8 (17.0,18.6) 603 31.6 (31.6, 39.8) 686 85.1 (77.6, 93.3) 221 103.4 (96.6) 
Inflammation (%) 620 3 609 33 290 43 228 5 
Anaemia (%) 626 7 609 32 481 8 227 19 
Iron deficiency (%) 623 37 606 18 686 11 227 3 
Chapter 4 
107 | P a g e  
 
The MAF of this SNP in the African American cohort was closest to that of the Africans 
(31%) in the 1000 Genomes Project. In comparison to the Europeans (41%, 1000 
Genomes Project), all  the African ancestry cohort have lower MAFs for this SNP. For 
the SNP rs2413450, MAFs were ~12% in the Kenyan, Tanzanian and South African 
cohorts and 24% in the African American cohort. These frequencies were comparable to 
those of Africans in the 1000 Genomes Project (17%), however, they were lower than 
what has been observed in Europeans within the 1000 Genomes Project (42%). 
Minor allele frequencies of rs228918 were (~40%  across our African ancestry cohorts  
and comparable to those of the Europeans (41%) and Africans (40%) in the 1000 
Genomes Project. On the other hand rs1421312 was more common in the African cohorts 
(Kenya=58%, Tanzanian=66% and South Africa=68%) compared to the Europeans in the 
1000 Genomes Project (41%), but had a comparable 
MAF to that of the Africans in the 1000 Genomes Project (58%). For the same SNP 
(rs1421312), the African American cohort had a MAF of 43%. For rs4820258 and 
rs2413450, the minor allele is the risk allele while for rs1421312 and rs228918 there is 
no clear evidence whether the minor allele is the risk allele. 
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Figure 1: Minor allele frequency of SNPs in comparison to African and European 
population in 1000 Genomes Project 
MAF 1000 A, Minor allele frequency Africans- 1000 genomes; MAF 1000 E, Minor allele 
frequency Europeans- 1000 Genomes Project 
In linear regression analyses with haemoglobin concentrations as the dependent 
outcome, inverse associations were observed for the A allele of rs10904850 in CUBN  (-
=0.38, 95 CI 0.07, 0.69g/dL; P=0.02) as well as the G allele of rs4820268 in TMPRSS6 
(=-0.28 , 95 CI 0.22, 0.34 µg/L; P=0.01) in the Kenyan children (Table 2). Conversely, 
the minor allele A of rs10421768 in HAMP was positively associated with Hb 
concentrations (=0.37 , 95 CI 0.10, 0.64 µg/L; P=0.01) in this population.  
After meta-analyses of data from all three African cohorts, the minor allele (T) of 
rs3811658 in TF was associated with an higher Hb concentrations of 0.36 g/dL (P=0.02) 
while minor alleles of both rs2413450 (A) and rs4820268 (G) in TMPRSS6  were 
associated with a lower Hb concentrations of 0.23 g/dL and 0.18 g/dL respectively 
(P=0.01 for both associations). These associations remained similar after including the 
African American cohort in the meta-analysis. There was no heterogeneity between 
studies for these SNPs. 
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Table 2: Associations of single nucleotide polymorphism with iron status parameters in four cohorts of African ancestry with meta-
analyses 
 
SNP=Single nucleotide polymorphism; Ke=Kenyan cohort; Tz=Tanzanian cohort; SA=South African cohort; AA=African American cohort; Met-African=meta analyses of beta and SE values 
from African cohorts; Met_All= meta analyses of beta and SE values from African cohorts; Direction=direction of association based on beta value Hb=Haemoglobin, Values in bold are 
significant. Results are presented as mean (SE) change per copy of the minor allele from regression analysis using additive genetic model and with adjustment for age and sex for 
associations involving Hb, and age and sex and CRP concentrations for associations involving ferritin. Ferritin values are Log10 back transformed data. † Values not adjusted for gender as all 
participants were women, Values in bold are significant before FDR correction for multiple testing. Variance explained ranged from < 1% to 3 %, with the highest being 3% for rs10421768 in 
the Kenyan population 
 
  
















Allele β (se) P β (se) P β (se) P β (se) P 
P 




g/dL TF                 
 
rs3811658 3 T 0.01(0.13) 0.95 1.57(0.99) 0.11 0.10(0.04) 0.49 0.36(0.04) 0.02 0.26 0.08(0.16) 0.61 0.09(0.03) 0.01 0.45 
CUBN                 
 
rs10904850 10 A -0.38(0.16) 0.02 0.91(1.19) 0.44 0.07(0.11) 0.56 -0.11(0.10) 0.14 0.05 0.03(0.16) 0.86 -0.07(0.14) 0.63 0.10 
HAMP                 
 
rs10421768 19 A 0.37(0.14) 0.01 0.46(0.94) 0.62 -0.01(0.15) 0.93 0.19(0.18) 0.29 0.17 0.14(0.12) 0.12 0.17(0.10) 0.09 0.30 
TMPRSS6                 
 
rs2413450 22 A -0.20(0.12) 0.10 -0.65(1.13) 0.57 -0.23(0.18) 0.20 -0.23(0.10) 0.01 0.93 -0.09(0.14) 0.55 -0.19(0.08) 0.02 0.84 
 
rs4820268 22 G -0.28(0.11) 0.01 -0.26(0.87) 0.76 -0.05(0.14) 0.74 -0.18(0.07) 0.01 0.43 -0.09(0.13) 0.48 -0.16(0.07) 0.04 0.55 
Ferritin TF                 
µg/L rs1525892 3 A 1.01(1.06) 0.80 1.05(1.07) 0.46 1.09(1.08) 0.26 1.05(0.62) 0.05 1.00 1.10(1.10) 0.37 1.07(0.54) 0.04 1.00 
 
rs1799852 3 A -0.98(1.09) 0.80 1.20(1.15) 0.18 -0.62(1.2) 0.01 -0.15(0.68) 0.41 0.34 1.23(1.17) 0.21 0.18(0.60) 0.76 0.37 
TFR2                 
 
rs7385804 7 C -0.86(1.07) 0.02 -0.95(1.08) 0.48 1.15(1.08) 0.06 1.03(0.64) 0.05 0.27 1.07(1.10) 0.52 0.09(0.58) 0.88 0.32 
TNF                 
 rs1800629 6 A 1.02(1.10) 0.85 1.05(1.12) 0.62 1.03(1.09) 0.74 1.03(0.64) 0.10 1.00 -0.76(1.15) 0.03 0.61(0.56) 0.27 0.60 
 TMPRSS6                 
rs228918 22 G -0.99(1.04) 0.90 1.05(1.07) 0.55 -1.02(1.07) 0.75 -0.33(0.68) 0.62 0.32 1.10(1.10) 0.25 0.01(0.60) 0.02 0.29 
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The minor allele of rs1799852 in TF was associated with lower SF concentrations in the 
South African cohort (0.62 µg/L; P=0.01). Additionally, the minor alleles of rs7385804 in 
TFR2 and of rs1800629 were associated with decreased ferritin concentrations in the 
Kenyan and African American cohorts (0.86 µg/L, P=0.02; and -0.76 µg/L, P=0.03, 
respectively). After meta-analyses of data from all three African cohorts, no significant 
associations were observed, although, associations with the minor alleles of rs1525892 
and rs1867504 in TF and of rs7385804 in TFR2 were marginally significant (P=0.05). 
After including the African American cohort in the meta-analysis, the minor alleles of 
rs1525892 in TF and rs228918 in TMPRSS6  were both significantly associated with 
increased serum ferritin concentrations (1.7 µg/L, P=0.02; and 0.01 µg/L, P= 0.04, 
respectively). Complete information on associations of all 20 SNPs with concentrations of 
haemoglobin and serum ferritin can be found in Supplementary table 1. None of the 
associations for either Hb or SF as outcome measures were significant after FDR 




We report here the first candidate gene association study focussing on the genetics of 
iron status in selected African ancestry populations. We have observed significant 
associations with lower Hb concentrations involving the minor alleles A of rs2413450 
and G of rs4820268, both in the TMPRSS6  gene, and the minor allele T in rs3811658 in 
the TF gene. In associations with SF concentrations, the minor alleles A in rs1525892 of 
TF and G in rs228918 of TMPRSS6 were associated with increased ferritin 
concentrations. Additionally, there were marginally significant associations for the 
minor alleles of rs1525892 and rs1867504 in TF and rs7385804 in TFR2 with increased 
serum ferritin concentrations. We further observed that many of the candidate SNPs 
genotyped in our cohorts, were more common in the European ancestry cohort in the 
1000 Genomes Project as compared to our African ancestry cohorts. 
 The most consistent association in terms of direction as well as statistical significance 
was observed for rs2413450 and rs4820268 in the TMPRSS6  gene. Similar observations 
have previously been made within populations of European and Asian ancestry [6, 9, 24, 
25]. The exact mechanism through which TMPRSS6 action is exerted is still under 
investigation. It has generally been hypothesised that TMPRSS6  polymorphisms affect 
hepcidin transcription, thereby influencing hepcidin concentrations in response to 
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systemic iron concentrations [26-28]. However, two recent studies [29, 30] did not 
confirm an intermediate role for hepcidin in the SNP-iron status parameter associations. 
Currently, it is proposed that matriptase-2 could regulate hepcidin expression by 
cleaving HJV to decrease BMP-SMAD signalling [31].  
We also observed associations between rs3811658 in the TF gene and increased 
Hb concentrations. This SNP is in linkage disequilibrium with rs3811647 that has 
previously been negatively associated with serum iron, serum transferrin, serum 
transferrin receptor, body iron and serum ferritin concentrations and positively 
associated with serum transferrin concentrations, as well as transferrin saturation [8, 
32]. Also, the SNP has been associated with increased risk of iron deficiency in a 
population of men and women of European descent. As we would have expected to see 
negative associations with haemoglobin concentrations based on the previous 
observations, this finding requires further investigation. Previously, three variants in TF 
(rs3811647, rs1799852 and rs2280673) plus the HFE C282Y mutation have been 
observed to explain approximately 40% of genetic variation in serum transferrin. This 
once again indicates the importance of the TF  locus in iron metabolism. We however 
only observed significant associations of rs1799852 with serum ferritin in the South 
African cohort. Furthermore, we did not have information on associations of rs2280673 
and HFE C282Y. As stated above, transferrin (TF) is a crucial biological carrier of iron in 
blood plasma [33], thus, severe mutations in the transferrin gene lead to 
atransferrinaemia [34], and have been determined to cause microcytic anaemia 
accompanied by hepatic accumulation of iron in humans [35] and mice [36]. Further 
investigations are required to determine whether less severe mutations in transferrin, 
which cause some loss in iron binding capacity, may lead to iron deficiency.  
We observed that none of the associations for either Hb or SF as outcome measures were 
significant after FDR correction for multiple testing. This indicates that the study was 
probably underpowered to detect associations. 
A large portion of iron deficiency undoubtedly results from non-genetic factors. 
Environmental factors such as diets low in bioavailable iron [37] as well as a high 
inflammation burden [38], are probably the foremost factors predisposing to iron 
deficiency. In this regard, it would have been more informative if iron status were 
corrected for iron intakes. We attempted to correct for this in the African American as 
well as South African cohorts, and there was negligible difference between the crude and 
adjusted regression models. This was, however, not undertaken for the Kenyan and 
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Tanzanian cohorts where this consideration may have been even more vital, as diets in 
African populations are typically low in bioavailable iron [39]. To account for other 
environmental and individual influences on iron status, we have adjusted for major 
biological confounders that affect Hb and ferritin concentrations including age, gender 
[40] and acute phase proteins CRP [38] to increase precision. Age and gender are a 
physiological characteristic that influences iron status [41, 42], and since all association 
analyses were corrected for age and gender, variation in Hb and ferritin due to these 
factors was accounted for. 
It is noteworthy that we did observe population specific significant associations that 
were not replicated in all cohorts. This was particularly observed in the Kenyan cohort 
that consisted of school going children (mean age 9.0 years). In this cohort we specifically 
highlight the association of the A allele of rs10421768 in HAMP with Hb. The HAMP 
gene encodes hepcidin, which is a 25-amino acid peptide produced and secreted mainly 
by hepatocytes and is a major regulator of systemic iron homeostasis [31]. No functional 
studies to investigate the role of the assessed HAMP polymorphism on hepcidin 
expression of healthy subjects have previously been performed. There is therefore a need 
for further investigation to examine how this polymorphism affects hepcidin 
concentrations. Knowledge of this would be useful to assess responsiveness to iron 
interventions designed to alleviate iron deficiency.  
A limitation inherent to our study is that our cohorts were smaller than those used in 
GWA studies and therefore may have lacked power to confirm previously observed 
associations. The sample size for detecting associations between disease and SNP 
markers is affected by prevalence of the condition under study, allele frequency, linkage 
disequilibrium (LD), inheritance models (e.g., additive, dominant, and multiplicative 
models), and effect size of the genetic variants (e.g., odds ratio, relative risk, etc.) [43-45]. 
For example, assuming an additive model, 780 individuals are required to conduct 
association analyses for a SNP explaining 1% of the variation in the outcome measure, 
with α = 0.05 and power of 80 %. Most of the SNPs investigated in this study explained 
less than 1% of the variation in iron status thereby requiring a larger sample size. All of 
our cohorts were not specifically designed to study the genetics of iron metabolism and 
therefore all these factors were not taken into account. However our study does offer an 
initial indication of what genetic loci would be important for iron status in African 
ancestry cohorts. 
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Another important consideration not taken into account in our analyses is the linkage 
disequilibrium  structure in African ancestry populations. The linkage structure between 
Europeans and individuals of African descent is different as there is greater variation 
within the genome of African ancestry populations [46]. It is thus possible that actual 
disease markers are not in LD with the SNPs we investigated in our African cohorts 
therefore explaining why only a few significant associations were observed. 
Previously, studies on the genetics of iron metabolism have been carried out mainly in 
populations of European ancestry. The assumption in this case would then be that 
European ancestry cohorts might productively be used for discovery of risk variants in 
non-Europeans. We have attempted to replicate previous findings from European 
ancestry populations to African ancestry populations with limited success. This may 
partly be due to the greater genetic variation within the African ancestry populations 
[47] meaning European ancestry populations are not sufficient to fully uncover the 
variants underlying iron deficiency within African ancestry populations. Additionally, 
populations vary by ethnicity in terms of allele frequencies [48] and biological 
adaptations due to various environmental factors. For these reasons, population specific 
studies on the genetics of iron metabolism are warranted. Specifically, GWA studies in 
African ancestry individuals should reveal more novel genetic variants with modest 
effects and/or allele frequencies. It should also be taken into account that to accurately 
quantify the variation in iron status measures explained by genetic factors, other known 
factors influencing iron status should be assessed and corrected for in analyses. Finally, 
functional studies on the effect of discovered variants on iron status are also required as 
a next step to confirm the findings as well as elucidate further the action of alleles in 
relation to iron status.  
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Supplemental Appendices 
Supplementary Table 1: Associations of single nucleotide polymorphism with iron status parameters 
  

















β (se) P β (se) P β (se) P β (se) P 
P 
(Het) 
β (se) P β (se) P P (Het) 
Hb g/dL OPRD1                 
 
rs482692 1 A -0.20(0.20) 0.33 -2.56(1.33) 0.06 0.09(0.12) 0.45 -0.06(0.16) 0.70 0.31 -0.56(0.28) 0.05 0.22(0.20) 0.27 0.03 
 SRPRB                 
 
rs1830084 3 T -0.14(0.14) 0.32 0.16(1.04) 0.88 -0.18(0.14) 0.20 -0.16(0.10) 0.11 0.93 0.11(0.16) 0.47 -0.08(0.08) 0.32 0.54 
 TF                 
 
rs1358024 3 A 0.19(0.27) 0.49 3.52(4.68) 0.45 0.87(0.54) 0.11 0.39(0.31) 0.10 0.42 -0.21(0.36) 0.57 0.17(0.20) 0.41 0.35 
 
rs1525892 3 A 0.12(0.11) 0.29 0.11(0.81) 0.90 0.04(0.12) 0.74 0.08(0.08) 0.16 0.89 0.12(0.14) 0.37 0.09(0.07) 0.18 0.96 
 
rs1799852 3 A -0.32(0.18) 0.07 1.64(1.62) 0.31 0.41(0.28) 0.14 0.09(0.36) 0.80 0.05 0.05(0.25) 0.84 0.03(0.22) 0.87 0.10 
 
rs1867504 3 A -0.02(0.12) 0.90 -0.12(0.82) 0.88 -0.06(0.12) 0.59 -0.04(0.08) 0.31 0.97 0.04(0.14) 0.75 -0.02(0.07) 0.79 0.96 
 
rs3811647 3 A 0.08(0.13) 0.53 0.53(0.88) 0.55 0.02(0.11) 0.83 0.05(0.08) 0.26 0.81 0.10(0.15) 0.51 0.06(0.07) 0.40 0.92 
 
rs3811658 3 T 0.01(0.13) 0.95 1.57(0.99) 0.11 0.10(0.04) 0.49 0.36(0.04) 0.02 0.26 0.08(0.16) 0.61 0.09(0.03) 0.01 0.45 
 
rs4525863 3 A 0.17(0.13) 0.17 -0.68(0.8) 0.39 -0.24(0.14) 0.09 -0.07(0.19) 0.36 0.07 -0.20(0.13) 0.14 -0.10(0.13) 0.43 0.09 
 
rs7638018 3 G 0.06(0.12) 0.63 0.34(0.94) 0.72 0.07(0.14) 0.62 0.07(0.09) 0.22 0.96 -0.18(0.16) 0.26 0.09(0.08) 0.23 0.93 
 TNF                 
 
rs1799964 6 G 0.04(0.13) 0.74 0.65(0.89) 0.47 -0.16(0.13) 0.21 0.10(0.07) 0.15 0.40 -0.05(0.17) 0.75 -0.05(0.08) 0.52 0.62 
 
rs1800629 6 A -0.03(0.18) 0.86 2.02(1.27) 0.11 -0.02(0.14) 0.87 -0.08(0.07) 0.25 0.28 0.18(0.20) 0.39 0.04(0.10) 0.71 0.35 
 TFR2                 
 
rs7385804 7 C -0.12(0.13) 0.36 1.16(0.85) 0.17 0.09(0.12) 0.43 0.01(0.08) 0.53 0.26 0.45(0.38) 0.25 0.05(0.08) 0.55 0.26 
 CUBN                 
 
rs10904850 10 A -0.38(0.16) 0.02 0.91(1.19) 0.44 0.07(0.11) 0.56 -0.11(0.10) 0.14 0.05 0.03(0.16) 0.86 -0.07(0.14) 0.63 0.10 
 HAMP                 
 
rs10421768 19 A 0.37(0.14) 0.01 0.46(0.94) 0.62 -0.01(0.15) 0.93 0.19(0.18) 0.29 0.17 0.14(0.12) 0.12 0.17(0.10) 0.09 0.30 
 KIAA1468                 
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rs9948708 18 A 0.03(0.11) 0.82 0.03(0.73) 0.97 0.14(0.1) 0.18 0.09(0.07) 0.20 0.76 0.01(0.12) 0.91 0.07(0.06) 0.28 0.83 
 TMPRSS6                 
 
rs1421312 22 G -0.11(0.10) 0.27 0.09(0.76) 0.91 -0.05(0.11) 0.64 -0.18(0.11) 0.10 0.90 -0.14(0.12) 0.24 -0.10(0.06) 0.12 0.94 
 
rs228918 22 G 0.14(0.10) 0.16 -0.86(0.74) 0.25 0.08(0.1) 0.44 0.10(0.07) 0.15 0.39 -0.08(0.12) 0.49 0.05(0.06) 0.37 0.31 
 
rs2413450 22 A -0.20(0.12) 0.10 -0.65(1.13) 0.57 -0.23(0.18) 0.20 -0.23(0.10) 0.01 0.93 -0.09(0.14) 0.55 -0.19(0.08) 0.02 0.84 
 





              
 
rs482692 1 A -0.95(1.10) 0.63 -0.99(1.12) 0.94 1.08(1.08) 0.45 -0.27(0.39) 0.70 0.31 -0.78(1.20) 0.16 -0.37(0.56) 0.51 0.47 
 SRPRB                 
 
rs1830084 3 T -0.95(1.07) 0.45 -0.58(1.29) 0.47 -1.00(1.10) 0.99 -0.87(0.66) 0.09 1.00 1.02(1.12) 0.79 -0.38(0.57) 0.47 0.53 
 TF                 
 
rs1358024 3 A -1.00(1.14) 0.97 -0.86(1.50) 0.72 -0.92(1.32) 0.76 -0.94(0.75) 0.11 1.00 -0.98(1.29) 0.94 -0.95(0.65) 0.14 1.00 
 
rs1525892 3 A 1.01(1.06) 0.80 1.05(1.07) 0.46 1.09(1.08) 0.26 1.05(0.62) 0.05 1.00 1.10(1.10) 0.37 1.07(0.54) 0.04 1.00 
 
rs1799852 3 A -0.98(1.09) 0.80 1.20(1.15) 0.18 -0.62(1.2) 0.01 -0.15(0.68) 0.41 0.34 1.23(1.17) 0.21 0.18(0.60) 0.76 0.37 
 
rs1867504 3 A 1.04(1.06) 0.54 1.05(1.07) 0.52 1.03(1.08) 0.69 1.04(0.62) 0.05 1.00 1.05(1.10) 0.62 1.04(0.54) 0.05 1.00 
 
rs3811647 3 A 1.03(1.07) 0.66 1.02(1.07) 0.85 1.10(1.07) 0.19 1.05(0.62) 0.09 1.00 1.07(1.10) 0.45 1.05(0.54) 0.05 1.00 
 
rs3811658 3 T 1.05(1.07) 0.48 1.05(1.10) 0.63 -1.02(1.09) 0.82 0.36(0.69) 0.60 0.30 -0.98(1.12) 0.78 0.04(0.59) 0.95 0.32 
 
rs4525863 3 A 1.09(1.06) 0.18 1.07(1.07) 0.26 -0.98(1.09) 0.83 0.41(0.68) 0.54 0.30 -0.98(1.10) 0.78 0.07(0.59) 0.90 0.30 
 
rs7638018 3 G 1.00(1.06) 0.97 -0.96(1.10) 0.62 1.00(1.09) 0.99 0.37(0.64) 0.57 0.34 1.02(1.12) 0.76 0.52(0.55) 0.34 0.49 
 TNF                 
 
rs1799964 6 G -0.92(1.06) 0.17 -0.99(1.07) 0.92 -0.88(1.08) 0.12 -0.93(0.62) 0.13 1.00 1.05(1.12) 0.62 -0.47(0.54) 0.39 0.49 
 
rs1800629 6 A 1.02(1.10) 0.85 1.05(1.12) 0.62 1.03(1.09) 0.74 1.03(0.64) 0.10 1.00 -0.76(1.15) 0.03 0.61(0.56) 0.27 0.60 
 TFR2                 
 
rs7385804 7 C -0.86(1.07) 0.02 -0.95(1.08) 0.48 1.15(1.08) 0.06 1.03(0.64) 0.05 0.27 1.07(1.10) 0.52 0.09(0.58) 0.88 0.32 
 CUBN                 
 
rs10904850 10 A -0.92(1.08) 0.31 1.02(1.12) 0.81 1.04(1.08) 0.61 0.37(0.66) 0.29 0.34 1.07(1.12) 0.47 0.55(0.96) 0.17 0.49 
 HAMP                 
 
rs10421768 19 A 1.02(1.07) 0.73 1.02(1.10) 0.72 1.06(1.10) 0.53 1.03(0.63) 0.10 1.00 1.00(1.12) 0.99 1.02(0.55) 0.06 1.00 
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 KIAA1468                 
 
rs9948708 18 A -0.98(1.05) 0.73 1.02(1.07) 0.82 1.03(1.07) 0.71 0.34(0.68) 0.62 0.30 -0.91(1.07) 0.24 0.03(0.57) 0.96 0.33 
 TMPRSS6                 
 
rs1421312 22 G -0.94(1.02) 0.22 1.02(1.07) 0.68 1.01(1.07) 0.90 0.33(0.67) 0.60 0.90 -0.89(1.07) 0.15 0.03(0.55) 0.56 0.34 
 
rs228918 22 G -0.99(1.04) 0.90 1.05(1.07) 0.55 -1.02(1.07) 0.75 -0.33(0.68) 0.62 0.32 1.10(1.10) 0.25 0.01(0.60) 0.02 0.29 
 
rs2413450 22 A 1.08(1.05) 0.11 1.05(1.10) 0.73 1.02(1.12) 0.90 1.05(0.63) 0.09 1.00 -0.93(1.10) 0.49 0.56(0.55) 0.30 0.49 
 
rs4820268 22 G -0.99(1.04) 0.83 -0.96(1.07) 0.61 -0.95(1.09) 0.60 -0.97(0.62) 0.12 1.00 -0.98(1.10) 0.82 -0.97(0.54) 0.07 1.00 
SNP=Single nucleotide polymorphism; Ke=Kenyan cohort; Tz=Tanzanian cohort; SA=South African cohort; AA=African American cohort; P(Het)=P value of heterogeneity testing; Met-
African=meta analyses of beta and SE values from African cohorts; Met_All= meta analyses of beta and SE values from African cohorts; Direction=direction of association based on beta 
value Hb=Haemoglobin, Values in bold are significant 
Results are presented as mean (SE) change per copy of the minor allele from regression analysis using additive genetic model and with adjustment for age and sex for associations involving 
Hb and age and sex and CRP concentrations for associations involving ferritin 
† Values not adjusted for gender as all participants were women 
Values in bold are significant before FDR correction for multiple testing 
Variance explained ranged from < 1% to 3 %, with the highest being 3% for rs10421768 in the Kenyan population 
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Supplementary Figure 1a:OPRD1 SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 




121 | P a g e  
 
 
Supplementary Figure 1b:OPRD1 SNPs and associations with serum ferritin (µg/L) 
Values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 95% CIs, 
black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors for the 
summary estimates. Effect allele = A  
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Supplementary Figure 2a: SRPRB1 SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
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Supplementary Figure 2b: SRPRB1 SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
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Supplementary Figure 3a: TF SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
with the lateral tips of the open diamond indicating the standard errors for the summary estimates. Effect allele = T for 
rs3811647, rs3811658, rs4525863, and G for rs7638018 
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Supplementary Figure 3b: TF SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
with the lateral tips of the open diamond indicating the standard errors for the summary estimates. Red indicate 
summary estimates that were significant. Effect allele = A for rs1358024, rs1525892, rs1799852 and rs1867504 
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Supplementary Figure 4a: TF SNPs and associations with ferritin µg/L  
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Effect allele = T for rs3811647, rs3811658, rs4525863, and G for rs7638018 
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Supplementary Figure 4b: TF SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Red indicate summary estimates that were significant. Effect allele = A for rs1358024, 
rs1525892, rs1799852 and rs1867504 
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Supplementary Figure 5a: TNF α SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
with the lateral tips of the open diamond indicating the standard errors for the summary estimates. Effect allele = A for 
s1800629 and G for rs1799964 
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Supplementary Figure 5b: TNF α SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Effect allele = A for s1800629 and G for rs1799964 
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Supplementary Figure 6a: TFR2 SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
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Supplementary Figure 6b: TFR2 SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Effect allele = G for rs7385804 
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Supplementary Figure 7a: CUBN SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
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Supplementary Figure 7b: CUBN SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Effect allele = A for rs10904850 
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Supplementary Figure 8a: HAMP SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
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Supplementary Figure 8b: HAMP SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates Effect allele = A for rs10421768 
Associations between common variants in iron-related genes with haematological traits in populations of 
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Supplementary Figure 9a: KIAA1468 SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
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Supplementary Figure 9b: KIAA1468 SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
for the summary estimates. Effect allele = A for rs9948708 
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Supplementary Figure 10a: TMPRSS6  SNPs and associations with haemoglobin (g/dL) 
Black squares are point estimates for each study, horizontal lines are 95% CIs, black diamonds are summary estimates 
with the lateral tips of the open diamond indicating the standard errors for the summary estimates. Effect allele = A for 
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Supplementary Figure 10b: TMPRSS6  SNPs and associations with ferritin µg/L 
Ferritin values are Log10 back transformed data. Black squares are point estimates for each study, horizontal lines are 
95% CIs, black diamonds are summary estimates with the lateral tips of the open diamond indicating the standard errors 
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Abstract 
Background: Tumour necrosis factor-α (TNF-α) is central to the immune response to 
Plasmodium infection. Its plasma concentration is influenced by allele variants in the 
promoter region of the TNF-α gene. 
Objectives: To assess the effect of TNF-α allele variants (TNF‒1031, TNF‒308) on 1) malaria 
rates in young Tanzanian children; 2) the severity of malaria as indicated by 
haemoglobin concentrations at the time of presentation with febrile episodes; 3) the 
association between Plasmodium infection and haemoglobin concentration in 
symptomless parasite carriers. 
Methods: We used data from a placebo-controlled trial in which 612 Tanzanian children 
aged 6–60 months with height-for-age z-score≤−1.5 SD. Those with Plasmodium 
infection at baseline were treated with artemether-lumefantrine. An episode of malaria 
was pre-defined as current Plasmodium infection with an inflammatory response 
(axillary temperature ≥37.5°C or whole blood C-reactive protein concentration ≥8 mg/L) 
in children reported sick. Cox regression models used in the primary analysis accounted 
for multiple episodes per child. 
Results: We genotyped 94.9% (581/612) children for TNF‒1031 (rs1799964) (TNF‒1031T>C); 
allele frequency was 0.39. Corresponding values for TNF‒308G>A (rs1800629) were 95.4% 
(584/612) and 0.17. Compared to their common genotype, malaria rates were increased 
in the TNF‒1031GG genotype (hazard ratio, HR [95%CI]: crude 1.41 [1.01‒1.97], adjusted 
1.31 [0.97‒1.76]) but decreased in those with the TNF‒308AA genotype (crude HR: 0.13 
[0.02‒0.63], adjusted HR 0.16 [0.04‒0.67]). These associations were weaker when 
analysing first episodes of malaria. We found no evidence that allele variants of TNF‒1031 
and TNF‒308 affected haemoglobin concentration at first episode of malaria, or that they 
modified the association between Plasmodium infection and haemoglobin concentrations 
at baseline. 
Conclusion: In this cohort of Tanzanian children, the TNF‒1031CC genotype was 
associated with increased rates of malarial episodes, whereas the TNF‒308 AA genotype 








Tumour necrosis factor-α (TNF-α) is central to the immune response to Plasmodium 
infection because of its pyrogenic properties and its key role in triggering the cascade of 
pro inflammatory cytokines that regulate immune cells. It is secreted predominantly by 
activated macrophages following exposure to Plasmodium antigens, and acts to suppress 
parasitaemia. Its plasma concentration is elevated during malarial episodes but also in 
symptomless parasite carriers [1]. In patients with malaria, a high TNF-α production 
capacity can result in faster clearance of fever and parasitaemia [2], but TNF-α acts as a 
two-edged sword: excessive production, as may occur during hyperparasitaemia, can 
contribute to pathological features of severe malaria [3, 4].  
Allele variants in the promoter region of the TNF-α gene have been associated with 
changes in gene expression and plasma TNF-α concentration response to infection. 
Within this promoter region, the rs1799964 allele variant concerns a T>C change at the -
1031 position relative to the transcription start site of the TNF-α gene, whilst the 
rs1800629 allele variant consists of a G>A change in the -308 position. In a case-control 
study in India, the TNF-1031C allele was associated with elevated plasma TNF-α 
concentrations and increased susceptibility to severe falciparum malaria [5].  
Homozygotes for the TNF‒308A allele (TNF‒308AA) produce more TNF-α in response to 
infection than their heterozygote counterparts (TNF‒308GA) and those with the common 
genotype (TNF‒308GG) [6, 7]. Evidence that the TNF‒308AA genotype is associated with an 
increased susceptibility to severe malaria is inconsistent [8], perhaps in part due to 
limitations in the case-control design of these studies. 
There have been few cohort studies to longitudinally assess the effect of these TNF-α 
allele variants on malaria outcomes. Children with an elevated TNF-α response to 
Plasmodium infection are more likely to become ill than their peers with a lower TNF-α 
response capacity, so that the former may experience more frequent episodes of malaria. 
On the other hand, in children exposed to chronic or repeated Plasmodium infections, an 
increased TNF-α response associated with the TNF‒308AA genotype may intensify a 
hepcidin-mediated block in iron absorption and consequently induce or exacerbate iron 
deficiency [9], which probably protects against malarial episodes [10, 11]. 
We aimed to assess the effect of the rs1799964 and rs1800629 allele variants on malaria 
rates in young Tanzanian children. Additionally, we aimed to investigate the effect of 
these variants on the severity of malaria as indicated by haemoglobin concentrations at 
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the time of presentation with febrile episodes. Lastly, we assessed the influence of these 
variants on the association between Plasmodium infection and haemoglobin 




Study area and population 
We used data from a randomized trial that aimed to assess the effect of supplementation 
with zinc and other micronutrients on malaria rates. The trial was conducted between 
February 2008 and March 2009 in four rural villages in Handeni District, north-eastern 
Tanzania. Residents primarily belong to the Wazigua and Wabondei Bantu tribes, but 
settlement of migrant plantation workers has resulted in a mixture of tribes with 
different origins and much intermarriage. The area is mainly populated by poor farmer 
families involved in subsistence farming. Malaria transmission is intense and perennial, 
with nearly all infections being due to P. falciparum [12]. Apart from several local 
traditional healers the research dispensary was the only health facility in the area. The 
study was approved by the Ethical Review Committee of Wageningen University, The 
Netherlands and the National Health Research Ethics Review sub-Committee, Dar es 
Salaam, Tanzania. Informed consent was obtained from community leaders, local 




All resident children were eligible for randomisation when aged 6–59 months and with a 
height-for-age z-score below –1.5 SD. Children with severe wasting (weight-for-age z-
score < –3 SD), haemoglobin concentration < 70 g/L, signs of chronic illness, and those 
unlikely to remain permanently resident or comply with the supplementation for the 
duration of the trial, or whose parents or guardians declined consent, were excluded 
from the study. Venous blood samples were collected in EDTA tubes and centrifuged 
immediately. An aliquot of 90 μL erythrocyte sediment with the buffy coat was mixed 
with 90 μL phosphate-buffered saline and 180 μL of DNA stabilizing buffer (AS1; 
Qiagen, Hilden, Germany) and stored at 4°C for subsequent genotyping. Plasma samples 
were stored in liquid nitrogen (‒196°C) in the field and at ‒80°C during transport and 
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subsequent storage until biochemical analysis in The Netherlands. Haemoglobin 
concentration was measured in an aliquot of whole blood by a haematology analyser 
(Sysmex KX21, Kobe, Japan). We detected Plasmodium infection in fresh blood by rapid 
dipstick test (CareStart, Access Bio, Monmouth Jct, USA). Children with a positive test 
result were treated immediately with artemether-lumefantrine. The location of the 
child’s homestead was determined using a global positioning system. Further details 
about recruitment procedures are reported elsewhere [13]. 
 
Experimental intervention 
Children were randomized within 6 strata defined by Plasmodium infection (binary) and 
age class (6‒17 months, 18‒35 months and 36‒60 months) and randomly permuted 
blocks with size randomly selected of 4 or 8. They then received daily supplements with 
either zinc alone (10mg as gluconate), multi-nutrients without zinc, zinc combined with 
multi-nutrients or placebo. Supplements, in the form of powder in color-coded capsules, 
were contained in blister packs, and administered orally after suspending capsule 
contents in clean water or breast milk. Supplementation was performed by local 
community volunteers, who reported adherence daily to field staff at the research 
dispensary. 
 
Follow-up and case detection 
A clinical officer was on duty at the research clinic day and night. At recruitment, 
parents or guardians were requested to bring participating children to the dispensary 
immediately when detecting fever or any other illness during the intervention period. In 
samples collected at baseline and from sick children, the presence of parasite-specific 
lactate dehydrogenase (P. falciparum and other Plasmodium species) was detected by 
rapid tests (Monmouth Jct, USA) Axillary temperature was measured using an 
electronic thermometer and dipstick tests were administered for children with guardian-
reported fever; for those with positive test results, we collected plasma samples and 
measured whole-blood C-reactive protein concentrations using a point-of-care test. 
Plasma was stored as described for the recruitment procedure. Artemether-lumefantrine 
(Novartis Pharma, Basel, Switzerland) was administered to any child with current 
Plasmodium infection upon enrolment, or with reported fever and a positive dipstick test 
result during the follow up period.  
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Laboratory procedures 
For children who presented with malarial episodes, whole-blood concentrations of 
haemoglobin and C-reactive protein were measured using point-of-care tests (HemoCue, 
Ängelholm, Sweden and QuikRead, Orion Diagnostica, Espoo, Finland, 
respectively).Plasma concentrations of P. falciparum-specific histidine-rich protein-2 
(HRP2) in samples collected during the first malaria episode were measured using a 
commercial enzyme-linked immunosorbent assay kit (Malaria Ag Celisa; Cellabs, 
Brookvale NSW, Australia). Plasma concentrations of C-reactive protein were measured 
(Meander Medical Centre, Amersfoort, The Netherlands) on a Beckman Coulter Unicel 
DxC880i system according to the manufactures’ instructions. Genotypes were 
determined using Illumina’s VeraCode™ GoldenGate Genotyping Assay on a 
BeadXpress™ platform. TNFα variant allele clustering was assessed visually to 
determine success of genotyping. Further quality control cut-offs were: a GenCall Score 




Anthropometric indices were calculated using Epi Info software (version 3.3.2; 
http://www.cdc.gov/epiinfo). All analyses were performed using SPSS (v15·0 for 
Windows, SPSS, Chicago, IL), CIA (v2.1.2) [15] and STATA (v11; College Station, Tx). 
For each TNF-α genotype, we used Fisher’s exact test to assess whether populations 
were in Hardy-Weinberg equilibrium. We calculated differences in baseline 
characteristics using the homozygote wildtype group as the reference for each variant 
using CIA (v2.1.2). Because variables of interest were normally distributed, we report 
means, SDs and 95% CIs.  
 
Effect of TNF-α genotype on malaria rates The primary outcome, an episode of malaria, 
was pre-defined as a positive result for either a pLDH or a HRP2 dipstick test with any 
of the following: a) confirmed fever (axillary temperature ≥ 37.5°C as measured by 
electronic thermometer), or b) guardian-reported but unconfirmed 24-h history of fever 
in the presence of inflammation (whole blood C-reactive protein concentrations >8 mg/L), 
separated by at least 14 days from a previous malaria episode. We calculated incidence 
per TNF-α genotype, and incidence ratios based on time to first episodes, with wild type 
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homozygotes as reference group. In the primary analysis, we compared group rates using 
Cox regression with robust estimates of the standard error to account for multiple 
episodes within children. We explored to what extent supplementation with either zinc 
or multi-nutrients including iron influenced the magnitude of the effect of TNF-α 
genotype on malaria rates. We also examined to what extent adjustment for baseline 
factors that were a priori expected to be prognostic for malaria (Plasmodium infection 
status, distance between homestead and clinic [continuous variable], height-for-age z-
score [continuous variable], mosquito net use [binary variable]) and experimental 
intervention influenced the estimated effect of genotypes. In this adjusted analysis, we 
included experimental intervention as a binary variable indicating pooled groups 
receiving multi-nutrients (with or without zinc) and pooled groups receiving no multi-
nutrients (with or without zinc). We also used Kaplan-Meier analysis with Peto tests to 
assess effects of TNF-α genotypes on time-to-first episode of malaria. 
 
Influence of TNF-α genotype on the association between P. falciparum infection and 
haemoglobin concentration at baseline 
For each genotype, we indicated three classes by two dummy variables, resulting in two 
interaction terms per variant. Regression models were then used to assess the influence 
of genotypes on the associations between P .falciparum and haemoglobin concentration. 
We included main terms for P. falciparum infection and genotype dummies, and we 
adjusted as pre-planned for age class, mosquito net use, height-for-age z-score and 
distance between the child’s homestead and the dispensary in regression analyses. 
 
Influence of TNF-α genotype on the association between P. falciparum infection and 
haemoglobin concentration at first episode of malaria 
For each genotype, we indicated three classes by two dummy variables. Influence of 
TNF-α genotype on the association between P. falciparum infection and haemoglobin 
concentration at first episode of malaria was then assessed by ANOVA and adjusted for 
age class, height-for-age z-score and distance between the child’s homestead and the 




Of 612 children recruited in the original study, 581 (94.9%) and 584 (95.4%) respectively 
had DNA typed for TNF‒1031 and TNF‒308, respectively. Only 3% (20/612) of children 
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failed to complete the trial. Minor allele frequencies were 0.39 (TNF‒1031) and 0.17 
(TNF‒308), respectively. Regarding these TNF-α alleles, we found no evidence that the 
population was in Hardy-Weinberg disequilibrium (P=0.90 and 0.57 for TNF‒1031 and 
TNF‒308 respectively); thus there was no indication that were errors in genotyping of the 
two variants. 
 
Baseline factors associated with TNF-α genotypes (Table 1)  
Children with TNF‒1031C allele seemed to have larger weight-for-age z-scores than their 
peers with the common variant (0.14 SD and 0.41 SD in heterozygotes and homozygotes, 
respectively, compared to ‒0.18 SD in those with the common genotype). The TNF‒308A 
allele seemed to be associated with increased Plasmodium infection, but the evidence 
was weak (p-value: 0.09). We found no evidence of other factors being associated with the 
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Table 1. Factors associated with rs1799964 and rs1800629 allele variants in the promoter region of the TNF-α gene 
Allele variant/factor Wild type Heterozygote Difference (95% CI) 
Homozygote 
mutant 
Difference  (95% CI) 
 
P-value 
rs1799964 -1031TT -1031TC  -1031CC   





Age (months) 33.4±15.5 31.9±16.1 ‒1.5 (‒4.2,1.2) 28.06±14.9 ‒5.3 (‒11.6, 0.99) 0.18 
Sex (%male) 48.0% (171) 48.0% (96) 0.0% (‒8.6%, 8.6%) 44.0% (11) ‒4.0% (‒22.1%, 15.6%) 0.93 
Haemoglobin concentration, g/L 102.7±12.3 103.4±13.8 0.0 (‒2.1,2.1) 101.5±10.4 ‒1.2 (‒6.2, 3.8) 0.71 
Anaemia, % (n) ¶ 69.1% (246) 66.0% (132) ‒3.1% (‒11.3%, 4.9%) 76.0% (19) 6.9% (‒13.1%, 20.4%) 0.50 
Plasmodium infection, % (n) 43.8% (156) 43.0% (86) ‒0.8% (‒9.3%, 7.8%) 36.0% (9) ‒7.8% (‒24.4%, 12.3%) 0.75 
Inflammation, % (n) † 32.3% (114) 32.0% (64) 0.0% (‒7.9%, 8.2%) 32.0% (8) ‒0.3% (‒15.6%, 19.8%) 0.58 
Mosquito net use, % (n) †† 32.9% (117) 32.0% (64) ‒0.1% (‒8.8%, 7.3%) 32.0% (8) ‒0.9% (‒16.5%, 19.3%) 0.99 
Distance from homestead to 
dispensary, km ** 
3.5±2.1 3.5±2.2 0.0 (‒0.4, 0.4) 3.8±2.6 0.3 (‒0.6, 1.2) 0.90 
Anthropometric indices 
     
 
Height-for-age z-score ‒2.45±0.70 ‒2.38±0.69 0.07 (‒0.05, 0.19) ‒2.48±0.78 ‒0.03 (‒0.32, 0.26) 0.48 
Weight-for-height z-score ‒0.18±0.81 ‒0.04±0.85 0.14 (0.00, 0.28) 0.23±1.00 0.41 (0.08, 0.75) 0.02 
Weight-for-age z-score ‒1.63±0.74 ‒1.52±0.75 0.11 (‒0.02, 0.24) ‒1.42±0.76 0.21 (‒0.09, 0.51) 0.13 
rs1800629 -308GG -308GA  -308AA   
n 477 104  3   
Age 32.1±15.7 34.8±15.3 2.7 (‒0.6, 6.0) 47.08±11.7 15.0 (‒2.9, 32.8) 0.08 
Sex (%male) 46.8% (223) 53.8% (56) 7% (‒4%, 17%) 66.7% (2) 20% (‒26%, 48%) 0.34 
Haemoglobin concentration, g/L 102.3±12.8 105.2±12.2 2.9 (0.2, 5.6) 105.0±19.2 2.7 (‒11.9, 17.3) 0.10 
Anaemia, % (n) ¶ 69.0% (329) 64.4% (67) ‒4.5% (‒14.9%, 5.0%) 66.7% (2) ‒2.3% (‒48.4%, 25.2%) 0.54 
Plasmodium infection, % (n) 41.1% (196) 51.9% (54) 10.8% (0.3%, 21.1%) 66.7% (2) 25.6% (‒20.5%, 53.1%) 0.09 
Inflammation, % (n) † 31.0% (148) 33.7% (35) 2.6% (‒6.8%, 12.9%) 33.3% (1) 2.3% (-25.2%, 48.4%) 0.23 
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Mosquito net use , % (n) †† 32.9% (157) 30.8% (32) ‒2.1% (‒11.3%, 8.1%) 33.3% (1) 0.4% (‒27.1%, 46.5%) 0.95 
Distance from homestead to 
dispensary, km ** 
3.6±2.2 3.6±2.2 0.0 (‒0.5, 0.5) 3.5 ±1.0 ‒0.10 (‒2.6, 2.4) 1.00 
Anthropometric indices       
Height-for-age z-score ‒2.42±0.69 ‒2.47±0.74 ‒0.05 (‒0.20, 0.10) ‒2.69±0.72 ‒0.27 (‒1.06, 0.52) 0.61 
Weight-for-height z-score ‒0.11±0.84 ‒0.17±0.85 ‒0.06 (‒0.24, 0.12) 0.07±0.78 0.04 (‒0.92, 1.00) 0.73 
Weight-for-age z-score ‒1.57±0.75 ‒1.64±0.75 ‒0.07 (‒0.23, 0.09) ‒1.56±0.92 0.01 (‒0.84, 0.86) 0.72 
P-values for the associations between each factor and the allele variants investigated. Mean ± SD or % [n] unless indicated otherwise 
% figures represent %with feature/%without feature (number with feature/number without feature).Difference is relative to the wild type group 
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Effect of TNF-α genotype on malaria rates (Table 2)  
Overall, there were 1,511 malaria episodes recorded in 400 child-years of observation 
(incidence: 3.8/child-year). Of 581 children, 489 children (84%) experienced at least one 
malaria episode while recurrent episodes occurred in 406 (69%) children. Compared to 
the common genotype, malaria rates (all episodes) in homozygotes for the TNF‒1031C 
allele (TNF‒1031CC) were elevated by 41% (hazard ratio 1.41; crude analysis). In the 
analysis of first episodes, malaria rates also seemed elevated for this genotype (hazard 
ratio 1.17, Table 2), but the statistical evidence for such an association was much 
weaker. Only one episode of malaria occurred in homozygotes for the TNF‒308 A allele 
(TNF‒308AA). This genotype was nonetheless associated with a decrease in malaria rates 
by 87% (hazard ratio 0.13; all episodes). Malaria rates were similarly decreased in the 
analysis of first episodes, but the statistical evidence was weak. Kaplan-Meier analysis 
did not indicate marked group-specific differences in malaria rates for specific time 
periods of follow-up for either of the two TNF-α genotypes investigated (Figure 1). 
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Table 2: Associations between TNF-α genotype and rates of first episode malaria or all episodes of malaria 
 
Homozygotes Heterozygotes Homozygote mutants 
rs1799964 -1031TT -1031TC -1031CC 
All episodes of malaria       
n  356  200  25 
Incidence 2.93 (907/309.1) 2.92 (502/171.9) 4.15 (90/21.7) 
Hazard ratio, crude 1.00 Reference 0.99 [0.85-1.14] 1.41 [1.01-1.97] 
Hazard ratio, adjusted† 1.00 Reference 0.95 [0.82-1.09] 1.35 [1.01-1.80] 
First episode of malaria       
Incidence 2.85 (296/104.0) 3.09 (168/54.4) 3.29 (20/6.07) 
Incidence ratio 1.00 Reference 1.08 [0.89-1.31] 1.15 [0.68-1.76] 
Hazard ratio, crude 1.00 Reference 1.08 [0.90-1.31] 1.17 [0.90-1.31] 
Hazard ratio, adjusted† 1.00 Reference 1.07 [0.89-1.31] 1.11 [0.66-1.86] 
rs1800629 -308GG -308GA -308AA 
All episodes of malaria       
n  477  104  3 
Incidence 2.97 (1216/409.2) 3.08 (282/91.5) 0.36 (1/2.8) 
Hazard ratio, crude 1.00 Reference 1.04 [0.87-1.24] 0.13 [0.02-0.63] 
Hazard ratio, adjusted† 1.00 Reference 1.10 [0.93-1.29] 0.14 [0.04-0.48] 
First episode of malaria       
Incidence 2.89 (392/135.6) 3.27 (91/27.8) 0.53 (1/1.9) 
Incidence ratio 1.00 Reference 1.13 [0.90-1.44] 0.18 [0.00-0.98] 
Hazard ratio, crude 1.00 Reference 1.07 [0.86-1.33] 0.27 [0.03-2.86] 
Hazard ratio, adjusted† 1.00 Reference 1.14 [0.91-1.44] 0.33 [0.03-3.59] 
Values between brackets indicate (episodes/child-years observed) or [95% CIs]. 
† Estimates adjusted for baseline Plasmodium infection status, distance between homestead and clinic (continuous variable), height-for-age z-score 
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Figure 1. Effect of TNF-α genotype on time to first episode of malaria, as assessed by Kaplan-Meier analysis 
Values indicate the number of children, by TNF-α genotype group, who had remained free of malaria at 0, 100, 200, 300 and 400 days of follow-up. For TNF‒1031 allele variant (top panel), 
pairwise group comparison with the common genotype as the reference group yielded p-values of 0.78 and 0.74 for heterozygotes TNF‒1031TC and homozygotes (TNF‒1031CC), respectively; for 
the TNF‒308 allele variant (top panel), corresponding p-values for heterozygotes (TNF‒308GA) and homozygotes (TNF‒308AA) were 0.54 and 0.31, respectively (Peto tests). For homozygotes of 
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Effect of TNF-α genotype on haemoglobin concentration at first malarial episode (Figure 2): 




Figure 2. Association between TNF-α genotype and haemoglobin concentration at time of first episode of malaria 
Left panel: TNF‒1031 (rs1799964) genotype; bottom panel: TNF‒308 (rs1800629) genotype. Genotypes are homozygous wildtype, heterozygous and homozygous mutant from left to right. Line 
bars indicate 95% CIs. Values on top of bars indicate differences in group means with corresponding 95% CIs as obtained by multivariate regression analysis. All values are adjusted for 
Plasmodium infection status, distance between homestead and clinic, height-for-age z-score, mosquito net use and experimental intervention. The 95% CI for haemoglobin concentration of 
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Influence of TNF-α genotype on the association between Plasmodium infection and haemoglobin concentration at baseline (Figure 3) 
We found no evidence that heterozygosity for either TNF‒1031C or TNF‒308A modified the association between Plasmodium infection at 
baseline and haemoglobin concentrations at baseline (p-values or interaction: 0.47 and 0.57, respectively). Similarly, we found no 
evidence that this association was modified by homozygosity for either TNF‒1031C (p-value0.56) 






























Figure 3. Association between Plasmodium infection and haemoglobin concentrations at baseline, by TNF-α genotype 
Line bars indicate 95% CIs. No confidence interval indicated for TNF‒308AA because there was only one case of Plasmodium infection. All values are adjusted for age 
class, mosquito net use, height-for-age z-score and distance from homestead. 
 




In our cohort of Tanzanian children, malaria rates due to P. falciparum were increased 
in homozygotes for the TNF‒1031C allele (TNF‒1031CC) and decreased in homozygotes for 
the TNF‒308A allele (TNF‒308AA). We found no evidence that allele variants of TNF‒1031 
and TNF‒308 were associated with haemoglobin concentration at first episode of malaria, 
or that they modified the association between Plasmodium infection and haemoglobin 
concentrations at baseline. 
The associations between TNF-α allele variants and malaria rates were generally more 
pronounced in the analysis of all episodes than in the analysis of first episodes (Table 2). 
Thus the question arises how such differences should be interpreted. Some children 
experience malaria more frequently than others. This between-individual variation may 
be due to differences in exposure to infectious mosquito bites, immunity (and thus age) 
and therapy-seeking behaviour. In the presence of such heterogeneity in susceptibility to 
malaria, ‘high risk’ individuals tend to become sick more rapidly than ‘low risk’ 
individuals, and once they have experienced an episode they are no longer considered in 
a time-to-first-event analysis. Thus, with the passing of follow-up time, only the ‘low risk’ 
individuals remain in the risk set and, accordingly, the event rate observed will 
decrease. In cohort studies such as ours, this decrease is generally more pronounced in 
groups with high overall event rates, which have ‘high-risk’ individuals dropping out 
more efficiently. Thus in a time-to-first-event analysis, group contrasts can become 
underestimated and effects on malaria may appear decrease with time. For this reason, 
we believe that analysis of all episodes more validly reflects associations between TNF-α 
allele variants and malaria rates than analysis of first episodes. In addition, the former 
better reflects effects on the total population burden of disease. 
There was no evidence that the association between TNF‒1031CC genotype and malaria 
rates were confounded by Plasmodium infection status, distance between homestead and 
clinic, height-for-age z-score and mosquito net use factors assessed at baseline, or by the 
experimental intervention. Similarly, we found no evidence for such confounding on the 
association between TNF‒308AA and malaria rates. These associations should 
nonetheless be interpreted with caution, because the statistical evidence was weak in 
the analysis of first episodes, even though the direction of these associations was similar. 
We also have no good explanation why the TNF‒1031CC genotype was associated with 
increased malaria rates whilst the TNF‒308AA genotype was associated with a decrease 
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in these rates, even though both genotypes have been reported to be associated with 
elevated plasma TNF-α concentration [5‒7]. 
Our findings add to the growing but conflicting evidence that allele variants of the TNF-
α gene are associated with susceptibility to malaria [8, 16, 17]. Several factors can 
explain apparent discrepancies in results obtained thus far in various studies. First, 
studies varied in design. Most studies compared hospitalised cases of severe malaria 
with hospital- or community-based controls [8, 16, 18, 19]. Such studies can be 
implemented quickly and at a relatively low cost, but they are inherently vulnerable to 
selection bias if the distribution of TNF-α allele variants differs between cases and 
controls in the absence of a true association between these allele variants and malaria. 
As a consequence, for studies that recruited controls from a hospital setting, the strength 
of the association between TNF-α allele variants and malaria will be underestimated if 
these controls suffered from a condition that is associated with TNF-α genotype. This is 
plausible, because TNF-α genotypes have also been associated with a variety of disorders 
other than malaria [20-23]. A better approach is to select controls that are representative 
of the population that produced the cases. Thus Clark et al. [8] selected as controls cord 
blood samples obtained from birth clinics in the same hospital from which they recruited 
cases of severe malaria. Even so, bias may still have occurred in that study if TNF-α 
genotypes varied in frequency of delivery in hospital, or in the frequency of care-seeking 
behavior and hospital admission for severe malaria. Such differentials may have 
occurred, for example, if the geographical distribution of TNF-α genotypes in relation to 
the hospital is uneven, or if TNF-α genotypes vary in the risk of birth complications. In 
addition, it is difficult to rule out that the results of TNF-α genotyping performed by 
Clark et al. (2009) in cord blood may have been affected by maternal DNA originating 
from contamination of cord blood at birth by maternal cells or by contact with maternal 
blood or tissue [24]. In our cohort study, bias may have occurred if there was differential 
loss to follow-up such that the risk of being lost to follow-up was related both to malaria 
and TNF-α genotype, or if there were group differentials in the detection of malarial 
episodes. However, loss to follow-up was very low (3%), genotyping was successful for 
almost all (95%) children, and we believe to have captured virtually all malaria cases 
[25]. 
Second, the relationship between TNF-α genotype and susceptibility to malaria may 
depend on population-specific factors. For example, as noted in our introduction, TNF-α 
allele variants that are associated with an enhanced TNF-α response to chronic or 
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repeated infections can possibly protect against newly acquired Plasmodium infections 
through an altered iron metabolism. Such protection is conceivably more effective in 
children who already have marginal iron status than in their iron-replete peers, and in 
children who are frequently exposed to infection.  
Third, differences in results may be due to haplotype heterogeneity between populations 
studied. It has been suggested that the causal allele variants regulating TNF-α 
responses may actually be located some distance downstream of the TNF-α gene, and 
that TNF-α allele variants considered are in sufficient linkage disequilibrium with the 
causal variant in some populations, but not in others [8]. 
In conclusion, in pre-school Tanzanian children living in an area of intense transmission, 
the TNF‒1031CC genotype was associated with increased rates of malarial episodes, 
whereas the TNF‒308 AA genotype was associated with decreased rates. Further studies 
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Although a large portion of the variation in iron status undoubtedly results from non-
genetic factors, the role of genetic factors in influencing iron absorption, uptake and 
transport, and therefore eventual iron status, has recently come to the fore. The studies 
herein were therefore conducted to unravel the genetics of iron status in populations of 
African ancestry.  
With the success of genome-wide association (GWA) studies, many common genetic 
variants underlying iron metabolism have been identified. These genetic loci could refine 
the biological understanding of iron metabolism and in so doing, contribute to strategies 
to address iron deficiency. Furthermore, this would also impact on the development of 
appropriate biomarkers to assess iron status. A major drawback of current genetic 
association studies is that they have been limited to populations of European ancestry. 
This is a problem as European populations contain only a subset of the human genetic 
variation present globally. Additionally, populations vary in terms of their allele 
frequencies, biological adaptations and other properties that may affect the detectability 
and importance of risk variants associated with iron status across populations.  
Before genetic markers associated with iron status are utilised in African populations at 
the public health level, they must be rigorously assessed using among others, association 
analyses. The research presented in this thesis is a step towards understanding the 
genetics of iron status in African populations using mainly the candidate gene approach. 
As presented in the general introduction, this research focussed on several research 
questions. 
The primary research question was therefore:  
Do the single nucleotide polymorphisms previously identified as being associated with 
iron status in non-African populations present with similar associations in African 
populations?  
The secondary research questions were:  
1. Are the minor allele frequencies of single nucleotide polymorphisms associated 
with iron status in African populations similar to those of non-African populations? 
2. How do the single nucleotide polymorphisms associated with iron status influence 
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In this chapter, we present the main findings determined in the studies presented herein 
and highlight some of the methodological considerations that may have impacted on 
their internal and external validity. Finally, we offer insights into future perspectives on 
investigating the genetics of iron status in African populations. 
6.1 Main Findings 
 
In this section, we discuss the contribution of our studies to the objectives previously 
stated, as well as to recent findings from other studies. The main findings are 
summarized in Table 6.1. 
A large number of GWA studies point to the importance of TMPRSS6  variants in iron 
metabolism in populations of European ancestry but no data is available from 
populations of African ancestry 
Before the start of this project, genetic epidemiological research into iron status markers 
or haematological measures focussed mainly on populations of European ancestry, with 
limited studies from populations of Asian ancestry [1-4]. These studies resulted in the 
conclusive identification of TMPRSS6 variants as being associated with iron status 
measures. In order to shed light on the contradictory findings from the different GWA 
studies and to evaluate the role of ethnicity as an explanatory factor, we performed a 
systematic review with meta-analysis of loci in the TMPRSS6 gene as identified in 
cohorts of various ancestry [5]. We observed that risk alleles in the key TMPRSS6 loci 
such as rs855791 and rs4820268 are associated with lower Hb and serum ferritin 
concentrations across both European and Asian ancestry populations. We also observed 
that there were differences in the minor allele frequencies of these variants across 
ethnicities investigated. Since there are currently no GWA studies on iron status 
parameters in African populations, genetic association studies conducted in African 
American populations can be leveraged to identify regions where African ancestral 
alleles are associated with iron status. At the time that we conducted the study selection 
for the review, only one study included information from a cohort of African ancestry. 
Since then, results from five GWA studies that were either conducted in African 
Americans only or included African Americans as part of cohorts studied have been 
reported [6-10]. In a paediatric cohort of 7943 African American children, no TMPRSS6  
variant reached genome wide significance in association testing with 8 haematological 
traits. This same study consisted of 6234 Caucasian children in which the variant 
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rs855791 was significantly associated with mean corpuscular haemoglobin as well as 
mean corpuscular volume [7]. In four other studies [6, 8-10] conducted among African 
American adults, there was no association of the TMPRSS6  loci with measures of iron 
status. These findings suggest that the genetic architecture of haematological traits may 
differ by ethnicity. This first study constructed the foundation for conducting the next 
studies described in Chapters 3 and 4. 
Our candidate gene association study in a cohort of South African women generally did 
not confirm findings from studies on the genetics of iron status in populations of 
European ancestry. Furthermore, the minor alleles of single nucleotide polymorphisms 
that were investigated were more common in populations of European ancestry 
compared to our South African cohort. 
The study described in Chapter 3 is the first extensive candidate gene association study 
on the genetics of iron status conducted in an African population. The candidate genes 
selected for genotyping were based on information from GWA studies conducted in 
populations of European ancestry [1-4]. We were generally unable to uncover genetic loci 
associated with iron status with convincing statistical evidence (p<0.05). Only two single 
nucleotide polymorphisms (SNPs) in TF (rs3811647 and rs1799852) were significantly 
associated with various iron status measures. These associations have previously been 
observed in European ancestry populations [11]. We also observed that generally the 
minor allele frequencies (MAFs) of investigated SNPs were lower than those of the 
populations of European ancestry included in the 1000 Genomes Project. Investigations 
on gene-gene interactions revealed that the chromosome 6 SNP allele combination (AAA) 
consisting of rs1799964 and rs1800629 both in TNF α and rs2071592 in the NFKBIL1 
was associated with higher odds for low serum ferritin concentrations. The TNF α and 
NFKBIL1 loci are both involved in the inflammatory response [12]. Elevated serum and 
tissue levels of TNF are found in inflammatory and infectious conditions [13, 14] and 
serum levels correlate with the severity of infections [15, 16]. Nuclear Factor-kappa B 
(NF-κB) which is encoded by NFKBIL-1, on the other hand is required for the 
transcriptional activation of the TNF α gene [17]. 
Our observation corroborated a previous finding in which a similar allele combination 
consisting of both  rs1799964 and rs1800629 as well as other loci was associated with an 
increased risk of iron deficiency in a cohort of West African children [12]. Though further 
investigations are required, this confirms that the regulation of iron status through 
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inflammatory pathways is an area necessitating of attention in African populations. One 
implication of this finding is that among other strategies, treatment of infectious 
diseases in African populations may be important in lowering the iron deficiency burden 
in African populations compared to other populations. Additionally, this finding suggests 
that assessment of iron status using serum ferritin (SF) may be less useful in Africa This 
is because the use of serum ferritin is limited due to confounding by inflammation [18]. 
Further candidate gene association studies in various cohorts of African ancestry pointed 
to TMPRSS6  variants as possibly being important in iron metabolism in African cohorts 
(Chapter 4), however, only few single nucleotide polymorphisms were associated with 
iron status measures. 
We performed a candidate gene association study involving various cohorts of African 
ancestry (Kenyan, Tanzanian and South African cohorts). Thereafter, meta-analyses of 
the genetic association results from these cohorts was conducted and compared with an 
African American cohort. The results of the meta-analyses point to the need to further 
investigate the influence of TMPRSS6 and TF loci on iron status in African populations. 
We additionally observed that the candidate SNPs genotyped were more common in 
European ancestry populations. This study further contributed to the evidence that 
genetic variants associated with iron status measures in cohorts of European ancestry do 
not necessarily translate into similar associations in cohorts of African ancestry. Further 
population specific studies are therefore required to uncover the genetic architecture of 
iron metabolism in African populations. 
It is vital to explore how information from genetic association studies may be useful in 
the African context. In Chapter 5, a study was performed to explore how single 
nucleotide polymorphisms within the tumour necrosis factor alpha (TNF α) gene 
(previously associated with iron status) influence malaria severity in a cohort of 
Tanzanian children.  
Iron is essential for the survival of the malaria parasite [19]. The relationship between 
TNF α (an inflammatory cytokine) and iron status, and by extension malaria severity, 
has been a subject of recent investigations. TNF α has previously been identified as a 
modifier of body iron status [17]. On the other hand, during P. falciparum malarial 
infection, the cytokine TNF α has been described as both protective and pathogenic [20]. 
It has further been reported that the SNPs (i.e. rs1799964, rs1799724, rs1800750, 
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rs1800629 and rs361525) in the promoter region of the TNF α gene have different 
associations with malaria in various populations [21-23].  
We investigated the association of two SNPs in the TNF α gene TNF−1031 (rs1799964) and 
TNF−308 (rs1800629) with malaria incidence and severity. It was observed that compared 
to their common allele variants, malaria rates were increased in those with the 
TNF‒1031CC genotype by 30-40%, but decreased in those with the TNF‒308AA genotype by 
84-87%. We found no evidence that either allele variant affected haemoglobin 
concentration at first episode of malaria, or that they modified the association between 
Plasmodium infection and haemoglobin concentrations at baseline. In this study, we 
concluded that replication studies and mechanistic studies are required to further 
validate our findings. Results from this study further underscore the need to treat 
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Table 6.1: Main findings of the studies described in this thesis 
Chapter Study design Study population Objectives Main Findings 
2 Systematic review 
with meta analyses 
Several European, Asian 
and mixed ancestry 
cohorts of varied ages 
Investigate potential inter-ethnic differences in 
associations of genetic variants within the transmembrane 
protease, serine 6 (TMPRSS6 ) gene with iron status 
indicators 
 Differences in minor allele frequencies (MAF) of 8 
TMPRSS6 SNPs (rs855791, rs4820268, rs2111833, 
rs1421312, rs228921, rs228918, rs228919 and 
rs575620) across investigated cohorts were observed; 
with the MAF of rs855791 considerably higher in 
Asian populations than in Caucasians (0.55 vs 0.42) 
 The A allele of rs855791 was associated with lower 
haemoglobin and ferritin concentrations and 
increased serum transferrin receptor and transferrin 
concentrations in all populations. Similar 
associations for the G allele in rs4820268 made.  
 No data from African cohorts 
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3 Candidate  
gene association study 
686 South African women 
(mean age: 50 years) 
Compare frequencies of minor alleles identified in 
populations of European ancestry to those of a South 
African cohort of women 
Investigate associations of reported SNPs with iron 
status in a female black South African cohort 
Investigate gene-gene interactions that influence iron 
status 
 MAFs were lower than those reported for European 
ancestry populations in the 1000 Genomes Project 
 Two SNPs in TF were associated with iron status: 
rs1799852 with decreased serum ferritin and body iron 
and increased serum transferrin receptor concentrations; 
rs3811647 with serum transferrin receptor and body iron 
(U-shaped association) 
 Chromosome 6 allele combination (AAA) consisting of 
rs1799964 and rs1800629, both in TNF α and rs2071592 
in NFKBIL1, was associated with higher odds for low 
serum ferritin  concentrations 
  
 The chromosome 22 allele combination (GG) of rs228918 
and rs228921 in the TMPRSS6 gene was associated with 
lower odds for increased sTfR concentrations 
 
4 Candidate  
gene association study 
686 South African  
women (mean age: 50 y)  
628 Kenyan children  
(mean age: 9 y)  
609 Tanzanian children  
(mean age: 3 y) 
228 African American men and 
women (mean age: 67 y) 
Compare minor allele frequencies between several 
cohorts of African ancestry 
Compare combined associations of 20 SNPs with 
markers of iron status between the African cohorts 
and an African American cohort 
Compare combined associations of 20 SNPs with 
markers of iron status between the African ancestry 
cohorts (including African American cohort) with 
findings from European ancestry cohorts 
 
 Minor allele frequencies of candidate SNPs were 
generally lower in the African ancestry cohorts as 
compared to Europeans in the 1000 Genomes Project 
 
 Associations of two TMPRSS6 single nucleotide 
polymorphisms, rs2413450 and rs4820268, with lower 
haemoglobin concentrations replicated in combined 
associations of all African cohorts, as well as African 
cohorts together with the African American cohort. 
 rs3811658 in TF associated with higher haemoglobin 
concentrations, rs1525892 in TF and rs228918 in 
TMPRSS6  with increased ferritin concentrations in 
combined associations of all African cohorts as well as 
African cohorts together with the African American 
cohort. These associations have previously been observed 
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5 Candidate  
gene  
association study 
581 Tanzanian children (mean 
age: 3 y) 
 
Assess the effect of SNPs at the TNF α locus 
rs1799964 (TNF‒1031) and rs1800629 (TNF‒308) 
allele variants on malaria incidence.  
 
Investigate the effect of these variants on the severity 
of malaria as indicated by haemoglobin concentrations 
at the time of presentation with febrile episodes as 
well as at baseline 
 
 Compared to their common genotype, malaria rates were 
increased in the TNF-1031GG genotype (hazard ratio, HR 
[95%CI]: crude 1.41 [1.01-1.97], adjusted 1.31 [0.97-1.76]) 
but decreased in those with the TNF ̵308AA genotype 
(crude HR: 0.13 [0.02-0.63], adjusted HR 0.16 [0.04-0.67]) 
 
 No evidence that allele variant of TNF‒1031 or TNF‒308 
affected haemoglobin concentration at first episode of 
malaria, or that they modified the association between 
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6.2 Methodological considerations 
 
We have already outlined some of the methodological aspects that may have impacted on 
results from the specific studies reported in Chapters 2, 3 and 4. In this section, we 
elaborate further on the methods used, from study design to data analysis, which could 
possibly impact on both the internal and external validity of our studies.  
The discovery of associations in an observational study is a fundamental first step in 
understanding disease aetiology [24]. We attempted to replicate findings of GWA studies 
from European ancestry populations in various African cohorts using the candidate gene 
association method and only found a few associations. It is possible that most of the 
previous observations were not replicated for the following reasons: 
 
Heterogeneity between our study populations and European cohorts 
Population heterogeneity across studies may lead to differences in associations. There 
exists in Africa today a rich diversity of environments (diet, geography, climate, 
pathogen exposure and many other factors) that likely act in concert to modulate iron 
status in ways that may overlap but may also be different than in non-African 
populations. It has been shown that including a non-confounding covariate associated 
with a quantitative trait is beneficial as it may explain some of the variability in the 
outcome, thus reducing noise and increasing power to detect genetic associations [25]. To 
address the effects of differences due to environments and factors specific to cohorts, we 
adjusted analyses for factors that could potentially influence iron status such as age, 
gender, iron intake, BMI and menopausal status.  
In terms of diet, the intake of animal foods are the most important dietary determinant 
of iron status of a population [26]. It is thus necessary to obtain information on dietary 
iron intake when conducting studies on the genetics of iron status. We included haem 
iron intake as a proportion of total dietary iron intake as a covariate in association 
analyses described in Chapter 3. In Chapter 4, total iron intake was included as a 
covariate in association analyses involving the African American cohort. There was 
however only a negligible difference in effect estimates between the crude model and the 
model adjusted for iron intake in this second case. We therefore did not adjust for iron 
intake in associations involving the African American cohort. We additionally did not 
adjust for iron intake in any of the cohorts involved in the study described in Chapter 4.  
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The finding that adjusting for iron intake had no impact on effect estimates within the 
African American cohort probably means that there are more important factors that 
determine iron status within this population. One explanation may be the effect of 
comorbidities, for example, chronic kidney disease that is increased among African 
Americans. However it has been observed that haemoglobin levels remain lower in 
African Americans than in white persons even after taking into account disease status, 
behavioural risk factors, nutritional intake, and iron status [27, 28]. This may point to 
the influence of polymorphisms retained in the genome that were previously useful in 
adaptation to environments of high inflammation found in Africa. For example, a recent 
study has reported a SNP in the Glucose-6-phosphate dehydrogenase (G6PD) gene to be 
significantly associated with ferritin in an African American cohort [6]. Glucose-6-
phosphate dehydrogenase (G6PD) deficiency due to polymorphisms in the G6PD is 
associated with protection from severe malaria, and potentially uncomplicated malaria 
phenotypes in African populations [29]. The genetics of iron status does therefore require 
further research in African American populations. Information on dietary iron intake 
was not available for the Tanzanian and Kenyan cohorts, implying that effect estimates 
obtained from analyses in these cohorts may be somewhat less precise.  
We additionally adjusted for age and gender in all analyses, and for inflammation for 
analyses involving ferritin concentrations. While dietary iron remains the foremost 
determinant of iron status, scientific evidence suggests that adiposity may also be a 
determinant of iron status [30]. An inverse association between adiposity and iron status 
has been observed [31-33]. Whereas studies have shown that adiposity might increase 
the risk of iron deficiency, adiposity has additionally been shown to induce elevation of 
ferritin concentrations [34]. This has been attributed to the fact that ferritin is an acute-
phase protein that may be elevated by the low-grade inflammation that occurs when 
adipose tissue is enlarged [32]. Menstrual blood loss has also been observed to affect iron 
status [35, 36]. When BMI and menopausal status were included as covariates in 
association analyses for the South African cohort there were negligible differences 
between the crude and adjusted models, indicating that these two factors may not be 
crucial in explaining the lack of associations between genetic factors and iron status in 
this cohort of women. 
Since the cohorts included in this thesis were not specifically designed to investigate the 
genetics of iron status, not all covariates of interest may have been assessed. This 
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especially relates to information on dietary iron intake as well as information on G6PD 
deficiencies and any thalassemias present. Since such important covariates are often not 
taken into account, association results from GWA studies may lack validity. Our studies 
therefore provide more accurate effect estimates than previously reported estimates as 
we took into account some of the covariates that explain iron status.  
 
Difference in minor allele frequencies and impact on sample sizes required 
In Chapters 3 and 4 we observed that the SNPs investigated in this thesis were 
generally less common in our cohorts compared to European ancestry populations. The 
statistical power to detect a significant association depends on the effect size of the 
association and the frequency of the allele of interest [37]. SNPs with low allele 
frequencies would need to have large effect sizes in order to be detected in a candidate-
gene study with small numbers. The sample sizes in Chapters 2 and 3 were therefore too 
small for estimation of small genetic effects with high precision (e.g. 780 individuals are 
required to conduct association analysis for a SNP explaining 1% of the variation in the 
outcome measure, with α = 0.05 and power 80%). Lack of power can be addressed by the 
combination of multiple studies by way of meta-analyses. Such studies have confirmed 
many associations that were unclear from individual study reports [38-40]. To overcome 
the sample size issue, we attempted to combine results from various African cohorts 
using meta-analytic methods in Chapter 4. In general, we were unable to replicate 
previously observed associations from populations of European ancestry apart from 2 loci 
in the TMPRSS6  gene (rs241450 and rs4820268) as well as rs3811658 in the TF gene.  
In Chapter 3, we have not observed associations with any TMPRSS6  variants probably 
due to the small sample size. As information from more genetic studies become available 
in Africa, meta-analytic methods as a means to increase power will continue to be a 
useful tool in identification of SNPs associated with low iron status. One of the SNPs 
that was significantly associated with serum ferritin in chapter 3, rs3811647 is in 
linkage disequilibrium (LD) with rs3811658. This further emphasizes the potential 
importance of the TF locus in determining iron status. 
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Difference in linkage disequilibrium structure between European ancestry populations 
and African cohorts 
It has previously been observed that European tag SNPs performed poorly in the African 
population, capturing only an average of 35% of SNP variation [41]. This could be due to 
differences in LD structure between the European ancestry populations and the African 
population. A genetic marker that is targeted in an association study may not be a 
disease-causing locus itself, but may be linked to a causal one, such that passage of the 
marker from one generation to the next is correlated with passage of the disease-causing 
mutation. The resulting linkage disequilibrium (LD) then yields a significant association 
between the marker and the disease itself. The degree of linkage disequilibrium (LD) 
may be less in individuals of recent African descent because of the greater variation in 
the genome within this group [42]. We did not examine linkage patterns between our 
cohorts so as to compare with those of European ancestry cohorts. Determining linkage 
disequilibrium in a pilot sample could have been useful to optimize SNP selection and 
could have provided information about possible haplotypes for analysis. This presents an 
area for further study. 
6.2.1  Implications of findings: Does information on genetics of iron status have practical 
applications? 
 
One of the questions from public health practitioners would be the manner by which 
information on the genetics of iron status could be utilized to influence population 
health. Genetic variation that confers subtle differences in nutrient requirements may 
exert greater effect in certain subgroups or populations and contribute to iron deficiency 
in certain environmental contexts. Much genetic variation associated with iron status 
remains undiscovered, especially in African populations that have existed in unique and 
diverse nutritional environments for many generations where adaptive alleles may have 
expanded. In suggesting a way forward, it is necessary to first state what practical 
implications our results may have especially concerning potential benefits for public 
health.  
We have observed that the TMPRSS6  as well as TF loci are important insofar as iron 
status in African populations is concerned. The TMPRSS6  SNPs, rs241350 and 
rs4820268, are quite common with MAFs of approximately 15% and 25% and reduction 
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of Hb of approximately 0.20 g/dL per copy of each minor allele. Although the reduction in 
Hb is not large, further research on the TMPRSS6  locus and its influence on iron status 
is required. This is because variants in this locus have consistently been associated with 
iron status measures. Additionally,  a significant proportion of the population harbours 
the minor alleles of these variants. We also demonstrated that rs1525892 in TF with a 
MAF of approximately 25% increased serum ferritin concentrations by approximately 1 
µg/L per copy of each minor allele in African populations. Other polymorphisms in TF 
(rs17999852 and rs3811647) were also associated with iron status measures in the 
population of black South African women. Since the effect sizes of these variants were 
small and the fact that the polymorphisms were not present in large proportions of the 
population, the application of these findings for public health may be limited at present. 
However, this does not preclude the need for further studies to investigate these loci. 
One of the examples of the manner in which genetics can be applied to influence public 
health is the case of the hereditary hemochromatosis. Hereditary hemochromatosis (HH) 
due to mutations in the HFE gene are associated with iron overload, which is a strong 
risk factor for several non-communicable diseases [43, 44]. The HFE gene Cys282Tyr 
polymorphism has already affected government policy, with Denmark and Sweden 
stopping their iron fortification policies, in part because of a potential risk to persons at 
risk of hereditary hemochromatosis [45, 46]. In the case of iron deficiency in African 
populations, the discovery of loci that predispose populations or sub groups to iron 
deficiency could lead to a refinement of iron fortification or supplementation policies. In 
terms of having a further impact on strategies that address iron deficiency, we have also 
observed findings that support current efforts to treat malaria in malaria endemic areas 
as a means to alleviate iron deficiency. We found that the TNF‒1031 CC (MAF 22%) is 
associated with increased malaria rates. This SNP has previously been identified as a 
risk factor for iron deficiency [12]. It therefore follows that treatment of malaria in an 
area where this SNP is common would substantially reduce prevalence of iron deficiency. 
Genetics may also redefine how iron adequacy or inadequacy is defined. Recommended 
dietary allowance (RDA) for a particular nutrient is defined based on development of 
deficiency diseases, but with greater understanding of the genetics of iron status, it may 
be possible to formulate more appropriate RDAs to prevent iron deficiency. 
Finally, investigating the genetics of iron status may also aid in development of reliable 
biomarkers to define iron deficiency. Currently, commonly used biomarkers of iron 
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status, sTfR and serum ferritin, lack sensitivity and specificity as they are influenced by 
inflammation [47]. Novel biomarkers may be used in future to identify population groups 
that would benefit most from strategies to address iron deficiency. For example, recently, 
a study has found that the expression of the iron hormone hepcidin distinguishes 
different types of anaemia in African children [48]. Therefore, a better understanding of 
the molecular regulation of iron metabolism may lead to the discovery of new 
biomarkers.  
 
6.3 Future directions: which way forward? 
 
The increasing availability of high throughput genotyping technologies makes it 
plausible that genetic association studies will continue and will in the future provide 
useful information on the genetics of iron status. However, because we have shown that 
many of the loci previously associated with iron status in populations of European 
ancestry are not replicated in African populations, it may be necessary to conduct GWA 
studies within the latter to discover novel loci associated with iron status. After the 
GWA studies have been conducted, candidate gene studies can be used to validate 
findings as well as explore the interactions between genes with factors such as age, 
gender, and other demographic characteristics. 
To more specifically identify genetic markers associated with iron deficiency, fine 
mapping studies are required. Fine mapping is the process of searching a region 
identified by GWA studies for possible risk alleles, and they can be used to precisely 
characterise risk alleles for certain conditions. An example of this is the fine mapping of 
associations of the fat mass and obesity associated (FTO) gene locus with BMI and 
diabetes [49]. Knowledge about exact location of risk alleles for iron deficiency can 
preclude the need for investigations based on marker loci, thus reducing the error and 
variability in association testing.  
Animal models present a useful option to elucidate action of polymorphisms identified 
from fine mapping studies. With animal studies, it is possible to control iron intake and 
environmental factors rigorously in the different groups under study. Knockout mice are 
particularly important for studying the role of reported genes whose functions have not 
been determined. Knockout mouse models have been extensively used to study the 
regulation of TMPRSS6   and its activity [50, 51]. However, these models have not yet 
been used to study the response to dietary iron at different concentrations. Animal 
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models are advantageous in that dose response questions can be assessed in ways that 
are difficult in human studies. Establishment of exposure challenge-response data is 
critical to a better understanding of the mechanism, and ultimate relevance, to iron 
deficiency. 
Finally, several options exist to conduct human studies to assess action of risk alleles in 
the presence of high or low iron diets. In Africa specifically, the potential to conduct 
intervention studies investigating the genetics of iron status is largely untapped. One 
option is to conduct targeted intervention studies in which individuals with or without 
risk alleles are involved. This would provide a clearer picture of the manner in which 
individual factors such as age and gender, as well as diet, interact with genes to 
influence eventual iron status. Another option is to incorporate collection of DNA 
samples as part of biological material collected from participants within the numerous 
micronutrient intervention studies that are ongoing. This information may help to 
explain the heterogeneity in response to iron interventions. DNA material may also be 
collected immediately after interventions to determine gene expression. Such functional 
studies will assist to confirm the role of putative polymorphisms in iron deficiency. 
The studies described in this thesis only provide a first attempt towards the 
understanding of the genetic regulation of iron status in African populations. The 
potential underlying the discovery of novel variants associated with iron deficiency 
would offer opportunities towards combating iron deficiency in African populations. This 
thesis higlights the need for population-specific systems biological approaches to unravel 
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Anaemia has been associated with increased mortality and morbidity as well as with 
decreased physical functioning and quality of life. On average, globally, 50% of anaemia 
is assumed to be attributable to iron deficiency. There exists in Africa today a rich 
diversity of environments (diet, geography, climate, pathogen exposure and many other 
factors) that likely act in concert to influence the development of iron deficiency. Of 
interest is the manner in which genetic factors interact with environmental factors such 
as diet to increase susceptibility to iron deficiency. Understanding the genetics of iron 
status is key to optimizing strategies to address iron deficiency as well as discovering 
appropriate biomarkers to monitor iron status in populations.  
With the success of genome-wide association (GWA) studies, many common genetic 
variants underlying iron status have been uncovered. These genetic loci could refine the 
biological understanding of iron metabolism and in so doing, contribute to strategies to 
address iron deficiency. Furthermore, this would also impact on the development of 
appropriate biomarkers to assess iron status. As European populations contain only a 
subset of the human genetic variation present globally, this limits transferability of 
association results to African populations. Additionally, African populations when 
compared to European populations vary in terms of their allele frequencies and 
biological adaptations which are all factors that may affect the detectability and 
importance of risk variants associated with iron status. Before markers associated with 
iron status are utilised in African populations at the public health level, they must be 
rigorously assessed using among others, association analyses. 
 
In Chapter 2, we performed a systematic review with meta-analysis of loci in the 
TMPRSS6 gene that have previously been associated with iron status measures in 
European ancestry cohorts. This study was performed in order to get a more precise 
evaluation of identified TMPRSS6  single nucleotide polymorphism associations with 
iron status in cohorts of differing continental ancestry. We observed that risk alleles of 
the key TMPRSS6  variants such as rs855791 and rs4820268 are associated with lower 
Hb and serum ferritin concentrations across both European and Asian ancestry 
populations. We also observed that there were differences in the minor allele frequencies 
of these variants across ethnicities investigated. At the time that we conducted the study 
selection for the review, only one study included information from a cohort of African 
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In Chapter 3, we report the results of the first extensive candidate gene association 
study on the genetics of iron status conducted in a population of black South African 
women. The candidate genes selected for genotyping were based on information from 
GWA studies conducted in populations of European ancestry. We were generally unable 
to uncover genetic loci associated with iron status measures with convincing statistical 
evidence (p<0.05). Minor allele frequencies (MAF) of the investigated SNPs from the 
female participants in the PURE population were lower compared to those of males and 
females of European ancestry populations in the 1000 genomes project. In the TF gene, 
the single nucleotide polymorphism (SNP) rs1799852 was associated with decreased 
serum ferritin (p=0.01) and body iron (p=0.03) and increased serum transferrin receptor 
(sTfR) concentrations (P=0.004), while rs3811647 was associated with transferrin 
receptor and body iron (both P=0.03). The chromosome 6 SNP allele combination (AAA) 
consisting of rs1799964 and rs1800629 both in TNF α and rs2071592 in NFKBIL1 was 
associated with higher odds of low serum ferritin concentrations (serum ferritin<15µg/L; 
OR:1.86 (95%-CI, 1.23-2.79)). The chromosome 22 SNP allele combination (GG) 
consisting of rs228918 and rs228921 in the TMPRSS6  gene was associated with a lower 
odds of  increased sTfR concentrations (sTfR>8.3mg/L; OR:0.79 (95%-CI,0.63-0.98). 
 
In Chapter 4 we investigated single nucleotide polymorphisms associated with iron 
status in several cohorts of African ancestry. This was a candidate gene association 
study and thereafter, meta-analyses of the genetic association results from the 
individual African cohorts (Kenyan, Tanzanian and South African) was undertaken to 
compare these results to association results of an African American cohort. We also 
combined all results from the four cohorts and compared this to previous association 
findings from cohorts of European ancestry. We successfully replicated reported 
significant associations with lowered haemoglobin concentrations for two variants in 
TMPRSS6  (rs2413450 and rs4820268) and with increased haemoglobin concentrations 
for one variant in TF (rs3811658). When ferritin was considered as an outcome measure, 
we replicated associations with increased ferritin concentrations in two loci namely 
rs228918 in TMPRSS6  and rs1525892 in TF (P<0.05 for all significant associations). No 
other significant associations with either concentrations of haemoglobin or serum 
ferritin were observed. 
 
In Chapter 5 a study to explore the association of two SNPs in the TNF  α gene namely 
TNF−1031 (rs1799964) and TNF−308 (rs1800629) with malaria incidence and severity in a 
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cohort of Tanzanian pre-school children was conducted. Our main finding was that 
compared to their common allele variants, malaria rates were increased in those with 
the TNF‒1031 CC genotype by 30-40%. We determined no evidence that either allele 
variant affected haemoglobin concentration at first episode of malaria, or that they 
modified the association between Plasmodium infection and haemoglobin concentrations 
at baseline.  
Finally, the main findings and the methodological aspects that may have impacted on 
internal and external validity of our findings are discussed in Chapter 6. The public 
health implications and recommendations, and directions for future research are also 
presented.  
To our knowledge the work presented herein presents the first extensive investigation of 
the genetics of iron status in African populations. In conclusion, we observed that most 
of the associations previously identified in populations of European ancestry do not 
replicate in African ancestry populations. Additionally minor allele frequencies of single 
nucleotide polymorphisms associated with iron status in European ancestry cohorts are 
higher than those of African ancestry populations. This finding may indicate that novel 
loci may be responsible for the heritability of iron status in African populations. The 
observation that a common TNF α variant TNF−1031 (rs1799964) increased malaria rates 
indicates that to alleviate iron deficiency in malaria endemic areas- prevention and 
treatment is necessary. This is because malaria is known to negatively impact on iron 
status. Based on our observations, further investigations are necessary to uncover 
genetic variants associated with iron status in African populations. Several important 
factors should be taken into consideration in the design and execution of future 
association studies such as sample size, and collection of all information that could 
impact on iron status such as dietary iron intake, age, and measures of inflammation. 
Furthermore mechanistic studies would be useful to further ascertain action of identified 
variants. Single nucleotide polymorphisms that influence iron status will continue to 
help advance our understanding of iron metabolism and homeostasis. Besides 
contributing towards the development of biomarkers that are devoid of the shortfalls of 
current iron status biomarkers, unravelling the genetics of iron status is promising in 
efforts aimed at optimizing strategies to address iron deficiency.  
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Bloedarmoede is geassocieerd met verhoogde mortaliteit, morbiditeit en met een 
verminderd fysiek functioneren en kwaliteit van leven. Wereldwijd wordt aangenomen 
dat ongeveer 50% van de bloedarmoede komt door een tekort aan ijzer. Vandaag de dag 
zijn er in Afrika een veel factoren (dieet, geografische ligging, klimaat, blootstelling aan 
ziektekiemen en vele andere factoren), die wellicht in combinatie met elkaar de 
ontwikkeling van ijzertekort beïnvloeden. De wijze waarop genetische factoren samen 
hangen met milieufactoren, zoals dieet, is van belang in de ontwikkeling en vatbaarheid 
van een ijzertekort. Inzicht in de genetica van ijzerstatus is de sleutel tot het 
optimaliseren van strategieën om ijzertekort te verminderen, evenals het ontdekken van 
geschikte biomarkers om de ijzerstatus in populaties te monitoren. 
Met succesvolle genoombrede associatie (GWA) studies zijn veel gemeenschappelijke 
genetische varianten die met ijzerstatus verbonden zijn ontdekt. Met deze genetische 
varianten is de kennis van het ijzer metabolisme vergroot en daarnaast heeft het 
bijgedragen aan de ontwikkeling van strategieën om ijzertekort aan te pakken. 
Bovendien heeft dit ook invloed op de ontwikkelen van geschikte biomarkers voor het 
monitoren van de ijzerstatus. Omdat de Europese bevolking slechts over een klein deel 
van de wereldwijd beschikbare menselijke genetische variatie beschikt, wordt de 
generaliseerbaarheid van resultaten naar de Afrikaanse bevolking beperkt. Daarnaast 
varieert de Afrikaanse populatie in vergelijking met Europese populaties qua allel 
frequenties en biologische aanpassingen, allemaal factoren die invloed hebben op de 
detecteerbaarheid en het belang van risico varianten die verbonden zijn met ijzerstatus. 
Voordat biomarkers die geassocieerd zijn met ijzerstatus worden ingezet op 
volksgezondheidsniveau voor de Afrikaanse populatie, moeten ze eerst grondig 
onderzocht worden met onder andere associatie studies. 
In hoofdstuk 2 hebben we een systematisch review inclusief meta-analyse uitgevoerd 
met loci in het TMPRSS6 gen waar in eerdere studies, in cohorten met een populatie van 
Europese afkomst, associaties zijn gevonden met ijzerstatus. Deze studie werd 
uitgevoerd om een nauwkeuriger beeld te krijgen van de eerder geïdentificeerde 
associatie van het TMPRSS6 single nucleotide polymorfisme met ijzerstatus in cohorten 
van verschillende continenten. 
We vonden dat risico-allelen van de belangrijkste TMPRSS6 varianten zoals rs855791 en 
rs4820268 een associatie vertoonden met lagere Hb en serum ferritine concentraties voor 
zowel populaties van Europese als Aziatische afkomst. We hebben ook geconstateerd dat 
er verschillen waren in de minor allel frequenties van deze varianten voor verschillende 
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etnische groepen. Op het moment dat we de studies selecteerden voor inclusie in de 
review, werd slechts één onderzoek gevonden met informatie over een cohort van 
Afrikaanse afkomst, in dit geval van Afro-Amerikanen. Er was geen informatie 
beschikbaar over Afrikaanse bevolkingen. 
In hoofdstuk 3 beschrijven we de resultaten van de eerste grote kandidaat-gen associatie 
studie over de genetica van ijzerstatus, uitgevoerd onder zwarte Zuid-Afrikaanse 
vrouwen. De onderzochte selectie van kandidaat-genen voor genotypering waren 
gebaseerd op informatie van GWA studies in populaties van Europese afkomst. Wij 
hebben geen overtuigend statistisch bewijs gevonden (p<0,05) dat specifieke genetische 
loci geassocieerd zijn met ijzerstatus. Minor allel frequenties (MAF) van de onderzochte 
SNP's van de vrouwelijke deelnemers van de PURE populatie waren lager dan die van 
mannen en vrouwen van Europese kom af uit het 1000 genome project. In het TF-gen, 
werd een associatie gevonden tussen de enkel-nucleotide polymorfie (SNP) rs1799852 en 
een verlaagd serum ferritine (p=0,01) en lichaamsijzer (p=0,03) en verhoogde serum 
transferrine receptor (sTfR) concentraties (P=0,004), terwijl rs3811647 was geassocieerd 
met de transferrine receptor en lichaamsijzer (beide P=0,03). De chromosoom 6 SNP allel 
combinatie (AAA) bestaande uit rs1799964 en rs1800629, beide in TNF α en rs2071592 
in NFKBIL1, waren geassocieerd met een verhoogde kans op lage serum ferritine 
concentraties (serum ferritine <15 ug/L, OR: 1,86 (95%BI, 1,23 -2,79)). De chromosoom 
22 SNP allel combinatie (GG), bestaande uit rs228918 en rs228921 in het TMPRSS6 gen, 
werd geassocieerd met een lagere kans op verhoogde concentraties sTfR (sTfR> 8.3mg L, 
OR: 0,79 (95%BI, 0,63-0,98). 
In hoofdstuk 4 onderzochten we enkel-nucleotide polymorfismen die geassocieerd zijn 
met ijzerstatus in verschillende Afrikaanse cohorten. Dit was een kandidaat-gen 
associatie studie en daarna werden meta-analyses van de resultaten van de genetische 
associaties van de individuele Afrikaanse cohorten (uit Kenia, Tanzania en Zuid-Afrika) 
vergelijken met de resultaten van een Afro-Amerikaans cohort. We hebben ook alle 
resultaten uit de vier cohorten gecombineerd en vergeleken met eerdere bevindingen uit 
Europese. Wij hebben met succes associaties gereproduceerd voor verlaagde hemoglobine 
concentraties met twee varianten in TMPRSS6 (rs2413450 en rs4820268) en voor een 
verhoogde hemoglobine concentratie met één variant in TF (rs3811658). Wanneer 
ferritine als uitkomstmaat werd genomen, hebben we associaties gereproduceerd voor 
verhoogde ferritine concentraties met twee loci namelijk rs228918 in TMPRSS6 en 
rs1525892 TF (P<0,05 voor alle significante associaties). Verder werden geen significante 
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associaties met hemoglobine of serum ferritine concentraties waargenomen. 
In hoofdstuk 5 is een studie beschreven die de associatie verkent tussen twee SNPs in 
het TNF α-gen namelijk TNF-1031 (rs1799964) en TNF-308 (rs1800629) en het optreden 
en de ernst van malaria aanvallen in een cohort van Tanzaniaanse kinderen. Onze 
belangrijkste bevinding was dat in vergelijking met hun gemeenschappelijke allel 
varianten, een verhoging van 30-40% van malaria bij kinderen met het TNF-1031 CC 
genotype werd gevonden. We vonden geen bewijs dat een van beide allel varianten het 
hemoglobinegehalte beïnvloed bij de eerste malaria aanval, of dat de associatie tussen 
Plasmodium infectie en hemoglobine concentratie veranderde bij aanvang van de studie. 
Tot slot, worden de belangrijkste bevindingen en de methodologische aspecten die 
mogelijk invloed hebben gehad op de interne en externe validiteit van onze bevindingen 
besproken in hoofdstuk 6. Daarnaast worden ook de implicaties en adviezen voor de 
volksgezondheid, en aanbevelingen voor toekomstig onderzoek beschreven. 
Voor zover wij weten is het werk dat hier gepresenteerd word het eerste uitgebreide 
onderzoek naar de genetica van ijzerstatus in de Afrikaanse populatie. We concluderen 
dat de meeste associaties die eerder geïdentificeerd zijn in Europese populaties niet zijn 
gevonden in Afrikaanse populaties. Daarnaast zijn minor allel frequenties van enkel-
nucleotide polymorfismen geassocieerd met ijzer-status in Europese cohorten hoger dan 
in Afrikaanse populaties. Deze bevinding duidt er op dat nog niet ontdekte enkel-
nucleotide polymorfismen de ijzerstatus in de Afrikaanse populatie zouden kunnen 
beïnvloeden. De waarneming dat bij een veel voorkomende TNF-α variant, TNF-1031 
(rs1799964), malaria vaker voorkwam geeft aan dat om ijzertekort te verminderen in 
malaria endemische gebieden- preventie en behandeling noodzakelijk is. Te meer omdat 
het bekend is dat malaria een negatieve invloed heeft op de ijzerstatus. Op basis van 
onze observaties, is nader onderzoek nodig om genetische varianten geassocieerd met 
ijzerstatus in de Afrikaanse populatie te onderzoeken. Een aantal belangrijke factoren 
moeten in aanmerking worden genomen in het ontwerp en de uitvoering van 
toekomstige associatie studies zoals de steekproefgrootte, en het verzamelen van alle 
belangrijke gegevens die van invloed kunnen zijn op ijzerstatus zoals ijzer uit de 
voeding, leeftijd, en het vaststellen van de aanwezigheid van ontstekingen. Verdere 
mechanistische studies zouden nuttig zijn om de specifieke actie van de geïdentificeerde 
varianten nader vast te stellen. Enkel-nucleotide polymorfismen die ijzerstatus 
beïnvloeden zullen helpen tot een beter begrip van ijzer metabolisme en homeostase. 
Naast een bijdrage aan de ontwikkeling van biomarkers die niet beïnvloed worden door 
Samenvatting 
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de tekortkomingen van de huidige ijzerstatus biomarkers, is het ontrafelen van de 
genetica van ijzerstatus veelbelovend voor de inspanningen die gericht zijn op het 
optimaliseren van strategieën om ijzertekort te verminderen. 
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